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Introduction, background, research questions and methods 
Introduction 
One of the few certainties that life holds for us is the inevitability of death; it comes to us all. Despite 
its inevitability, many people do not prepare for their own death and do not discuss their preferences for 
care at the end of life, either with their families or with health care professionals. Advance care planning 
(ACP) is a process of discussion about future care between a capable patient, their professional carers, 
and their family and friends1-3. The rationale behind ACP is that it provides information to health care 
professionals and relatives about a person’s wishes and preferences in case the time comes when they 
are unable to express themselves. ACP is also a possible means by which people can exert greater control 
over their treatment, often but not exclusively relating to end-of-life issues4. While essentially simple in 
conception, the process of ACP encompasses many complexities in practice that hinder both patients 
and health care professionals from initiating such conversations5;6. The initiation of ACP may be most 
appropriate with a health care professional who knows the patient well7;8 and in Belgium, as in many 
other countries, this is likely to be their general practitioner (GP). The present dissertation aims to 
contribute to the field by describing the Belgian public’s involvement in ACP and their information 
preferences when facing a life-limiting illness, providing insights into the complexities of ACP for GPs 
and developing a complex intervention to support the initiation of ACP in general practice.  
Firstly, we will provide a short background and guide the reader toward the objectives of this dissertation. 
The wider demographic developments, advances in medical technology and the increased value of 
personal autonomy and self-determinations that took place in modern society are broadly outlined. 
Secondly, a brief history of ACP is given along with the possible outcomes of the process of ACP in 
Belgium. Thirdly, an explanation is provided of why this dissertation aims to study public opinion on 
ACP on the one hand and gives particular attention to ACP in general practice on the other hand. Lastly, 
the research questions, the study design and methodologies used for this dissertation are discussed, and 
the outline of this dissertation is specified. 
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Background 
Due to advances in medical knowledge and technological innovation, aiming care at prolonging life as 
much as possible has become more than ever a realisable option. The ability to keep people alive using 
potentially burdensome and invasive medical procedures has evolved, but there has also been an 
increasing realisation by patients and health care professionals that life-prolonging treatments are not 
always appropriate9. While evolving treatments have had enormous benefit, they are not infallible or 
without the potential for adverse outcomes. In many circumstances, treatments may prolong a person’s 
life or merely the dying process at the expense of quality of life, in such a way that the person themselves 
may not have wished to receive that particular treatment if they had been given the choice. 
Understandably, many people want to be involved in these important decisions and the concept of 
recording wishes about medical treatment in advance has evolved as a result. In the past it was more 
common for doctors and other health care professionals to protect patients from bad news, such as the 
diagnosis or prognosis of a life-threatening disease (paternalism). But there has been a change in public 
attitudes and the deontology of physicians towards a growing openness about such issues and the 
involvement of patients in health care decisions10;11, although this does not apply to everyone12;13.  
Increased value is being put on personal autonomy in modern societies – exercising one’s own choices 
about treatment - and the right to self-determination, and these values are also increasingly being 
recognized at the end of life14;15. One of the key aspects of good quality care at the end of life is that the 
care provided is in accordance with the patient’s wishes16;17. Internationally, there is consensus that to 
achieve this goal good communication and information is an important prerequisite18. Discussions about 
which care and treatments are desired at the end of life can take place at the moment when a patient’s 
situation requires it. However, it may be difficult for relatives and/or physicians to make decisions when 
they are not sure what the patient would have wanted, especially in situations of high medical emergency 
when patients lack the capacity to make decisions or when their cognitive function is restricted.  
 
Advance Care planning 
Advance care planning (ACP) provides a means of increasing the congruence between a patient’s wishes, 
values and needs and their future care19. ACP is a voluntary process of communication between the 
patient, their healthcare providers and their family and important others, regarding the kind of care that 
will be considered appropriate when the patient is unable to make decisions about care20;21. It is a 
multistage communication process to achieve a shared understanding of the patient’s current state of 
health, their goals of care and their values and preferences for future treatment and end-of-life care22. 
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Brief history: a shift from static documentation of specific treatment preferences towards an on-going 
process of communication about a patient’s wishes 
Advance care planning (ACP) initially began in the USA as a movement to establish advance directives 
(ADs) to refuse treatment, also known as living wills. Emphasis was mainly put on the documentation 
of an agreement regarding medical care between the physician and patient. It was considered necessary 
to jointly prepare and complete a document regarding the patient’s wishes and to record this document, 
for example in the patient’s medical file23.  
The concept of an AD or a living will was initially proposed in 1969 in the USA as a legal mechanism 
to guide the use of potentially life-prolonging medical treatments. It was embedded in US legislation 
following two high profile cases in the 1970s and 1980s which involved the withdrawal of life support 
from two young women left in persistent vegetative states, Karen Quinlan and Nancy Cruzan24. In the 
Nancy Cruzan case, it took 7 years before her parents were authorized to withdraw her artificial life 
support. As a direct result of the Nancy Cruzan case, the Patient Self-Determination Act was passed in 
1991, providing a legal basis for living wills and with the aim of encouraging competent adults to 
complete ADs24. The Patient Self-Determination Act requires health care facilities receiving Medicare 
and Medicaid funding to ask incoming patients whether they have an AD and if not, to provide written 
information on treatment options, right-to-die information, and AD forms to adult patients25;26. 
As a result of developments in the USA, ADs have gradually been introduced in other countries, which 
for the first time allowed individuals to specify their choices regarding medical treatment before the loss 
of capacity. Yet, despite the legal and pragmatic utility of these documents, their uptake remains limited. 
Evidence also shows that there is no guarantee that these documents improve end-of-life care or 
correspond with future care preferences27-30. More recently, there has been growing recognition that the 
completion of documents alone is insufficient to ensure that patients receive care that is consistent with 
their values and preferences. ADs are too narrowly focused on the patient’s right to refuse unwanted life 
sustaining treatment, they are often physically unavailable when needed, too vague to be useful in 
decision-making or at odds with the patient’s current clinical circumstances.  
Following the evidence regarding the limitations of ADs, a new model of ACP emerged in the mid-
1990s in which emphasis is placed on the potential for discussions instead of documents31. While the 
traditional model of ACP was mainly focused on preparing for the incapacity of patients by having 
specific treatment choices on paper, the developing model of ACP also focuses on empowering 
competent patients to have a say about their care and treatments1;32. ACP is now defined as a 
comprehensive, on-going process of communication by which patients discuss and reflect with their 
care providers upon topics such as wishes and goals for future care or treatment, quality of life, decision-
making preferences, fears and anxieties, and also palliative care options, do-not-resuscitate orders, end-
of-life decisions and surrogate decision-making in case of evolving disease stages33;34. These discussions 
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may or may not result into the documentation of a patient’s preferences in ADs and are a potential 
outcome of the ACP process35;36.  
ACP allows health care providers and relatives to better assess what the patient’s wishes would be in a 
given situation if they lose capacity. Therefore, ACP has the potential to improve end-of-life care by 
enabling patients to discuss and record their future health and care wishes and also to appoint someone 
as an advocate or surrogate, thus increasing the likelihood of these wishes being known and respected 
at the end of life37.  
In Belgium, the increased societal value of patient autonomy is reflected in the law on patient rights 
from 200238. The law on patient rights, together with the law on palliative care and law on euthanasia 
(2002), forms the legal framework of ACP in Belgium39;40. The law on patient rights states that every 
patient has a right to quality care that meets their needs. In addition, each patient is entitled to all 
information that is needed to gain insight into their illness condition and its probable evolution. Patients 
have the right to be informed in advance about; and to consent to any intervention by the practitioner38. 
Furthermore, patients are always entitled to good care and, more specifically towards the end of life, 
patients have a right to good palliative care. 
 
Documentation of Advance Care Planning 
The content of ACP discussions can be placed on record, if a patient chooses to do this. The exact form 
of implementation and the terms used, differ across states and countries41. For the purpose of 
documenting ACP discussions, a number of possibilities are available in Belgium:  
Advance Directive (AD) to refuse treatment. Valid and applicable ADs are legally binding statements 
(written documents) that allow patients to refuse specific medical treatments if they lose capacity in the 
future. This may involve the refusal of cardiopulmonary resuscitation, mechanical ventilation, 
antibiotics, admission to the intensive care unit, etc. An AD to refuse treatment is basically indefinite 
and can always be withdrawn by the patient as long as they have capacity. This AD only comes into 
effect when the patient loses capacity. 
Nomination of a surrogate decision-maker. The law also allow patients to appoint a specific surrogate 
decision maker via an advance directive, who has the authority to represent the patient if and as long as 
the patient lacks the capacity to exercise his or her rights. The designation of a surrogate decision-maker 
must be done in writing and is binding until the patient revokes this. The designated surrogate decision 
maker may, but does not need to, be a family member. The directive must be signed by the patient and 
the designate surrogate decision-maker with the date indicated. If the patients does not designated a 
specific surrogate decision maker, the following sequence is used: the (cohabiting) partner, an adult 
  General introduction 
15 
 
child, a parent, an adult brother or sister. The highest in rank is the authorized surrogate decision-maker, 
even if family members lower in rank disagree with a decision taken. If nobody wants to perform this 
task, or if nobody is available to perform this task, a professional can take over the task of surrogate 
decision maker by means of multidisciplinary consultation, which is also the case when surrogate 
decision makers of the same rank disagree. In all cases where the surrogate decision-maker would take 
a decision that manifestly puts a patient’s health at risk, a professional may overrule and make a decision 
in the best interest of the patient.  
Advance statements. These are statements in which the patient can set out general wishes or personal 
values and views about future care and treatment. They can be about medical treatment or about social 
aspects of care, such as palliative sedation, admission to a care home, funeral arrangements, pain 
management, etc. These advance statements are also called “positive” ADs because they are about what 
patients would still want if they could no longer ask for it themselves, as opposed to ADs to refuse 
treatments or examinations. These advance statements are not legally binding for physicians.  
Belgium is a specific case as it recognizes a type of positive AD that does not exist in most other 
countries. People in Belgium can draft an indicative advance directive on euthanasia in case they find 
themselves in specific situations of incapacity42. The law on euthanasia allows people with mental 
capacity to draw up a prior declaration of intent to request euthanasia should they be in an irreversible 
state of unconsciousness and no longer able to ask for euthanasia themselves. This AD must be recorded 
in writing and signed by two adult witnesses, of which one must not have any material interest regarding 
the patient’s death. Patients can withdraw their AD on euthanasia at any time40. The maximum period 
of validity for this AD is five years and must therefore be reconfirmed regularly. If not reconfirmed, it 
cannot legally come into effect. An AD for euthanasia is not legally binding and only acts as a guide for 
the treating physician. These statements may be officially registered (at the city hall), but this is not 
mandatory. 
 
The evidence base of Advance Care Planning 
Several intervention studies have identified benefits which result from ACP, although they report mixed 
results19;43. Among the largest and most frequently cited is the US SUPPORT study (Study to Understand 
Prognoses and Preferences for Outcomes and Risks and Treatments), in which nurse facilitators 
undertook discussions with seriously ill hospitalized patients and families to document their 
preferences44. It was found that this intervention, based around the completion of AD forms which were 
then made available to patients’ physicians, showed no improvement in patient control over their 
treatment. Moreover, this intervention had no impact on the style of communication between doctor and 
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patient, on the incidence or timing of do-not-resuscitate orders, or on the knowledge that doctors 
reported they had about a patient’s preferences. 
In the last years a number of studies have been published which shed light on the particular contribution 
that ACP, as a process of communication, can make to the quality of life of patients and families. A 
more recent randomised trial of ACP showed improved patient and family satisfaction and alleviation 
of anxiety in relatives of hospitalised patients45, which was confirmed by an observational study46. Other 
randomised trials and observational studies have shown that ACP increases the occurrence of 
discussions on prognosis, end-of-life issues and ADs47;48, improves concordance between patient’s 
preferences and end-of-life care received49;50 and improves quality of care at the end of life in different 
adult populations51. ACP is also often considered a means of making better use of healthcare resources 
at the end of life, however cost-effectiveness studies are still lacking52.  
Qualitative studies indicated that many patients see ACP as having other important roles besides 
enhancing the patient’s autonomy in healthcare decisions, such as lessening the burden on families and 
increasing trust and understanding between family members and with health professionals53;54. Health 
professionals seem to have similar views, seeing the value of ACP not only in terms of allowing a 
patient’s wishes to be honoured but also in giving peace of mind to patients and encouraging meaningful 
communication between family members about end-of-life issues55. These studies show the importance 
of the process outcomes of ACP, illustrating how ACP may be a means for communication about the 
end of life through enhancing mutual understanding and openness, enabling discussion of concerns, 
relieving burden and fears about the burden of decision-making for surrogate decision-makers, and 
strengthening family ties56.  
Previous systematic reviews have shown that encouraging health professionals’ involvement in ACP 
were most effective in increasing the uptake of ACP, whereas educational interventions directed at 
patients were least effective27;28;57, hence the choice of developing an intervention to improve ACP 
directed at health care professionals. 
 
The need to improve Advance Care Planning in general practice 
Evidence based guidelines recommend that ACP discussions should ideally be initiated in primary care 
or in the outpatient setting before individuals become acutely unwell21;58. In the Belgian health care 
system, GPs are core providers of medical care. The majority of people (95%) in Belgium also have a 
fixed GP with whom they have often built up a long-term relationship59;60. They are likely to have good 
clinical and contextual knowledge of their patients and are therefore considered ideally placed to initiate 
an ACP discussion in a timely manner61.  
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However, research shows that the practice of ACP among GPs in Belgium remains limited16;62. A cross-
national mortality follow-back study was undertaken in 2009-2010 via representative nationwide 
Sentinel Networks of GPs in Belgium, the Netherlands, Italy and Spain to investigate the prevalence 
and characteristics of two aspects of ACP in the last three months of life in each country: 1) GP-patient 
discussion of treatment preferences and 2) the nomination of a surrogate decision-maker (verbally or in 
writing)62. This study showed that, in a population of patients who died non-suddenly (i.e. patients whose 
death could be expected by the GP), GP-patient discussion of treatment preferences occurred for 25% 
of patients in Belgium in the last three months of life. GP-patient discussion of treatment preferences 
had taken place with 47% of Dutch, 10% of Italian and 7% of Spanish patients. Furthermore, 16% of 
the Belgian patients had appointed a surrogate decision-maker, which was most frequently done verbally 
and not in writing. Of the Dutch, Italian and Spanish patients respectively 29%, 6% and 5% had 
appointed a surrogate decision-maker. 
A discussion of the primary diagnosis between GPs and patients was strongly associated with both the 
discussion about treatment preferences and the appointment of a surrogate decision-maker, as well as 
more frequent contacts with the GP in the last months of life, GP provision of palliative care and the 
importance of palliative care as a treatment aim. Palliative care unit deaths and home deaths were also 
positively associated with discussions of preferences compared to hospital deaths. Furthermore, a 
dementia diagnosis was associated with less frequent discussion of treatment preferences. These 
findings show that the process of planning for the end of life often starts with the discussion of the 
primary diagnosis. So if avoided or delayed, opportunities for patient participation in decision-making 
may be missed62. Another key finding is that ACP relates strongly to the provision of palliative care. 
Although palliative care has much to offer from the early stages of a progressive disease, previous 
research demonstrated that palliative care is often initiated relatively close to death. This might suggest 
that ACP is initiated rather late in the illness trajectory, when death is imminent or end-of-life decision-
making comes to the fore and that obstacles to early ACP discussions for patients in general practice 
still prevail16. 
 
Public preferences on ACP 
Because of the potentially beneficial outcomes of ACP for patients and their families, the area is 
becoming increasingly important for health care professionals and the public63 and ACP is seen as a 
healthy and useful behaviour to promote among the general public64. A number of studies have shown 
that the general population places a lot of importance on self-involvement in end-of-life care decision-
making15;65. Nonetheless, little information is available on their involvement in ACP and the extent to 
which people already plan their end-of-life care. Little is also known on the extent to which people want 
to be informed about their own end-of-life care, which is an important prerequisite for being involved 
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in decision-making. A population-based cross-national survey in seven European countries revealed that 
a majority of people in all countries would always want to be informed about how much time they would 
have left in the scenario of having a serious illness with less than a year to live63. But no population-
based studies are available regarding information preferences on topics such as palliative care or end-
of-life decisions and the extent to which people would like their relatives to be informed about these 
topics. 
From a public health perspective, it is important to educate the public and raise awareness concerning 
the importance of communicating their preferences to their health care providers. Although more 
research is needed to confirm the positive effects of ACP as a process, ACP may be a potential 
contributor to end-of-life care. With an ageing population, the patterns of diseases and dying are also 
changing. Of the estimated 56 million people that die annually, the majority of deaths (66%) follow after 
a long period of chronic and degenerative diseases, predominantly cardiovascular diseases, cancers, 
respiratory diseases and diabetes66. Work done in the USA describing patterns of physical decline at the 
end of life suggest that the clinical course of patients with eventually fatal chronic illnesses appears to 
follow three main patterns67. The first trajectory is typified by cancer and generally follows a relatively 
predictable end-of-life course with maintenance of good function until a rapid decline in clinical status 
in the last weeks of life. The second trajectory, typically seen in patients with organ failure, is marked 
by a slow decline that is interrupted by acute deteriorations any of which might end in sudden death. 
The third trajectory, typically seen in frail older patients and patients suffering from dementia, follows 
a long term period of progressive decline in functional and mental capacity before death.  
As part of these demographic evolutions and changing patterns of dying, people today often require 
long-term care during their illness trajectory68. More people will die at an advanced age and physicians 
will be increasingly confronted with patients suffering from life-limiting conditions, for which ACP is 
particularly relevant20;69;70. Information-giving is an essential aspect of clinical care, so understanding 
the public preferences for information in advanced disease and participation in ACP is not only 
necessary to promote communication about future treatment and end-of-life care, but also to support 
and train clinicians in responding appropriately.  
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Study objectives and research questions 
The present dissertation has two main objectives: (1) to describe the experiences of the general 
population with regard to ACP and their information preferences when faced with life-limiting illness 
and (2) to develop an intervention to support the initiation of ACP in general practice.  
 
Objective 1: To describe the experiences of the general population with ACP and information 
preferences when faced with life-limiting illness  
The research questions are: 
1. To what extent did members of the general population talk to a physician about their wishes 
regarding medical treatments at the end of life, what is the prevalence of an AD on euthanasia 
in the general population and which socio-demographic, health status and health service use 
characteristics are associated with these aspects of ACP? 
2. To what extent do members of the general population want themselves and their relatives to be 
informed about diagnosis, chances of cure, life expectancy, treatment options, palliative care 
and the possibilities of prolonging or shortening life when faced with a life-limiting illness and 
which socio-demographic, health status and health service use characteristics are associated 
with these preferences? 
 
Objective 2: To develop an intervention to support the initiation of ACP in general practice for 
patients with a serious progressive or life-limiting illness 
The research questions are: 
3. What are the perceived factors that hinder or facilitate GPs in engaging in ACP with their 
patients? 
4. What are, from GPs’ perspective, the differences between patients with cancer, heart failure and 
dementia in barriers to initiating ACP? 
5. How do GPs conceptualise advance care planning, based on their experiences in practice?  
6. What are the key components of a complex intervention to support the initiation of ACP in 
general practice in patients with a life-limiting illness? 
Part II of this dissertation is concerned with monitoring the beliefs and preferences of the general 
population in relation to certain aspects of ACP (objective 1). Part III of this thesis focuses on the 
development of an intervention to support the initiation of ACP for a specific part of the population, i.e. 
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patients with serious progressive or life-threatening illnesses (objective 2). Current international 
guidelines suggest that ACP should be offered to all patients with a chronic life-limiting illness and in 
anticipation of deterioration, hence the focus of Part III in this dissertation. 
 
Methods 
I. Cross-sectional Health Interview Survey 
To address research question 1 and 2, we used data from the national Health Interview Study (HIS) that 
was collected in 2008 from a large representative sample of the Belgian population. The HIS is organized 
by the Belgian Scientific Institute of Public Health (WIV-ISP) and was conducted for the fourth time in 
2008-2009. Around 6000 private households were randomly selected from the National Population 
Register using a multistage stratified clustered sampling process. Of each selected household, a 
maximum of four members were eligible. The householder and partner were always selected, as well as 
two extra randomly selected members (or three if there is no partner). Data collection was performed 
via a self-administered questionnaire filled in by each selected person 15 years or older (N= 9651). The 
participation rate among the contacted households was 55% (around 6,000 households were contacted). 
More details on the methodology are described in PART II. 
Several procedures were used to ensure data quality: the content of the HIS questionnaire was discussed 
in workgroup sessions with academic experts, health government agencies and fieldwork experts. The 
questionnaires were pre-tested: firstly, questions from other European surveys that were added to the 
HIS 2008 questionnaire benefited from a large scale pre-test[12] and secondly, the HIS questionnaire 
was pre-tested by the WIV-ISP in a small, diverse sample of people to evaluate the length, 
comprehension, readability etc. of questions.  
Separate analyses were done for research question 1 and 2. Analyses were conducted with SPPS 22.0 
software using the complex samples procedure to account for the complex survey design. The protocol 
of the Belgian HIS 2008 was approved by the Superior Council of Statistics71.  
 
II. Medical Research Council (MRC) Framework for developing and evaluating complex 
interventions 
Throughout the development of an intervention to support the initiation of ACP in general practice, the 
UK Medical Research Council’s (MRC) Framework for Complex Interventions was used as a 
methodological guidance72;73. The framework aims to helps researchers identify the core components of 
interventions and adopt the appropriate evaluation methods. Since its publication, a number of 
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researchers in palliative care have applied the MRC framework to develop their interventions74-76. The 
MRC framework differentiates four different phases of 1) intervention development, 2) feasibility and 
piloting, 3) evaluation and 4) implementation, which take place as an iterative process (Figure 2)77;78. 
These phases include exploring relevant theories and potential components and modelling the 
preliminary complex intervention by selecting the main components of the intervention (Phase 0-I), 
testing the feasibility of the intervention components and pilot-testing the preliminary intervention 
(Phase II), evaluating the intervention in a definitive randomised trial (Phase III), and implementing the 
intervention over the long term (Phase IV).  
Each phase suggests the use of appropriate quantitative and/or qualitative methodologies depending on 
the specific objectives of the phase, and requires a specific study design taking into account the 
theoretical basis, any evidence on the issue and the context’s specificity. According to the MRC 
framework, this dissertation is a Phase 0-I study comprising the development and modelling of a 
preliminary complex intervention72. 
 
 
Figure 2 Medical Research Council Framework for complex interventions 
 
Within this Phase 0-I study, different methodologies were used to address the research objectives. In 
phase 0, a mixed method approach was chosen, using a systematic literature review and qualitative focus 
groups with general practitioners to study the barriers and facilitators for GPs to initiating ACP and their 
perceived role in the process. In phase 1, the results of the previous studies were integrated to develop 
a preliminary intervention to improve the initiation of ACP in general practice that was reviewed and 
refined by two expert panels. 
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Phase 0: Exploring potential components of the intervention 
Systematic literature review 
A systematic literature review about the barriers and facilitators for GPs to engage in ACP was 
performed to address research question 3. Four electronic databases were searched for studies published 
in English, French or Dutch between 1990 and 2011: PubMed, CINAHL, EMBASE and PsycINFO. A 
search strategy was developed for Medline and adapted to each database separately. A combination of 
controlled vocabulary and free text words was used to search in titles and abstracts: advance care 
planning, advance directives, advance decision, advance statement, living will, general practice, primary 
health care, general practitioners, family physicians, primary care, primary practice and family practice. 
The reference list of all identified studies was screened for additional relevant studies. The first author 
of each included study and known experts in the field of ACP were contacted for more studies. 
Furthermore, the most recent issues of 10 relevant journals were hand-searched for relevant papers. 
Studies were screened and included in the review on the basis of predefined inclusion- and exclusion 
criteria. Subsequently, the characteristics of the studies included were extracted to a standardized data-
extraction form under the headings of general information, country, research question, design, 
participants, barriers and facilitators and quality assessment scores. The quality of studies was appraised 
and evaluated using critical appraisal tools according to the study design of the studies included79;80. The 
studies were screened, analysed and graded for quality independently by two authors. 
In addition, the body of evidence from the multiple studies was graded81. The individual studies were 
categorized as high quality studies (scores from 8 to 10), medium quality studies (scores from 6 to 8) 
and low quality studies (scores equal to or lower than 5). 
 
Qualitative research: focus groups 
In order to have an in-depth understanding of the barriers and facilitators for GPs to engage in ACP 
(research question 5) and GPs’ perceptions regarding their role ACP (research question 6), a qualitative 
study design was considered the most suitable. Given the exploratory nature of the research questions 
in Phase 0 of this dissertation, focus groups were considered to be the best approach to obtain a wide 
range of experiences and opinions of GPs regarding ACP, given its meaningful process of sharing and 
comparing. The methodology of focus groups were used given the flexible approach that allows for 
opens discussion and interaction between the participants82. Five focus groups were conducted in 
Flanders, Belgium in 2012. 
The participants were purposefully sampled by using several recruitment strategies in order to maximize 
the variation in their experience, age and practice location. Three focus groups were organized within 
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local peer-review GP groups by contacting the chairs of six of these groups. Local peer-review GP 
groups are geographically determined groups of GPs from both individual and group practices that meet 
four times a year to discuss their practice. Every GP who wants to be accredited in Belgium, needs to 
be affiliated to a peer-review group and is obliged to attend two out of four meetings per year. A report 
from 2005 showed that more than 90% of active GPs in Belgium are affiliated to a peer-review group83. 
We chose to recruit via local peer-review groups to obtain a sample of GPs representing a wide range 
of experience related to the topic (maximum variation sampling)84. Secondly, because research shows 
that advance care planning usually takes place with patients who are terminally ill and close to death16, 
we specifically also wanted to enrol GPs who presumably have more experience with palliative patients 
and possibly communication in the last phase of life. We contacted coordinators of the palliative care 
networks in Flanders with the request to disseminate our invitation to GPs active in palliative home care 
teams. Palliative home care teams consist of experts in palliative care (physicians, nurses, psychologists) 
who, in addition to their own practice, advise and support palliative patients in their last phase of life 
and work closely with the surrounding caregivers to organize optimal care for the patient. However, 
because not many GPs from the palliative home care teams responded to our invitation (n=2) we 
complemented this focus group with GPs not working in a palliative home care team. These other GPs 
were recruited through professional contacts of the palliative care coordinators and already participating 
GPs that referred us to these participants (snowball sampling). A fifth focus group was organized with 
members from a group practice that is located in an urban region as opposed to the rural and semirural 
regions where the other focus groups took place. 
The focus groups lasted on average one and a half hours and were audiotaped, for which all participants 
gave their informed consent. The focus group discussions were transcribed verbatim. For analysing the 
data, constant comparative analysis was used85;86. The qualitative analysis software QSR NVIVO 10 
was used for this research. The Commission of Medical Ethics of the University Hospital of Brussels 
approved the research protocol. A signed informed consent was obtained from each participant before 
the focus group interview. Anonymity was assured by removing participant information that could lead 
to identification from the transcripts. 
 
Literature scope of existing ACP interventions 
A Medline search was conducted on systematic reviews with regard to ACP interventions. Journal 
articles were searched with the keywords “advance care planning” and publication type “systematic 
review”. Intervention studies were retrieved with a successful outcome on the occurrence of discussions, 
completion of advance directives, and improved patients’ end-of-life care and analysed for their 
components, to have a comprehensive overview of key features underpinning successful interventions 
and to identify potential components for the development of our intervention. 
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Phase I: Modelling the intervention to general practice with the help of expert panels  
In Phase I, a first draft of a complex intervention to support the initiation of ACP in general practice was 
developed by the research team, by selecting appropriate intervention components. Subsequently, this 
draft of the complex intervention was presented in two expert panels who reviewed the key components 
and the possible and best course(s) of action to implement the intervention in practice. The two expert 
panels (n=4, n=5) were held in January 2015 and consisted of five GPs, one hospital geriatric, one 
palliative care consultant and two academic researchers in the field of ACP and health care 
communication. The expert panel discussions were audiotaped and transcribed verbatim. The research 
team analysed these discussions and used the results to refine the intervention and its components.  
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Dissertation outline 
Following this general introduction, chapters 1 to 6 of the dissertation are based on scientific articles 
that have been published, accepted or submitted for publication. All of the chapters can be read 
independently. 
Part II is concerned with the information preferences and involvement of the general population in 
Belgium regarding ACP. Chapter 1 is devoted to the prevalence in the general population of advance 
directives on euthanasia and discussions of wishes regarding medical care at the end of life. Chapter 2 
examines the information preferences of the Belgian general population when faced with life-limiting 
illness.  
Part III of this dissertation deals with the development of a complex intervention to support the initiation 
of ACP in general practice. Chapters 3 to 5 provide insight into the complexity of factors influencing 
the initiation of ACP in general practice. Chapter 3 describes the barriers and facilitators for GPs to 
engage in ACP with their patients according to the literature In Chapter 4 the barriers to advance care 
planning in cancer, heart failure and dementia patients are explored, from GPs’ perspectives in Belgium 
(Flanders). Chapter 5 is concerned with GPs’ perspective on the concept of ACP and their role in ACP 
in Belgium (Flanders). The final Chapter 6 integrates the results of the previous studies, describes the 
development process and outlines the components of the complex intervention to support the initiation 
of ACP in general practice. 
Part IV consists of a summary of the main findings of the study, a general discussion, reflections on its 
strengths and limitations, and the implications of the findings for health practice and future research. 
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Table 1: Overview of the aims and methods used in each chapter of the dissertation 
Chapter  Research aims Method 
Chapter 1 To examine the information preferences of the 
Belgian general population when faced with life-
limiting illness 
Cross-sectional survey 
Chapter 2 To describe the prevalence in the general population 
of advance directives on euthanasia and discussion of 
wishes regarding medical treatment at the end of life 
Cross-sectional survey 
Chapter 3 To identify the perceived factors that hinder or 
facilitate GPs in engaging in ACP with their patients 
Systematic literature review 
Chapter 4 To identify the barriers, from GPs’ perspective, to 
initiating ACP and to gain insight into any differences 
in barriers between the trajectories of patients with 
cancer, heart failure and dementia. 
Focus groups 
Chapter 5 To explore how GPs conceptualise ACP, based on 
their experiences with ACP in their practice 
Focus groups 
Chapter 6 To develop an intervention to support the initiation of 
ACP by GPs in patients with a serious or life-limiting 
illnesses following Phase 0-I of the UK Medical 
Research Council’s (MRC) guidance for developing 
complex interventions 
Combined results of: 
! Systematic literature review 
! Focus groups 
! Literature scope of existing 
ACP intervention 
! Expert panels 
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Abstract 
Background: To determine the extent to which members of the general population have talked to their 
physician about their wishes regarding medical treatment at the end of life, to describe the prevalence 
of advance directives on euthanasia, and to identify associated factors. 
Method: This study used data from the cross-sectional Health Interview Study (HIS) 2008 that collected 
data from a representative sample of respondents aged 18 years or older (N=9324) of the Belgian 
population. 
Results: Of all respondents, 4.4% had spoken to their physician about their wishes regarding medical 
treatment at the end of life, while 1.8% had an advance directive on euthanasia. Factors positively 
associated with discussions regarding wishes for medical treatment at the end of life were being female, 
being older in age, having poorer health status and having more GP contacts. People older than 55 years 
and living in Flanders or Brussels were more likely than the youngest age categories to have an advance 
directive on euthanasia. 
Conclusion: Younger people, men, people living in the Walloon region of Belgium, people without a 
longstanding illness, chronic condition or disability and people with few GP contacts could represent a 
target group for education regarding advance care planning. Public information campaigns and 
education of physicians may help to enable the public and physicians to engage more in advance care 
planning. 
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Background 
Advance care planning (ACP) has gained international attention for its perceived benefits in enhancing 
patient autonomy, ensuring better quality of care and improving quality of life in the final stages of 
life[1;2]. ACP is the process through which patients are able to express their preferences regarding end-
of-life care [3;4]. ACP involves discussions about goals of care and preferences for treatment between 
patients and health professionals, which may involve family members or friends. ACP may include the 
designation of a surrogate decision-maker to make future health care decisions for the patient, or the 
completion of an advance directive (AD)[5].  
A recently published systematic review showed that interventions including communication about ACP 
improved the quality of communication and concordance between patient preferences and end-of-life 
care received[2]. Because of these benefits, ACP is seen as a useful behaviour to promote among the 
general public and in several countries public health campaigns to encourage it have been put in place 
such as the Speak Up campaign in Canada or the Dying Matters initiative in the UK[6;7]. Nonetheless, 
little information is available on the involvement of the general public in ACP and the extent to which 
people actually plan their end-of-life care, which is the focus of this population-based study of the 
Belgian general population. Improved understanding of the public’s involvement in ACP could help 
inform the development of public policy. Determining which subgroups of the population are engaged 
in ACP and which are not can help to define the communication and health campaigns about ACP within 
a context that is meaningful to the public[8].  
In Belgium the Law on Patients’ Rights (2002) gives people the right to reject any medical treatment 
and to appoint a surrogate decision-maker to advocate for their rights if they are unable to make decisions 
or speak for themselves[9]. Refusal of treatment can be documented in a legally binding negative AD, 
also known as a living will, which is similar to those in the Netherlands, the USA and Canada. 
Furthermore, people can document in advance specific wishes for end-of-life care in an advance 
statement, also called a positive AD, which is indicative but not legally binding on the physician. These 
advance statements are called “positive” ADs because they are about what patients would still want if 
they could no longer ask for themselves, as opposed to negative ADs to refuse treatments or 
examinations. Belgium is a specific case as it recognizes a type of positive AD that does not exist in 
most other countries. In 2002, the Belgian Parliament legalised euthanasia, i.e. the use of life-ending 
drugs by a physician on explicit patient request. People in Belgium can draft an AD on euthanasia in 
case they find themselves in specific situations of lack of capacity[10;11]. The law on euthanasia allows 
people with mental capacity to draw up a prior declaration of intent to request euthanasia should they 
be in an irreversible state of unconsciousness and no longer able to ask for euthanasia themselves. In 
practice, this means that an AD on euthanasia only applies to those in an irreversible coma. A request 
for euthanasia is not legally binding and acts as a guide for the treating physician. ADs on euthanasia 
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may be registered at the city hall, but this is not mandatory. In 2013, a total of 20,414 people in Belgium 
registered an AD on euthanasia, an increase compared with 12,728 people in 2012.  
The aim of this study is firstly to determine to what extent members of the general population have 
talked to a physician about their wishes regarding medical treatments at the end of life and what the 
prevalence is of an AD on euthanasia in the general population and secondly to determine to what extent 
socio-demographic characteristics, health status and health service use are associated with the 
involvement in ACP. 
 
Methods 
Design and population 
This study uses data from the cross-sectional Health Interview Study (HIS) that collects data from a 
large representative sample of the Belgian population. The HIS is organized by the Belgian Scientific 
Institute of Public Health (WIV-ISP) and was conducted for the fourth time in 2008-2009. Around 6000 
private households are randomly selected from the National Population Register using a multistage 
stratified clustered sampling process. Of each selected household, a maximum of four members are 
eligible. The householder and partner are always selected, as well as two extra randomly selected 
members (or three if there is no partner). This study includes only participants older than 15 years. 
 
Questionnaire 
Involvement in ACP was analyzed based on two items: (1) Have you ever spoken to your physician 
about your wishes regarding medical treatments at the end of life? and (2) Do you have an advance 
directive requesting euthanasia?. Possible responses were Yes and No. Data collection is performed via 
a self-administered questionnaire filled in by each selected person aged 15 years or older. However, 
only respondents aged 18 years or older are included in the analysis, because an advance directive on 
euthanasia can only be drafted by people older than 18.  
Several procedures were used to ensure data quality: the content of the HIS questionnaire was discussed 
in workgroup sessions with academic experts, health government agencies and fieldwork experts. The 
questionnaires were pre-tested: firstly, questions from other European surveys that were added to the 
HIS 2008 questionnaire benefited from a large scale pre-test[12] and secondly, the HIS questionnaire 
was pre-tested by the WIV-ISP in a small, diverse sample of people to evaluate the length, 
comprehension, readability etc. of questions.  
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Analysis 
The selection of the independent variables is based on their possible influence on involvement in ACP 
or the formulation of ADs, as shown in previous research[13-15]. Socio-demographic measurements 
include gender, age, educational level, marital status and region of residence. Health-related 
measurements include health status (having a longstanding illness, chronic condition or disability) and  
health service utilization (mean number of GP contacts in the past 12 months and mean number of 
specialist contacts in the past 12 months). 
The sample is weighted according to the stratified clustered sampling design of the survey to be 
representative of the Belgian population. Involvement in ACP is described using frequencies. The 
independent characteristics were tested for significant association with involvement in ACP using 
Pearson chi2 test (not shown in paper) and, when found significant, entered in multivariate logistic 
regression models in order to control for confounding effects and investigate their association with the 
dependent variables. Confidence intervals are calculated at the 95% level. Analyses are conducted with 
SPPS 22.0 software using the complex samples procedure to account for the complex survey design.  
 
Ethical considerations 
The protocol of the Belgian HIS 2008 is approved by the Superior Council of Statistics[12] . Providing 
the data by the participants involved giving implied consent. 
 
Results 
The participation rate among the contacted households was 55% (around 6,000 households were 
contacted). Of the 9324 respondents, 52.1% were female, 26.2% were between the ages of 18 and 34, 
37.5% were between the ages of 35 and 54, 25.6% between 55 and 74 and 10.7% 75 years or older 
(Table 1). For 38.7% of the respondents the highest educational level within the household was higher 
education (post-secondary). More than half of the respondents were married or had a registered civil 
relationship (56.6%) and lived in Flanders (58.3%). Of all respondents 32.7% suffered from a 
longstanding illness, chronic condition or disability. Around a quarter had seen their GP once every two 
months in the last year and the majority had not seen a specialist in the past 12 months (77.5%). 
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Involvement in advance care planning 
Of all respondents, 4.4% indicated they had talked to a physician regarding medical treatments at the 
end of life and 1.8% said they had an AD on euthanasia (Table 1).  Of all respondents who had discussed 
their wishes regarding medical treatment at the end of life with a physician, 22.2% had an AD on 
euthanasia.  Vice versa, 55.4% of all respondents who had an AD on euthanasia, had discussed their 
wishes regarding medical treatment at the end of life with a physician. Women, older persons, the 
widowed and people who suffer from a longstanding illness, chronic condition or disability had spoken 
more often about their wishes regarding medical treatment at the end of life, as had those who saw a GP 
or specialist more than once a month. Having an AD on euthanasia was also more common among older 
respondents, the widowed and people with a longstanding illness, chronic condition or disability. 
Remarkably, people with a lower educational level had spoken more with a physician about medical 
treatments at the end of life and had more often an AD on euthanasia than people with a higher 
educational level. However, a cross tabulation between age and educational level showed that the 
majority of older people were represented in the lowest educational levels, while the majority of younger 
had a higher educational level (not shown in the paper). 
 
Factors associated with involvement in advance care planning 
The probability of having spoken to a physician about wishes regarding medical treatments at the end 
of life was higher for women (OR= 1.5) and those with a longstanding illness, chronic condition or 
disability (OR = 1.5) (Table 2).  The probability of having discussed their wishes with a physician also 
significantly increased with age and with the number of GP contacts.  
Compared with the youngest age category, people older than 55 years were more likely to have an AD 
on euthanasia. Those living in the Walloon region of Belgium were less likely to have an AD on 
euthanasia compared with those living in Flanders (OR= 0.5).  
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Table 1: Participant characteristics of the sample of the Belgian general population (N= 9324) and proportions having spoken about 
wishes regarding medical treatments at the end of life with their physician and having an AD on euthanasia 
   Unweighted sample  
(Weighted %) 
Has spoken about 
wishes regarding 
medical treatment 
at the EOL to their 
physician 
Has an AD on 
euthanasia 
  N (%) % % 
Total respondents   4.4 1.8 
Socio-demographic factors 
Gender Man 
Woman 
 
4244 (47.9) 
5080 (52.1) 
3.3* 
5.4* 
1.7 
1.8 
Age 18-34 
35-54 
55-74 
75+ 
 
2222 (26.2) 
2906 (37.5) 
2216 (25.6) 
1980 (10.7) 
0.7* 
3.5* 
6.8* 
12.0* 
0.5* 
0.9* 
3.3* 
4.6* 
Highest 
educational level 
within the 
household 
≤ Primary education 
Lower secondary 
Higher secondary 
Higher education 
1437 (12.2) 
1511 (15.9) 
2770 (33.2) 
3302 (38.7) 
6.7* 
5.9* 
4.8* 
2.9* 
2.7 
1.8 
2.0 
1.4 
     
Marital status Single (never married) 
Married or registered civil 
relationship 
Widow/er (not remarried) 
Divorced (not remarried) 
 
2399 (26.4) 
4672 (56.6) 
 
1428 (8.2) 
804 (8.7) 
2.0* 
3.9* 
 
13.0* 
7.3* 
1.1* 
1.7* 
 
4.5* 
1.7* 
Region of 
residence 
Flemish region 
Brussels’ region 
Walloon region 
 
3304 (58.3) 
2750 (10.6) 
3270 (31.1) 
3.8* 
4.8* 
5.5* 
2.0* 
2.5* 
1.1* 
Health status 
Longstanding 
illness, chronic 
condition or 
disability 
Yes 
No 
 
3437 (32.7) 
5857 (67.3) 
7.8* 
2.7* 
2.6* 
1.4* 
Health service use 
Number of GP 
contacts 
 
Never 
1x/2 months 
1x/month 
≥1x/month 
 
4502 (53.2) 
2447 (26.9) 
1412 (12.5) 
811 (7.4) 
 
2.1* 
5.2* 
8.5* 
11.8* 
 
1.1* 
2.0* 
3.2* 
3.0* 
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Number of 
specialist contacts 
 
Never 
1x/2 months 
1x/month 
≥1x/month 
6930 (77.5) 
1384 (14.4) 
496 (5.1) 
302 (3.0) 
3.6* 
6.3* 
7.3* 
10.6* 
1.6 
1.8 
3.9 
2.4 
Involvement in ACP 
Has spoken about 
wishes regarding 
medical treatments 
at the EOL to their 
physician 
 
 412 (4.4) - 22.2* 
Has an AD on 
euthanasia 
 167 (1.8) 55.4* - 
Abbreviations: GP = General practitioner; EOL = end of life 
Sums may not always amount to the total sample number because of missing values on variables. Percentages may not always add 
up to 100 because of rounding. Percentages are row percentages. 
Missing values: for gender n=0, age n=0, for highest educational level in the household n= 304 (3.3%); for marital status n=21 
(0.2%); for region of residence n= 0; for having a longstanding illness, chronic condition or handicap n= 30 (0.3%); number of GP 
contacts n= 152 (1.6%); number of SP contacts n= 212 (2.3%); for having spoken about wishes regarding medical treatments at the 
EOL to their physician n= 2109 (22.6%); for having an AD on euthanasia n= 2128 (22.8%) 
* Significant at p <0.05 using Pearsons Chi2 test 
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Table 2: Factors associated with involvement in ACP of a representative sample of the Belgian general population 
   
  OR (95% CI) for yes vs. no* 
  Spoken about wishes 
regarding medical 
treatments at EOL to 
physician 
Having an advance 
directive requesting 
euthanasia 
Socio-demographic characteristics 
Gender Man (ref) Ref  
 Woman 1.5 [1.1 – 2.0]  
Age 18-34 (ref) Ref Ref 
 35-54 5.1 [2.6 – 9.9] 2.1[0.8 – 5.1] 
 55-74 8.2 [4.1 – 16.4] 6.4 [2.7 – 14.9] 
 75+ 11.1 [5.2 – 24.0] 6.3 [2.1 – 18.4]  
Region of residence Flemish region (ref)  Ref 
 Brussels’ region  1.5 [0.9 – 2.4] 
 Walloon region  0.5 [0.3 – 0.9] 
Health status    
Having a longstanding 
illness, chronic condition 
or handicap 
Yes 1.5 [1.1 – 2.0]  
No (ref) Ref  
Health care use    
Number of GP contacts Never (ref) Ref  
 1x/2 months 1.7 [1.1 – 2.6]  
 1x/month 2.2 [1.3 – 3.5]  
 ≥1x/month 3.0 [1.7 – 5.2]  
Abbreviations: OR= Odds ratio; ref= reference category; Ns= not significant. 
*Odds Ratio with 95% confidence interval from complex multivariate logistic regression analysis.  
Bold denotes significant at p< .05. 
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Discussion 
This study shows that 4.4% of a representative sample of the Belgian general public have spoken about 
their wishes regarding medical treatments at the end of life, while 1.8% have an AD on euthanasia. 
Discussions with a physician regarding wishes for medical treatment at the end of life were more likely 
to have taken place among women, as people get older, among people with a poorer health status and 
those having more GP contacts. Having an AD on euthanasia was more likely for people older than 55 
years and living in Flanders or Brussels. 
Discussions regarding wishes for medical treatment at the end of life with physicians are relatively rare 
among the Belgian general public. Even among those who have an AD on euthanasia only half of 
respondents (55.4%) had discussed their wishes regarding medical treatment with a physician. However, 
an AD on euthanasia does not need to be discussed with a physician, something about which some 
people might be hesitant. An AD on euthanasia must be drafted in the presence of two adult witnesses 
and they are responsible for notifying the treating physician of its existence should the patient fall into 
an irreversible coma. People can choose either to deliver copies of their AD on euthanasia to a number 
of people (of whom their physician might be one) or to register it at the city hall in a federal database, 
but this is not mandatory. It is however also possible that people do visit their physician with the 
intention of discussing the completion of an AD on euthanasia, but that the physician omits to take up 
the opportunity to elaborate on their wishes for medical treatment at the end of life.  
A cross-sectional survey in the Netherlands (one of the three countries, with Belgium and Luxembourg, 
where euthanasia has been legal since 2002) showed that 13% of the general population had discussed 
issues related to medical decision-making at the end of life with a physician [13]. It is known that, 
especially in the Netherlands, patients prioritize autonomy and control during the dying process [16]. 
Cross-country studies also repeatedly found that Dutch physicians discuss end-of-life issues more 
frequently than their European counterparts [17-19]. Of the Dutch general population, 3% reported they 
have an AD on euthanasia compared with 1.8% in the present study. Internationally, the interest of 
people in making ADs refusing medical treatments has been shown to be low, ranging between 18% 
and 34% in the general population of the USA [20-23] and between 3% and 19% in the general 
population in Europe [14;24]. 
A number of characteristics associated with the public’s engagement in ACP are consistent with earlier 
studies. Women and those with a serious illness or increased dependency have been shown to discuss 
their end-of-life care preferences more often with physicians or have higher AD completion rates 
[13;14;20;25]. As may be expected, older people were also more likely to have discussed or documented 
their end-of-life care wishes than those in the youngest age categories [13;26]. On the one hand, evidence 
suggests that people in general are unwilling to engage in ACP until they grow older or become ill; a 
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lack of information, procrastination or avoidance could be important reasons for the low completion 
rates among younger people [27;28]. Younger people in good health tend not to feel the need for ACP. 
On the other hand, physicians are also hesitant to initiate these discussions and often believe that ACP 
is unnecessary for young and healthy patients which compounds these barriers [29;30]. And although 
those who have been widowed are more involved in the process of ACP, marital status was surprisingly 
not a predictor of engagement in ACP in this study [31]. A population-based study on AD completion 
in Alberta showed that people who had looked after or given care to a dying person were more likely to 
complete an AD [32]. The authors argue that experience of death and dying are likely to have a greater 
impact on having an AD than socio-demographic characteristics. In our study, older age was a notable 
predictor of AD completion, but experiences with death and dying were not asked about. Older people, 
who are in general more likely to be widowed, could have experienced a death in their close environment. 
Also, the specific type of AD examined in this survey was an AD on euthanasia as opposed to an AD 
for medical treatment. Possibly, lived experiences could also greatly influence the level of involvement 
in ACP in Belgium. This is a focus for future research. 
Remarkably, people living in the Walloon region of the country were less likely to have an AD on 
euthanasia compared to people living in the Flemish part of Belgium. Unfortunately, reasons for the 
identified differences between the regions in Belgium could not be explored. Previous research on end-
of-life care in Belgium has suggested a difference in medical culture between the Dutch-speaking and 
French-speaking community, with a stronger appreciation of curative, technological and specialist 
medicine in the French-speaking community [33]. Perhaps, societal or culturally determined attitudes 
towards euthanasia might also differ between the regions in Belgium and influence the prevalence of an 
AD on euthanasia. However, these hypotheses need more research before solid conclusions can be 
drawn. This study also shows that having more contact with a GP was associated significantly with 
discussion of end-of-life care wishes. In the Belgian health care system a strong emphasis is put on 
primary care and most people have a long-lasting relationship with their GP whom they consult regularly 
(78% at least once a year) [34]. Moreover, the number of GP contacts increases exponentially with age 
(and probably health-related problems) and persons aged 75 or over are seen by their GP on an almost 
monthly basis. Future interventions might focus on stimulating GPs to initiate ACP discussions in good 
time as a sudden or serious chronic illness can render any adult incapable of decision-making. The aim 
of interventions should not only be to encourage the formulation of ADs on euthanasia, as such ADs 
only apply to very specific medical circumstances as described in the introduction, but to provide 
adequate information about the different types of ADs to those who are interested and to make the 
process of completing an AD an opportunity to have important conversations with physicians, family 
and friends. 
Even though a previous study has shown that the majority of people in Belgium are open to discussions 
on end-of-life care [35], only a small percentage of the population had discussed their wishes regarding 
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medical treatment at the end of life with a physician. This suggests that the stimulation of both patients 
and physicians to engage in end-of-life care discussions would be useful to enhance ACP in practice. 
Public information campaigns can increase awareness among the Belgian general public regarding the 
importance of timely ACP discussions. This study shows that younger people, men, those living in the 
Walloon region of Belgium and those with few GP contacts are a target group for education. Nonetheless, 
older people represent another key target group, as they are at higher risk of needing end-of-life care 
[32]. Of those older than 75 years, only 12% had ever had a discussion with their physician about their 
wishes regarding medical treatment at the end of life.  And although guidelines suggest that ACP should 
be initiated with people who suffer from a chronic, life-limiting illness, our results show that only 7.8% 
of people with a poorer health status had ever spoken with a physician about their wishes for medical 
treatment at the end of life. Public information campaigns can help to overcome important barriers to 
engagement in ACP, including the perception that ACP is irrelevant or the possession of insufficient 
information to engage in such discussions [5;28]. Secondly, a more active role for the physician in 
initiating such discussions could also enhance ACP. It has been suggested before that physicians have 
the responsibility to inform their patients and to initiate discussions in a timely manner [4;36;37]. 
However, they need to be trained and supported in how to do this, they often delay communication until 
the end of life or wait for patients to raise the topic [38-40].  
This is the first study on the general public’s involvement in ACP in Belgium. It is a population-based 
study founded on a representative sample of the Belgian population. Other important strengths include 
the large sample size, the robustness of the methodology and the quality of research procedures. We 
used data from the HIS, which has a long history of data collection in the Belgian population and is not 
based only on a specific interest in end-of-life care. However, this study also has some limitations. 
Firstly, the specific context of Belgium as one of the three countries where euthanasia is legal, might 
hamper the generalizability of our results to other settings. Secondly, because of the low response-rate 
(55%), non-response bias cannot be excluded. The missing values for the outcome variables are around 
23% and non-response analysis showed that missing values were more likely to be male, older, have a 
lower educational level and live in Wallonia or Brussels. As a result, it is possible that some of our 
findings are biased because of non-response. Thirdly, because this study examined the respondent’s own 
report of their involvement in ACP, the results may be subject to recall bias. 
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Conclusion 
Few people in Belgium have discussed their wishes regarding medical treatment at the end of life with 
their physician or have completed an AD on euthanasia. Younger people, men, people living in the 
Walloon region of Belgium, people without a longstanding illness, chronic condition or disability  and 
people with few GP contacts might represent a target group for education as they are less likely to engage 
in ACP. Public information campaigns and the education of physicians may encourage the public to 
engage in ACP and help to enable patients, families and physicians to have more conversations about 
care at the end of life.  
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Abstract 
Background: Giving the public and patients good information enables them to make effective choices 
about their care. This study describes public preferences for both themselves and their relatives on 
receiving information on end-of-life care topics when faced with a life-limiting illness and to identify 
associated factors. 
Method: This study used data from the cross-sectional Health Interview Study (HIS) 2008 that collected 
data from a representative sample (N=9651) of the Belgian population. 
Results: Around 82% of respondents wanted to be informed always about diagnosis, chances of cure 
and available treatments, 77% wanted to be informed on life expectancy, 72% on options regarding 
palliative care and 67% on possibilities of prolonging or shortening life. Around 55% wanted their 
relative to be informed always about diagnosis, chances of cure, life expectancy and different treatments 
available, while 50% wanted this in relation to the options regarding palliative care and 46% to the 
possibilities of prolonging or shortening life. Younger adults, people with more education and people 
with a regular GP were more likely to want to be informed always. Younger adults and women were 
less likely to want their relatives to be informed always. 
Conclusion: The majority of the Belgian population wants to be informed always about end-of-life care 
topics when faced with a life-limiting illness. Physicians should be aware of the desired level of 
information and tailor information to individual patient preferences. Understanding population 
preferences may help to tailor patient education and health promotion programmes appropriately.  
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Introduction 
In modern western societies, increased value is being put on personal autonomy, individualism, and the 
right to self-determination(1). With an aging population and rising numbers of deaths from chronic life-
limiting illnesses, these values are increasingly being recognized at the end of life(2). These attitudinal 
changes have been incorporated into national legal codes in the past 20 years, e.g. as the Patient Self-
Determination Act in the USA which is intended to promote awareness and discussion of health care 
issues in preparation for medical decisions at the end of life(3). 
A number of studies have shown that the general population places a lot of importance on self-
involvement in end-of-life care decision-making(2;4). Within Europe, four factors are associated with a 
preference for self-involvement: higher level of education, female gender, younger-middle age and 
valuing quantity over quality of life or valuing both equally. However little information is available on 
the extent to which people want to be informed about their own end-of-life care which is an important 
prerequisite of being involved in decision making. A population-based cross-national survey in seven 
European countries revealed that a majority of people in all countries would want always to be informed 
about how much time they would have left in the scenario of having a serious illness with less than a 
year to live(5). People younger than 70 years, men, those with personal experience of a serious illness 
such as cancer and those with higher educational attainment were more likely to want to know if they 
had limited time left. But to our knowledge, no population-based studies are available regarding 
information preferences on specific topics such as palliative care and end-of-life decisions or the extent 
to which people would like their relatives to be informed. For policy makers it is unclear what the 
preferences are in the general population and a population-based study can inform them on which steps 
to take, e.g. for the development of public health education campaigns to raise awareness of these 
matters in the population(6).  
Most studies exploring information preferences have been focused on specific populations of patients, 
usually involving cancer patients or the terminally ill(7-9). This is the first cross-sectional study to 
describe variations in the information preferences of the general public with regard to themselves and 
their relatives for six specific end-of-life care topics in a hypothetical scenario of a life-limiting illness. 
The aims of this study are 1) to determine to what extent members of the general population would want 
to be informed about diagnosis, chances of cure, life expectancy, treatment options, palliative care and 
the possibilities of prolonging or shortening life when faced with a life-limiting illness; 2) to describe to 
what extent members of the general population would want their relatives to be informed about these 
six topics and 3) to study to what extend people’s socio-demographic characteristics, health status and 
health service use is associated with their information preferences. 
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Methods 
Design and population 
This study uses data from the cross-sectional Health Interview Study (HIS) that collects data from a 
representative sample of the Belgian population. The HIS is organized by the Belgian Scientific Institute 
of Public Health (WIV-ISP) and was conducted for the fourth time in 2008-2009. Private households 
are randomly selected from the National Population Register using a multistage stratified clustered 
sampling process. Of the selected households, a maximum of four members per household are eligible. 
The householder and partner are always selected, as well as two extra randomly selected members of 
the household (or three if there is no partner). This study includes only participants older than 15 years. 
 
Questionnaire 
Two questions on information preferences in a scenario of a life-limiting illness were initially developed 
by KM, LVDB and LD and were incorporated into the HIS questionnaire of 2008. Data collection is 
performed via a self-administered questionnaire filled in by each selected person 15 years or older. The 
questions on information preferences (dependent variables) are formulated as a scenario imagining ‘If 
you were to develop a life-limiting illness, would you want your doctor to inform you on the following 
topics’: (1) diagnosis, (2) chances of curing the disease, (3) life expectancy with the disease, (4) the 
different types of treatments, their side effects and the expected outcome of each treatment, (5) options 
regarding palliative care, (6) possibilities of prolonging or shortening your life. Possible responses were 
‘Yes, in principle always’, ‘Yes, but only if I ask’, ‘No’ and ‘Don’t know’. A second question is 
formulated as the hypothetical scenario ‘If you were to develop a life-limiting illness, would you want 
your physician to inform your relative(s) on these six topics’, for which the same response categories 
apply. 
The selection of the independent variables is based on their possible influence on information 
preferences, as stated in previous research(5;8;10). Socio-demographic measurements include gender, 
age, highest educational level in the household, marital status, region and nationality. Health status is 
measured through the variables subjective health, severity of pain in the last four weeks, and having a 
longstanding illness, chronic condition or disability. Health service utilization measures include having 
a regular GP and inpatient hospitalizations in the past 12 months. 
The content of the questions on information preferences was determined on the basis of existing 
validated questionnaires about the information preferences of people with advanced lung cancer (8). 
Several procedures were used to ensure data quality: each module of the HIS was discussed in 
workgroup sessions with academic experts, health government agencies and fieldwork experts. The 
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questionnaires were pre-tested. Firstly, the adjunction of European questions in the HIS 2008 
questionnaires benefited from a large scale pre-test(11). Secondly, the HIS questionnaire was pre-tested 
by the WIV-ISP in a small, diversified sample of people to evaluate the length, comprehension and 
readability of questions, etc.  
 
Analysis 
The sample is weighted according to the stratified clustered sampling design of the survey to be 
representative of the Belgian population. The dependent variables are converted into a binary score: yes 
always = 1 vs. ‘Yes, but only if I ask’, ‘No’ and ‘Don’t know’= 0. Information preferences for the six 
topics are described. The bivariate associations between the independent and outcome variables are 
tested through cross-tabulations and binary logistic regression analysis (not shown in paper). Variables 
that are significantly associated (CI 95%) are included in multivariate logistic regression models in order 
to control for confounding effects and investigate their association with the dependent variables. 
Confidence intervals are calculated at the 95% level. Analyses are conducted with SPPS 22.0 software 
using the complex samples procedure to account for the complex survey design.  
 
Ethical considerations 
The protocol of the Belgian HIS 2008 is approved by the Superior Council of Statistics(11). Submission 
to the Ethical Committee of the WIV-ISP is not needed, because it is a recurrent project that had been 
approved in 2004. 
 
Results 
The participation rate among the contacted households was 55%. The characteristics of the sample (N= 
9651) are displayed in Table 1. 
 
Information preferences of the general population 
When faced with a life-limiting illness, the majority of people would always want to be informed about 
their diagnosis (82.1%), the chances of cure of the disease (81.7%) and the different treatments available 
with their side effects and outcomes (82.1%). About three-fourths of people would always want to be 
informed about their life expectancy with the disease (76.7%) and the options regarding palliative care 
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(72.3%). The proportion of people wanting to be informed always about the possibilities of prolonging 
or shortening life was 67.3% (Table 2).  
 
Information preferences for the relatives of the general population 
When faced with a life-limiting illness, 55.4% would always want their relatives to be informed about 
their diagnosis (Table 2). A similar result was found for the specific topics of chances of cure of the 
disease (55.4%), life expectancy with the disease (53.3%) and the different treatments available with 
their side effects and the outcomes of every treatment (54%). Half of people would always want their 
relative to be informed about the options regarding palliative care (50.4%) and less than half about the 
possibilities of prolonging or shortening life (46.6%).  
 
Factors associated with information preferences 
Compared with the youngest age category, people aged 25 to 34, 35 to 44 and 45 to 54 were more likely 
always to want information about the six topics (Table 3). This was also significantly more likely among 
people with an educational level of ‘higher secondary’ and ‘higher education’. People living in Wallonia 
were overall less likely to want information on these six specific topics always as opposed to people 
living in Flanders. 
Always wanting to know about diagnosis (OR= 1.9), chances of cure (OR = 2.0), life expectancy (OR= 
1.8) and different treatment options (OR= 1.8) was significantly related to having a regular GP. People 
who were divorced were more likely always to want information on palliative care, while those with of 
a non-Belgian and non-European nationality were less likely to want information on life expectancy. No 
significant association was found between subjective health status and information preferences. 
 
Factors associated with information preferences for the relatives 
Those who were married or legally cohabiting and those living in Flanders were more likely to have a 
preference for information to be provided to their relative(s) for all six topics (Table 4).  
People aged 25 to 34 and 35 to 44 were less likely to want their relative to know about their diagnosis 
and chances of cure, as were people with an educational level of lower secondary. On the other hand, 
being older than 75 years was associated with wanting relatives to know about these topics (OR= 1.5 
and OR= 1.5). Women were less likely to want their relative to know about their life expectancy, 
different treatment options, options regarding palliative care and possibilities of prolonging or 
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shortening life. No significant association was found between people’s nationality, having a regular GP 
or being hospitalized in the past 12 months and wanting relatives to know about one of the six specific 
topics. 
 
Discussion 
Our study shows that, when faced with a life-limiting illness, the majority of a representative sample of 
the Belgian general public would always want to be informed about diagnosis, chances of cure and 
different treatments available, while more than 70% wanted always to be informed about life expectancy, 
options regarding palliative care and possibilities of prolonging or shortening life. Furthermore, 
important differences with the preferences regarding relatives being informed were identified: around 
55% would want their relative to be informed always about diagnosis, chances of cure, life expectancy 
and different treatment options, while half wanted them always to be informed about the options 
regarding palliative care and fewer than half about the possibilities of prolonging or shortening life.  
We found that most respondents want information on disease and treatment-related matters in a 
hypothetical scenario of a life-limiting illness. Nonetheless, respectively 72.3% and 67.3% of the 
respondents still indicated they would always want information on palliative care and the possibilities 
of prolonging or shortening life. This might be explained by the open public debate on end-of-life issues 
in Belgium since the enactment of the laws concerning euthanasia, palliative care and patient rights in 
2002(12-14). A previous cross-country study showed strong variation in discussions of end-of-life 
preferences in patients who died non-suddenly from Italy, Spain, Belgium, and the Netherlands(15). The 
higher frequency of anticipatory decision-making in Belgium and the Netherlands as opposed to Spain 
and Italy was also considered to be related to the open public debate on end-of-life issues engendered 
by the process of legalization of euthanasia in both countries. A markedly high public acceptance of 
euthanasia was in 2008 also found in a small cluster of Western European countries, including the three 
countries that have legalized euthanasia, which strongly related to a belief in the right to self-
determination(16). The importance of self-determination and open public debate on end-of-life issues 
has probably also contributed to an increased public preference to be informed about these topics. 
The finding that younger adults and more highly educated respondents were overall more likely to want 
information always is in accordance with other studies indicating that these patients express more desire 
to receive detailed information with regard to their illness and to be involved in decision-making about 
care involving serious illness(4;6;7;17). We found that a shift in information preferences begins after 
the age of 54. This may be due to changing attitudes towards topics associated with aging or it may point 
to a cohort effect: possibly the younger generation will differ from the trend we found here and may 
want to receive more information when they get older. A European survey showed that besides people 
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younger than 70 years and those with a higher educational attainment, people with personal experience 
of a serious illness such as cancer were more likely to want to know about how much time they would 
have left, in the scenario of having a serious life-limiting illness(5). In our study, respondents with a 
poorer health status (measured in three different ways) did not have significantly different preferences 
as compared with those with a better health status. Several things might explain this difference. Firstly, 
this study did not specifically ask if the respondents wished to know that there was limited time left. 
Secondly, health status was measured as a broad concept and specific questions about e.g. the presence 
of a life-limiting illness such as cancer were not asked. However, a study on information preferences in 
advanced cancer patients regarding the same end-of-life care topics as used in this study revealed similar 
results(8). This points to a willingness in the general public to receive information on end-of-life care 
regardless of health status. 
We also found that people with a regular GP were more likely to want information. As in many countries, 
GPs in Belgium have built up long-term relationships with their patients and they play a central role in 
providing continuous and comprehensive care, including at the end of life(15;18;19). General practice 
is highly accessible: 95% of the population have a regular GP whom they consult regularly. The 
importance of a good physician-patient relationship has been acknowledged to facilitate better 
information provision(20;21) and possibly people feel comfortable discussing these topics with their 
own GP. Lastly, differences in information preferences between the three different regions of Belgium, 
could mean that societal or cultural differences between the regions play a role. Previous studies have 
shown significant differences in type and prevalence of end-of-life decisions between the Dutch-
speaking and French-speaking communities in Belgium(22). However, these factors need to be 
examined in more detail.  
As a minority of the people in our study did not want to receive any information either at all or only if 
they requested it, our findings highlight the importance of physicians checking their patients’ 
preferences in advance as to the extent and the specific topics about which they want to be informed. 
An examination of the role of relatives is also warranted, as only half of people want a relative to be 
informed always. Younger adults and women were less likely to want their relatives to be informed. An 
important concern of people when considering advanced cancer is being a burden on others(23) and 
these results may also reflect the importance to the general public of not wanting to worry their relatives 
by informing them on these topics(24). However, advance care planning guidelines emphasize the 
importance of involving relatives in discussions of end-of-life care(25;26). As relatives often play an 
important role in end-of-life care decisions(27), it follows that physicians should be adequately prepared 
to elicit both the patient’s information preferences and the role they desire their relatives to play in order 
to enhance effective communication(28). 
Information preferences of the general population 
61 
 
This is the first study on the information preferences of the general population for themselves and for 
their relatives and the first to describe variations in public information preferences for six different 
components of communication regarding illness and the end of life. Moreover, it is a population-based 
study founded on a representative sample of the Belgian population. Its other important strengths include 
the large sample size, the robustness of the methodology and the quality of the research procedures(11). 
We used data from the HIS which has a long history of data collection in the Belgian population and is 
not only based on a specific interest in end-of-life research, but obtains information about life style, 
health status, prevention and the use of health care facilities. However, this study also has some 
limitations. As the majority of the respondents considered their health to be good, it might have been 
difficult for them to imagine a scenario where they have a life-limiting illness and to foresee what their 
information preferences would be in that case. Secondly, because of the lower response rate (55%), non-
response bias cannot be excluded. The missing values for the outcome variables are around 25% and 
non-response analysis of those missing values further shows that those missing values were more likely 
to be male, older, have a lower educational level and live in Wallonia or Brussels. As a result, it is 
possible that some of our findings are biased because of non-response. Finally, the cross-sectional nature 
of the HIS prevents the drawing of conclusions about causal relationships between information 
preferences and individual factors.  
In conclusion, the majority of the Belgian population wants to be informed always about end-of-life care 
topics when faced with a life-limiting illness. However, people’s preference for always wanting their 
relatives to be informed about these topics is less prevalent. The results of this study can inform policy 
makers on the role people would want to fulfil during end-of-life care and the understanding of public 
information preferences can help tailor public education and health promotion programmes 
appropriately.  
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Key points: 
• The general population places a lot of importance on self-involvement in end-of-life care decision-
making; however little data is available on the extent to which people want to be informed about 
their own end-of-life care which is an important prerequisite of being involved in decision making. 
When faced with a life-limiting illness, around 82% of a representative sample of the Belgian 
general public would always want to be informed about diagnosis, chances of cure and different 
treatments available, while fewer wanted always to be informed about life expectancy (77%), 
options regarding palliative care (72%) and possibilities of prolonging or shortening life (67%). 
• Preferences regarding relatives being informed always were less strong: around 55% would want 
their relative to be informed always about diagnosis, chances of cure, life expectancy and different 
treatment options, while fewer wanted them always to be informed about the options regarding 
palliative care (50%) and the possibilities of prolonging or shortening life (46%). 
• Younger adults and more highly educated respondents were overall more likely to want information 
always. We found that a shift in information preferences begins after the age of 54. This may point 
to a cohort effect: possibly the younger generation may want to receive more information when they 
get older. 
• For policy makers it is unclear what the preferences are in the general population and which steps 
to take to raise awareness of these matters in the population. The results of this study can inform 
them on the role people would want to fulfil during end-of-life care and the understanding of public 
information preferences can help tailor public education and health promotion programmes 
appropriately. 
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Table 1: Socio-demographic characteristics, health status and health care utilization of the unweighted and weighted sample 
  Unweighted sample (N = 9651) Weighted sample 
  N % 95% CI 
Socio-demographic characteristics 
Gender Man 
Woman 
 
4417 
5234 
48.1 
51.9 
[47.2 – 49.1] 
[50.9 – 52.8] 
Age 15-24 
25-34  
35-44 
45-54 
55-64 
65-74 
75+ 
 
1209 
1340 
1503 
1403 
1337 
879 
1980 
14.3 
15.3 
17.9 
17.9 
14.1 
10.3 
10.2 
[13.2 – 15.4] 
[14.1 – 16.5] 
[16.7 – 19.2] 
[16.8 – 19.1] 
[13.0 – 15.2] 
[9.3 – 11.4] 
[9.4 – 11.1] 
Highest 
educational level 
within the 
household 
 
≤ Primary education 
Lower secondary 
Higher secondary 
Higher education 
 
1459 
1554 
2883 
3440 
11.9 
15.6 
33.3 
39.2 
[10.9 – 13.1] 
[14.3 – 17.1] 
[31.4 – 35.2] 
[37.2 – 41.2] 
     
Marital status Single (never married) 
Married or legally cohabiting 
Widow/er (not remarried) 
Divorced (not remarried) 
 
2725 
4673 
1428 
804 
29.8 
53.9 
7.8 
8.3 
[28.4 – 31.1] 
[52.5 – 55.6] 
[7.2 – 8.5] 
[7.5 – 9.2] 
Region of 
residence 
Flemish region 
Brussels’ region 
Walloon region 
 
3411 
2831 
3409 
58.2 
10.5 
31.3 
[57.0 – 59.4] 
[10.1 – 10.9] 
[30.2 – 32.4] 
Nationality Belgian 
Non Belgian EU 
Non Belgian non EU 
8440 
792 
393 
91.2 
5.8 
3.0 
[90.3 – 92.1] 
[5.1 – 6.5] 
[2.5 – 3.6] 
Health status 
Subjective health 
 
Good to very good 
Very bad to fair 
5633 
2023 
76.8 
23.2 
 
[75.3 – 78.1] 
[21.9 – 24.7] 
Severity pain in 
the last 4 weeks 
None 
Very mild - moderate 
Severe to very severe 
 
3963 
3340 
1048 
48.8 
39.2 
12.0 
[47.2 – 50.4] 
[37.7 – 40.7] 
[11.0 – 13.1] 
Longstanding 
illness, chronic 
condition or 
disability 
Yes 
No 
 
3470 
6150 
31.5 
68.5 
[30.2 – 32.9] 
[67.1 – 69.8] 
Health service utilization 
Regular GP 
 
Yes  
No 
8931 
687 
94.9 
5.1 
[94.2 – 95.5] 
[4.5 – 5.8] 
     
Inpatient 
hospitalisations in 
the past 12 months 
Yes 
No 
1222 
8364 
11.8 
88.2 
[10.9 - 12.8] 
[87.2 – 89.1] 
Sums may not always amount to the total sample number because of missing values on variables. Percentages may not always add 
up to 100 because of rounding. 
Missing values: for highest educational level in the household n= 315 (3.3%); for subjective health n=1995( 20.7%); for severity of 
pain the last 4 weeks n=1300 (13.5%). 
GP = General practitioner 
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Abstract 
Objective: The aim of this systematic review is to identify the perceived factors hindering or facilitating 
GPs in engaging in ACP with their patients about care at the end of life.  
Design: Studies (1990-2011) were searched in four electronic databases (PubMed, CINAHL, EMBASE, 
PsycINFO); by contacting first authors of included studies and key experts; and searching through 
relevant journals and reference lists. Studies were screened, graded for quality and analyzed 
independently by two authors; those reporting the perception by GPs of barriers and facilitators to 
engagement in ACP were included. 
Results: Eight qualitative studies and seven cross-sectional studies were included for data-extraction. 
All barriers and facilitators identified were categorized as GP characteristics, perceived patient factors 
or health care system characteristics. Stronger evidence was found for the following barriers: lack of 
skills to deal with patients’ vague requests, difficulties with defining the right moment, the attitude that 
it is patients who should initiate ACP, fear of depriving patients of hope. Stronger evidence was found 
for the following facilitators: accumulated skills, the ability to foresee health problems in the future, 
skills to respond to a patient’s initiation of ACP, personal convictions about who to involve in ACP, a 
longstanding patient-GP relationship and the home setting. 
Conclusion: Initiation of ACP in general practice may be improved by targeting the skills, attitudes and 
beliefs of GPs but changes in health care organization and financing could also contribute. 
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What is already known about this topic 
GPs can easily engage themselves in advance care planning (ACP) but the incidence of GPs engaging their 
patients in ACP remains low 
 
What this study adds 
This review adds to the knowledge in this field by also including studies on ACP discussions, whether or not 
these discussions results in written advance directives. 
Barriers and facilitators to engage in ACP were related to GP characteristics, perceived patient characteristics 
and health care system characteristics. 
Stronger evidence was found for GP skills, GP attitudes and GP beliefs regarding patients as barriers to 
engage in ACP 
 
Introduction 
Consistency between a patient’s wishes about end-of-life care and the actual care they receive at the end 
of life is considered an important aspect of both patient-centred care and quality end-of-life care [1-3]. 
This implies that the patient’s preferences regarding end-of-life care must be known before they lose the 
capacity to make these decisions themselves [4].  
ACP is defined as a voluntary process of discussion about future treatment and end-of-life care 
preferences between an individual, their family and their care providers should the individual become 
incapable of making decisions [5]. This process can result in three main outcomes, an ‘advance 
statement’ i.e. a documented statement of the patient’s general values and views about future care and 
treatment and/or an ‘advance directive’(AD), also known as a living will i.e. instructions regarding end 
of life care (e.g. the forgoing of specific treatment) and the appointment of a substitute decision-maker 
in the event of loss of capacity [6]. Internationally, different informal and legal documents related to 
ACP are used , depending on the specific jurisdiction in countries [7-10].  
The advantages of the timely initiating of ACP are well known: it facilitates access to palliative care, 
stimulates communication between the patient, family and physicians and results in greater satisfaction 
for the patient and the bereaved [11]. In an ageing population, more people will die from serious 
progressive illnesses, making timely initiation of ACP important [12;13]. General practitioners (GPs) 
are well-placed to encourage and engage in ACP [14;15] and the long-term relationship many patients 
have with their GP may be a good basis for initiating timely discussion [16;17]. Yet, previous research 
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has shown that the incidence of ACP discussions and the completion rate of ADs remain low among the 
general public and in specific patient populations [18-22]. Only 8% of the general public in England and 
Wales have completed an ACP document of any kind [23]. Surveys conducted in the USA show that 
only one-third of adults have an AD expressing their wishes for end-of-life care [24] and even among 
severely or terminally ill patients, fewer than 50% have an AD in their medical record [25]. In Belgium 
and the Netherlands GPs discussed ACP with terminally ill patients in a third of all cases and 
documented the discussion in only 8% (Belgium) and 16% (Netherlands) [26]. Although both patients 
and physicians support the idea of ACP, these results suggest that certain obstacles still prevail [27-29]. 
The objective of this systematic literature review is to identify the perceived factors that hinder or 
facilitate GPs in engaging in ACP with their patients; this has not been studied before though 
understanding of these barriers and facilitators is important for the development of interventions and 
training programmes aimed at facilitating ACP in general practice. 
 
Methods 
Search strategy for the identification of studies 
Four electronic databases were searched for studies published in English, French or Dutch between 1990 
and 2011: PubMed, CINAHL, EMBASE and PsycINFO. A search strategy was developed by ADV and 
DH for Medline and adapted to each database separately. A combination of controlled vocabulary and 
free text words was used to search in titles and abstracts: advance care planning, advance directives, 
advance decision, advance statement, living will, general practice, primary health care, general 
practitioners, family physicians, primary care, primary practice and family practice. 
The reference list of all identified studies was screened for additional relevant studies. The first author 
of each included study and known experts in the field of ACP were contacted for more studies. 
Furthermore, the most recent issues of 10 relevant journals were hand-searched for relevant papers. 
 
Inclusion and exclusion criteria 
An article was included if it reported (1) primary research (2) on barriers and facilitators (3) on GPs (4) 
on patient involvement in ACP. The inclusion criteria are defined as follows: 
(1) Primary research: Both quantitative and qualitative studies reporting original data that contain a 
clearly formulated research question or study aim were included. Editorials, narrative reviews, 
comments and expert opinion were excluded.  
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(2) Barriers and facilitators are conceptualized as predisposing factors, reported by the GP, that hinder 
or facilitate their engagement in the process of ACP with their patients such as skills, beliefs and 
experiences [30].  
(3) GPs: Articles reporting on general practitioners, family physicians or family doctors were included. 
Where a study reported on various types of health care professionals there must have been separate 
results for GPs.  
(4) ACP is defined as a voluntary process of discussion about future treatment and end-of-life care 
preferences between an individual, their family and their care providers should the individual become 
incapable of making decisions [5]. Studies only reporting on discussions about future care without 
involvement of the patient were excluded.  
 
Inclusion procedure 
Duplicates of the retrieved records were removed. Titles and abstracts of all identified reports were 
screened independently by ADV and DH using a standardized study selection form. The eligibility of 
selected studies was independently assessed by ADV and DH. Disagreement was resolved by discussion 
and a third reviewer (KP) was available for arbitration. 
 
Data extraction  
Characteristics of the studies included were extracted to a standardized data-extraction form. ADV and 
DH independently extracted data under the headings of general information, country, research question, 
design, participants, barriers and facilitators and quality assessment scores.  
Barriers and facilitators were extracted from the individual studies as mentioned in the article. Factors 
that were found as barriers and as facilitators in the same article were reported both as a barriers and 
facilitator. Factors only reported as barriers or only as facilitators in an article were also categorized 
only as barriers or facilitators. Discrepancies between reviewers were discussed and if consensus could 
not be reached, a third reviewer (KP) was consulted.  
 
Quality assessment and grading evidence 
The quality of studies was appraised and evaluated using the Critical Appraisal Skills Programme 
(CASP) [31]. Since no CASP tool is available for cross-sectional studies, an additional critical appraisal 
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tool developed by Crombie (21-items list) was used [32]. Total quality assessment scores for both 
qualitative and quantitative studies are presented as scores on a scale from 0 to10.  
In addition, the body of evidence from the multiple studies was graded using the three important 
elements for grading systems suggested by the Agency for Healthcare Research and Quality: quality, 
quantity and consistency [33]. The individual studies were categorized as high quality studies (scores 
from 8 to 10), medium quality studies (scores from 6 to 8) and low quality studies (scores equal to or 
lower than 5). Articles with low quality ratings were excluded from further data-extraction. Factors 
reported in two or more high quality studies were graded as stronger evidence. Factors reported in one 
high quality study or two medium quality studies were graded as medium evidence and factors reported 
in one medium quality study were graded as lower evidence. Consistency of the findings was achieved 
through the classification of all reported factors as barriers or facilitators, preceding the analysis of the 
results (Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Quality assessment 
 
 
 
Studies were categorized as: 
High quality (scores 8-10) 
Medium quality (scores 6-8) 
Low quality (scores ≤ 5) 
Low quality studies were excluded 
Stronger evidence: barrier or facilitator reported by ≥ 2 high 
quality studies 
Medium evidence: barrier or facilitator reported by 1 high 
quality study or ≥ 2 medium quality studies 
Lower evidence: barriers or facilitator reported by 1 
medium quality study 
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Results 
Identification of relevant studies (Figure 2) 
From the electronic databases searches 442 records were identified. After removal of duplicates and 
irrelevant reports, the title and abstract of 320 records was screened and 61 full-text articles were 
retrieved for detailed evaluation. Contact with the first authors of included articles and known experts 
in the field, a search in reference lists and hand-searching through relevant journals yielded 42 records. 
Sixteen articles met all inclusion criteria and were included for data-extraction and quality assessment 
as were nine qualitative studies and seven cross-sectional studies.  
 
Characteristics and quality assessment of relevant studies (Table I) 
Of the sixteen included studies, four were conducted in the USA, four in the UK, two in the Netherlands, 
two in Australia and one in Belgium, Canada, Singapore and Israel. Of the nine qualitative studies, six 
studies used semi-structured interviews and three studies used both interviews and focus groups. Data 
in all quantitative studies were collected through questionnaires. Different types of ACP were addressed 
in the included studies: eight reported on communication about end-of-life care in general, eight others 
on more specific types of ACP (e.g. ADs).  
Quality scores ranged from 4.5 to 8.5 for the qualitative studies and from 6.5 to 9 for the quantitative 
studies, both on a scale of 10. On the basis of these scores, four qualitative studies were considered as 
high quality, four as medium and one as low (excluded for further data extraction). Of the seven 
quantitative studies, we appraised five as high quality studies and two as medium quality studies.  
 
Barriers and facilitators for GPs (Table II) 
All reported barriers and facilitators were categorized as GP characteristics, perceived patient 
characteristics or health care system characteristics. 
 
GP characteristics 
Socio-demographic characteristics of GPs. There was medium evidence that the GP being younger was 
significantly and positively associated with the proportion of patients with whom they discussed end-
of-life decisions [34)]. 
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Figure 2: Flow diagram of literature search and selection of articles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
# of record that were identified through database 
searching: 
PubMed (271) 
Cinahl (86) 
PsycInfo (48) 
Embase (37) 
 
Total of 442 articles from 4 databases was retrieved 
363 records were retrieved after duplicates were removed 
320 records were screened by title and abstract 
61 full-text articles were retrieved for detailed evaluation 
259 records (titles 
and abstracts) were 
excluded because 
they did not meet 
the inclusion 
criteria 
16 articles were included for data extraction 
45 full-text articles 
were excluded 
because they did 
not meet the 
inclusion criteria 
43 records were 
excludes because 
they were not 
original studies 
(e.g. congress 
reports) 
# of records that were identified through other 
sources: 
Reference lists (27) 
Hand-searching journals (7) 
First authors/Experts (8) 
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Knowledge. Medium evidence was found for the reported lack of GP knowledge about ACP as a barrier 
to involving patients in ACP [35-37].  
Skills. There is stronger evidence that GPs perceive their own lack of skill in dealing with patients’ 
vague requests, and their difficulties in defining the right moment for initiating discussion, as barriers 
to engaging in ACP [14;37;38]. Medium evidence was found that they perceive their lack of skill in 
dealing with a patient’s changing preferences and with the emotional impact or discomfort of having 
ACP discussions as barriers [37;39;40]. Lower evidence supported the perceived lack of skill in advising 
patients on expressing their wishes, and the prognostic uncertainty for chronically ill patients as barriers 
[15;41]. Addressing patient initiation, accumulated skills and foreseeing health problems in the near 
future were factors reported as facilitators for which stronger evidence was found [14;15;39;41-43]. 
Experience. Medium evidence was found for the length of their experience as a GP and having a living 
will themselves as perceived facilitators [37;40]. Lower evidence supported positive experiences with 
end-of-life conversations in the past as a facilitator [15]. 
Attitudes. The attitude that GPs should initiate ACP was perceived a facilitator for which stronger 
evidence was found [37]. There is medium evidence that a conviction that it is their job to cure people 
whereas other healthcare professionals should initiate ACP prevents GPs engaging in ACP [14;39]. 
Doubts regarding the content and practical availability of living wills are hindering factors as well [39]. 
 
Perceived patient characteristics 
Perceived patient-related obstacles can hinder GPs in initiating ACP. The GP holding the following 
beliefs is perceived as a barrier and supported by lower evidence: patients lack knowledge of ACP, 
patients have a fear of upsetting their families and patients are reluctant to think about future health care 
problems [35;37;42;44]. Medium evidence supports that a patient’s denial of their terminal illness makes 
talking about preferences for end–of- life care very difficult [14]. 
Anticipated adverse outcomes. Fear of depriving a patient of hope or damaging the GP-patient 
relationship were cited as factors that keep GPs from engaging in the process of ACP, for which 
respectively stronger and medium evidence was found [15;34;39]. 
Personal convictions about who and who not to involve in ACP and when. When asked who should be 
approached about ACP, GPs designated terminally ill patients and healthy patients in medium quality 
studies [15;35;36;45]. GPs reporting that competent patients and cancer patients are more involved in 
ACP is supported by stronger evidence [26;34;38]. Medium evidence was found that three events trigger 
discussion between GPs and patients: admission or discharge of patients from the hospital, when end-
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of-life decisions are estimated by the GP to shorten patients’ life by more than one week and when 
patients receive treatment aimed at palliation in the last week of life [15;26;34;45]. 
 
Health care system characteristics 
Related to the GP practice. Stronger evidence supported a longstanding patient-GP relationship as a 
perceived facilitator for ACP [14;38]. GPs also considered it advantageous if talking about ACP could 
take place in the home setting [26;38]. There is medium evidence for the time available, and the chances 
of reimbursement being facilitators [14;45]. The limited resources available in primary care were 
perceived as a barrier [40]. 
Related to other healthcare providers. There is lower evidence that lack of collaboration with secondary 
care is perceived as an impediment to the process of ACP [15;44]. Consultation with other healthcare 
professionals and hospital policy supporting or requiring the use of ADs was considered as a facilitator, 
supported by medium evidence [34;45]. 
Related to legislation. GPs reported that legislation supporting the use of ADs as well as protecting GPs 
who following them would encourage them to offer ADs to patients, which is supported by medium 
evidence [35;45]. 
 
Discussion 
We found numerous perceived barriers and facilitators influencing GP engagement in ACP with 
patients. All reported factors were related to three groups: GP characteristics, perceived patient 
characteristics and health care system characteristics. Stronger evidence was found for lack of skills to 
deal with vague requests, difficulties with defining the right moment, the attitude that patients should 
initiate ACP and fear of depriving them of hope as perceived barriers. The perceived facilitators for 
which stronger evidence was found were accumulated skills, the ability to foresee health problems in 
the future, skills in addressing patient initiation of ACP, cancer patients, patients capable of decision-
making, a longstanding patient-GP relationship and a home setting.  
To our knowledge, this is the first study to provide a systematic overview of the perceived barriers to 
and facilitators for GPs engaging in ACP. All required methodological steps to complete a systematic 
review were implemented and performed separately by two reviewers. This review adds to the 
knowledge in this field by also including studies on ACP discussions, whether or not these discussions 
result in written advance directives [46]. This review also has limitations. Given the variation in how 
ACP is implemented and documented and the variation in GP practice, our findings may not be 
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generalizable to all countries and health care systems. Second, only barriers and facilitators reported by 
GPs were considered although understanding the barriers and facilitators for patients is equally 
important and deserves research. Third, we retrieved only qualitative research and observational studies 
though in our opinion such research designs provide the best way of addressing the research question. 
As the studies used different methods, it was not appropriate to combine data across the studies for meta-
analysis [47;48]. However, the methodological quality was assessed and in addition, the body of 
evidence was graded. This approach allows to provide a conclusion that incorporates both the results 
and quality of the studies [49]. 
Stronger evidence was found for the GP attitude that patients should initiate discussions being a barrier 
and for having the skill to address a patient’s initiation of discussion as a facilitator. Remarkably, many 
studies show that patients believe it is the physician’s responsibility to initiate ACP which suggests that 
there is a gap in expectation between patients and GPs. This difference has been pointed out in previous 
studies and may explain why ACP consultations are often initiated tardily when end-of-life decisions 
need to made [50-53].  
Most of the perceived barriers for GPs were classified as a lack of skills; it is recognized that physicians 
are less likely to initiate ACP when they believe they lack the skills required [54]. The perceived lack 
of skills to deal with a patient’s changing preferences and to address vague requests and difficulties with 
defining the right moment to initiate ACP were also found in other health care settings [28;55]. Many 
of the same barriers could also be found in the literature on communication at the end of life in general 
and may cover the same ground, since ACP is often initiated at the end of life [56-58].  
According to GPs, cancer patients are more involved in the process of ACP than non-cancer patients. 
As they often have a more predictable disease course, defining the right moment to initiate ACP might 
be easier. Research has shown that one of the reasons ACP was not initiated with patients with chronic 
obstructive pulmonary disease (COPD) was because of physicians’ lack of understanding that COPD is 
a life-threatening disease [21]. Not only physicians, but also chronically ill non-cancer patients often 
have a poor understanding of their illness [59;60]. It is possible that non-cancer patients initiate ACP 
less often because of a reduced awareness of their diagnosis and prognosis. Most patients and 
professionals agree that talking about ACP should take place around the time of diagnosis of a life-
threatening illness, but fear of depriving patients of hope is a barrier preventing GPs from initiating ACP 
for which stronger evidence was found [61;62]. 
The facilitators identified were often related to health care system characteristics. Previous research 
showed that conversations about ADs averaged 5.6 minutes and physicians spoke for two thirds of this 
time, making patient’s values and preferences rarely explored [63]. Financial compensation for the 
time spent on ACP could possibly encourage GPs to make ACP a current practice but it could also 
acknowledge the importance of this aspect of care.  
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Conclusion 
Understanding the barriers and facilitators is important for the development of interventions aimed at 
facilitating ACP in general practice. Initiation of ACP in general practice may be improved by 
targeting GP-related barriers and facilitators, but changes in health care organization and finances 
could also contribute. Training programmes are necessary to change skills, attitudes and beliefs 
preventing GPs from initiating ACP and to provide good role models for the difficult task of initiating 
communication about end of life in a helpful and empathetic way. 
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Abstract 
Background: The long-term and often lifelong relationship of general practitioners (GPs) with their 
patients is considered to make them the ideal initiators of advance care planning (ACP). However, in 
general the incidence of ACP discussions is low and ACP seems to occur more often for cancer patients 
than for those with dementia or heart failure.  
Objective: To identify the barriers, from GPs’ perspective, to initiating ACP and to gain insight into 
any differences in barriers between the trajectories of patients with cancer, heart failure and dementia. 
Method: Five focus groups were held with GPs (n=36) in Flanders, Belgium. The focus group 
discussions were transcribed verbatim and analyzed using the method of constant comparative analysis. 
Results: Three types of barriers were distinguished: barriers relating to the GP, to the patient and family 
and to the health care system. In cancer patients, a GP’s lack of knowledge about treatment options and 
the lack of structural collaboration between the GP and specialist were expressed as barriers. Barriers 
that occurred more often with heart failure and dementia were the lack of GP familiarity with the 
terminal phase, the lack of key moments to initiate ACP, the patient’s lack of awareness of their 
diagnosis and prognosis and the fact that patients did not often initiate such discussions themselves. The 
future lack of decision-making capacity of dementia patients was reported by the GPs as a specific 
barrier for the initiation of ACP. 
Conclusion: The results of our study contribute to a better understanding of the factors hindering GPs 
in initiating ACP. Multiple barriers need to be overcome, of which many can be addressed through the 
development of practical guidelines and educational interventions.  
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Introduction 
The expected increase in numbers of people developing dementia, the growing number of old people 
suffering and dying from serious chronic diseases and the rising costs of health care as a result of an 
aging population have focused attention on advance care planning [1]. Advance care planning (ACP) is 
the voluntary process by which patients discuss their future treatment and end-of-life care preferences 
with their care providers in case they lose the capacity to make decisions or communicate their wishes 
in the future. If a patient chooses to, the contents of such a discussion can be placed on record in the 
form of an advance statement (of wishes and preferences), or an advance decision to refuse treatment in 
specific circumstances and may include the appointment of a proxy decision-maker or lasting power of 
attorney [2;3] .  
The long-term relationship between general practitioners (GPs) and their patients is considered an ideal 
context for introducing the subject and starting the process of ACP before the patient becomes seriously 
ill [4-6]. Evidence shows that patients are comfortable discussing ACP with their GP when their 
condition is stable in anticipation of future ill-health [7]. In Belgium, as in many European countries, 
GPs have mostly built up long-term relationships with their patients [8]. However, a cross-national 
retrospective study showed that, in a population of patients who died non-suddenly, GP-patient 
discussion of treatment preferences occurred for 25% of patients in Belgium [9]. Cancer patients are 
also more often involved in the process of ACP than non-cancer patients, suggesting that initiation of 
ACP with other patient groups has its own challenges [10]. 
Current international guidelines suggest that all patients with a chronic life-limiting illness should be 
offered ACP before time-critical situations occur [3;11], but discussions about end-of-life care often 
takes place with those who are terminally ill and are relatively close to death [12-14]. However, an 
understanding of the three main illness trajectories of patients with chronic life-limiting diseases indicate 
that these patients may benefit from the timely initiation of ACP [15;16]. The first trajectory is typified 
by cancer and generally follows a relatively predictable end-of-life course with a maintenance of good 
function until a rapid decline in clinical status in the last weeks of life. Heart failure is typical of the 
second trajectory, marked by a slow decline that is interrupted by acute deteriorations any of which 
might end in sudden death. For these individuals there is considerable uncertainty about when death is 
likely to occur. The third trajectory, typically seen in patients suffering from dementia, follows a long 
term period of progressive decline in functional and mental capacity before death [17]. When patients 
are hospitalized for health crises resulting from their chronic incurable disease, the patient may be close 
to death, yet there often is no clearly recognizable starting point between being very ill and actually 
dying [18]. Reserving ACP discussions for the end-of-life may thus deny patients the chance to 
adequately prepare for and plan their future care while having the decision-making capacity to do so 
[19]. 
Chapter 4 
102 
 
Previous qualitative studies conducted in the UK and Australia identified a lack of time, a desire to 
maintain hope, prognostic uncertainty and the belief that patients are not willing or able to face 
discussions around death and dying as barriers to initiating ACP in primary care [20-22]. However, most 
of these studies have been focused on single patient groups (e.g. cancer patients) or on the initiation of 
ACP with terminally ill patients. The aim of this study is to identify the barriers, from GPs’ perspective, 
to initiating ACP and to gain insight into any differences in barriers between the trajectories of patients 
with cancer, heart failure and dementia. 
 
Methods 
Research design 
This exploratory study used the qualitative methodology of focus groups. The focus group approach was 
chosen because it is flexible in that it allows for open discussion and interaction in order to obtain in-
depth insight into the range of views and experiences of GPs regarding barriers to initiating ACP [23].  
 
Recruitment of participants 
Five focus group interviews with GPs were held in Flanders (Belgium) during March 2012. The 
participants were purposefully sampled by using several recruitment strategies in order to maximize the 
variation in their experience, age and practice location. Three focus groups were organized within local 
peer-review GP groups by contacting the chairs of six of these groups. Local peer-review GP groups are 
geographically determined groups of GPs from both individual and group practices that meet four times 
a year to discuss their practice. Every GP who wants to be accredited in Belgium, needs to be affiliated 
to a peer-review group and is obliged to attend two out of four meetings per year. A report from 2005 
showed that more than 90% of active GPs in Belgium are affiliated to a peer-review group [24]. We 
chose to recruit via local peer-review groups to obtain a sample of GPs representing a wide range of 
experience related to the topic (maximum variation sampling) [25]. Secondly, because research shows 
that advance care planning usually takes place with patients who are terminally ill and close to death 
[26], we specifically also wanted to enroll GPs who have experience with palliative patients and 
communication in the last phase of life. We contacted coordinators of the palliative care networks in 
Flanders with the request to disseminate our invitation to GPs active in palliative home care teams. 
Palliative home care teams consist of experts in palliative care (physicians, nurses, psychologists) who, 
in addition to their own practice, advise and support palliative patients in their last phase of life and 
work closely with the surrounding caregivers to organize optimal care for the patient. However, because 
not many GPs from the palliative home care teams responded to our invitation (n=2) we complemented 
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this focus group with GPs not working in a palliative home care team. These other GPs were recruited 
through professional contacts of the palliative care coordinators that referred us to these participants 
(snowball sampling). A fifth focus group was organized with members from a group practice that is 
located in an urban region as opposed to the rural and semirural regions where the other focus groups 
took place. 
 
Data collection 
A topic guide, consisting of open questions and a set of prompts for each question, was developed and 
reviewed within a multidisciplinary research team of sociologists (ADV, DH, LD), psychologists (KP, 
KB, CVA), a GP (RVS) and an anthropologist (RD), and covered four general themes: (1) experiences 
of GPs with ACP in their current practice (2) attitudes regarding ACP (3) perceived barriers to and 
facilitators for initiating ACP and (4) possible interventions to improve initiation of ACP in general 
practice (Figure 1). A definition of ACP was introduced at the beginning of each focus group and 
participants were asked whether they were familiar with this definition and the term ‘ACP’. ACP was 
defined as a voluntary process by which patients discuss their future treatment and end-of-life care 
preferences with their care providers in case they lose the capacity to make decisions or communicate 
their wishes for the future [2;3]. 
At the start of each focus group, the participants were informed about some important ‘ground rules’ of 
a focus group discussion, e.g. no talking across each other, keeping the information discussed 
confidential, etc. Each focus group was moderated and observed by two researchers (ADV, KP, RVS or 
LD) and took place in a quiet meeting room. The focus groups were conducted in Flemish and were 
translated by the first author. The focus groups lasted on average one and a half hours and were 
audiotaped, for which all participants gave their informed consent. Before the interview the participants 
also filled in a short questionnaire regarding their own characteristics. After conducting the first two 
focus groups, that focused on discussing the differences between the initiating of ACP with patients with 
cancer, dementia and heart failure, the research team decided to explore these differences further by 
focusing on one of the specific patients groups in each of the three following focus groups. To improve 
data collection the topic guide was slightly modified after the first two focus groups, without 
compromising consistency. However, during these focus groups the participants drew comparisons 
themselves between the trajectory chosen for discussion and the other trajectories. After five focus 
groups, the researchers evaluated that saturation had been reached. 
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Figure 1: Topic guide of the focus groups with general practitioners 
Introduction + Definition of ACP 
Theme 1: Experiences of GPs with ACP in practice 
1. Do you know the concept of ACP? 
2. Do you have any experience with ACP in your practice? 
Theme 2: Attitudes regarding ACP 
1. Can you describe your attitude regarding ACP? Do you feel that ACP can be useful? 
2. What are the main advantages and disadvantages of ACP for you? 
Theme 3: Perceived barriers and facilitators for initiating ACP 
1. Are there situations when the initiation of ACP is perceived as more difficult or easy for you? 
2. Do you think that the (one of the three) specific disease trajectory of patients has an influence on the 
initiation of ACP for you? 
Theme 4: Interventions to improve the initiation of ACP in general practice 
1. What do you think could contribute to the improvement of initiating ACP for general practitioners? 
 
Data analysis 
The focus group discussions were transcribed verbatim. For analyzing the data, constant comparative 
analysis was used [27;28]. Firstly, two researchers (ADV & KB) independently read and coded two full 
focus group transcripts. The codes were discussed and mutually compared for similarities and 
differences until a primary coding framework was constructed. Subsequently, the five focus group 
transcripts were independently read and compared with the primary coding framework by all the 
members of the research team. Codes were added, modified or merged where necessary. Notes were 
taken about the decisions that had been made during the coding process to ensure consistency of results. 
ADV coded the remaining transcripts by applying the final coding framework, which was additionally 
checked by KB and KP for agreement on interpretation. Once coding was completed, ADV & KP 
revised the transcripts and the coding framework. An ongoing refinement of the coding framework, by 
grouping the codes that had common elements, eventually resulted in categories that related to the 
research questions. Finally, quotes were selected (ADV & KP) and approved by the research team to 
illustrate the results. The qualitative analysis software QSR NVIVO 10 was used for this research.  
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Ethical aspects 
The research protocol was approved by the Commission of Medical Ethics of the University Hospital 
of Brussels. A signed informed consent was obtained from each participant before the focus group 
interview. Anonymity was assured by removing participant information that could lead to identification 
from the transcripts. 
 
Results 
A total of 36 GPs (n= 9, n= 11, n= 4, n= 5, n= 7) attended one of the five focus groups. Participants’ 
characteristics are presented in Table 1. 
Although the GPs identified end-of-life care conversations as an important aspect of general practice, 
many of them were not familiar with the term ACP. Once a general definition was introduced, most GPs 
indicated that they had some experience with end-of-life care discussions but stated that they were 
mostly conducted in an informal way. 
It [ACP] does not have to be anything formal, it may also be just a little chat in response to…I think it is 
very important that that is monitored. That [ACP] does not become a formality, a consensus on paper 
with a hierarchical structure and a number of conditions which must be complied with. (Female GP, 40 
years, FG 1) 
Is ACP also not something that is often discussed between the lines? (Female GP, 41 years, FG 1) 
 
GPs with more experience and expertise in palliative care were generally more familiar with the concept 
and process of ACP. Positive experiences with previous ACP discussions was, according to most GPs, 
also considered to be an important facilitator for the initiation of ACP.  
 
Barriers to initiating ACP according to GPs 
An overview of all the barriers that were mentioned in the focus groups is presented in Table 2. The 
perceived barriers were interpreted as barriers relating to the GP, to the patient and family and to the 
health care system (e.g. lack of time to discuss ACP in general practice). Most of the barriers identified 
related to the GP and could be classified as lack of GP communication skills, lack of GP knowledge 
regarding illness trajectories or GP attitudes and beliefs regarding ACP. There were barriers for which 
no differences between the trajectories of cancer, heart failure and dementia were perceived, e.g. lack  
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Table 1: Characteristics of participating GPs (N = 36) 
Characteristics FG 1 (n= 9) FG 2 (n=11) FG 3 (n= 4) FG 4 (n= 5) FG 5 (n= 7) Total 
Sex       
Male 5 7 4 5 6 27 
Female 4 4 0 0 1 9 
Age (years)       
≤ 29 1 0 0 0 0 1 
30-39 1 2 0 1 1 5 
40-49 5 3 1 2 2 13 
50-59 1 5 1 1 1 9 
60-69 1 1 2 1 3 8 
≥ 70 0 0 0 0 0 0 
Practice 
location 
      
Urban 9 0 0 0 0 9 
(Semi-)Rural 0 11 4 5 7 27 
Number of 
terminal 
patients in 
their practice 
in the last year 
      
None 2 1 1 0 0 4 
1-3 3 3 1 2 1 10 
4-6 3 1 2 2 3 11 
7-9 0 1 0 0 1 2 
≥ 10 1 5 0 1 2 9 
Active in a 
palliative 
home care 
team 
      
Yes 0 0 0 0 2 2 
No 9 11 4 5 5 34 
Clinical work 
experience 
(years) 
      
1-9 2 2 0 0 0 4 
10-19 2 1 0 2 2 7 
20-29 3 4 2 1 2 12 
≥30 2 4 2 2 3 13 
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Table 2: Barriers according to GPs to initiate ACP 
 
Barriers related to the GP 
Lack of communication & interpersonal skills of GPs: 
Difficulties for the GP with addressing non-specific patient issues 
GPs not feeling comfortable in talking about death and dying 
Lack of GP education about ACP 
Lack of GP experience with ACP 
Lack of GP experience with palliative patients 
 
Lack of GP knowledge regarding illness trajectories in order to initiate ACP: 
Lack of GP knowledge about treatments options in order to discuss ACP 
Lack of GP familiarity with the terminal phase of illness 
Difficulties for the GP with making accurate predictions of life expectancy 
Difficulties for the GP to define key moments to timely initiate ACP 
Lack of GP knowledge about the legal status of advance directives 
 
GP attitudes & beliefs concerning ACP: 
Fear of legal proceedings by implementing ADs 
Fear of losing the patient as a client by discussing end-of-life care 
Fear of destroying hope in the patient by initiating ACP 
Fear of creating anxiety by initiating ACP 
Uncertainty over appropriateness of ACP for non-chronically ill patients 
Lack of trust in the value of ACP to comply with patient wishes at the end of life 
Believing that patients will initiate ACP themselves if they are ready to discuss it 
Believing patients do not like to discuss end-of-life care 
Barriers related to the patient and family 
Lack of patient initiation 
Patients changing end-of-life care preferences 
Patients’ unawareness about the diagnosis and prognosis 
Patients’ and/or family members’ denial about imminent death 
Patients misinterpreting disease information 
Future lack of decision-making capacity 
Patients’ family hindering end-of-life care discussions 
Lack of a longstanding relationship with the patient 
Barriers related to the health care system 
Lack of structural collaboration with secondary care or other health care professionals 
Lack of time to discuss ACP in general practice 
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of time. The barriers for which differences were indicated between these trajectories are explored in 
depth below. 
 
Differences in barriers to initiating ACP between cancer, heart failure and dementia (Table 3) 
Lack of GP knowledge about cancer treatment options. Several GPs reported a lack of knowledge 
about existing treatments for different cancer types and their possible effects as a barrier, which they 
considered essential to the discussion of treatment decisions and end-of-life care preferences. 
For a good planning you need to be well informed, you need to know what are the possibilities and 
what aren’t the possibilities and I do feel that… that I often know too little. That might be because… 
maybe I should inquire about it more often, that may well be so, but I often get the feeling: I can’t 
assess this anymore, what benefits does it have, or doesn’t it have. I find it hard. (Female GP, 60 years, 
FG 5) 
 
This problem existed far less with regard to heart failure and dementia because of the perception by the 
GPs of the limited treatment options they offer. 
Heart failure is a pretty aggressive condition. Once you’ve got it, you can’t do anything about it anymore. 
(Male GP, 60 years, FG 4) 
 
Lack of GP familiarity with the terminal phases of heart failure and dementia. During the focus groups, 
it became clear that several GPs were less familiar with the terminal phases of heart failure and dementia; 
not only is the terminal phase less clear than with cancer but for some GPs the life-limiting nature of 
heart failure and especially dementia is not always apparent. Consequently, for some GPs the recognition 
of the need to discuss end-of-life care does not always arise. 
Do you die from dementia? (Male GP, 58 years, FG 4) 
Yeah, but in that case it’s from age? Well yeah, you have to die once. I mean… (Male GP, 45 years, FG 
4) 
However, during the focus groups, some GPs came to recognize the importance of timely initiation of 
ACP for heart failure and dementia patients: 
Yes, [for cancer patients] you can feel or sense that better as a GP. But for heart failure… I myself am 
actually a little stunned. It is true, there should actually be a discussion about it. (Male GP, FG 4, 38 
years) 
On the other hand, for a patient that is becoming demented, you may have to provide care for more than 
5 years, without him knowing. So actually it is important to know what they really care about and what 
not. (Female GP, 35 years, FG 2) 
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Table 3: Differences in barriers to initiate ACP between the trajectories patients 
with cancer, heart failure and dementia according to the GP 
 
 Cancer Heart 
failure 
Dementia Mentioned in 
FG 
Barriers related to the GP:     
Lack of GP knowledge about treatment options ↑   4, 5 
Lack of GP familiarity with the terminal phase of 
illness 
 ↑ ↑ 3, 4 
Difficulties for the GP to define key moments to 
timely initiate ACP 
 ↑ ↑ 2, 3, 4, 5 
     
Barriers related to the patient and family:     
Patients’ unawareness about diagnosis and 
prognosis 
 ↑ ↑ 3, 4, 5 
Future lack of decision-making capacity   ↑ 1, 3, 5 
Lack of patient initiation  ↑ ↑ 1, 2, 3, 4, 5 
     
Barriers related to the health care system:     
Lack of structural collaboration between primary 
and secondary care 
↑   1, 2, 3, 4, 5 
↑: barrier according to GPs for the initiation of ACP with a specific patient group in comparison to the 
other patient groups 
 
Lack of key moments for the initiating of ACP in the trajectories of heart failure and dementia. 
Although a number of key moments suitable for initiating ACP with cancer patients were raised during 
the focus groups (at diagnosis, when patients experience negative effects from medical treatment, when 
treatment is withdrawn and when patients are deteriorating at the end of life), the point when curative 
treatment is exhausted was considered the most appropriate according to most GPs. The majority of GPs 
acknowledged that the stage of advanced illness was too late to initiate ACP with heart failure patients 
but end-of-life care issues were generally raised when the patient’s condition was obviously declining 
after numerous acute hospital admissions. For dementia patients, no key moments were identified for 
the initiation of ACP. 
Because it’s obvious, they [cancer patients] have been diagnosed, for the time being I’m assuming most 
people have been informed of this diagnosis as well, and otherwise I’ll deliver it myself. And so I think 
it’s way easier to, sooner or later, start a conversation in response to that diagnosis, while it’s a lot harder 
in case of dementia, because there’s already some cognitive impairment. And it’s also very difficult in 
case of organ failure huh, because those people are doing well, there’s no sudden diagnosis, they’ve 
already been hospitalized for this before… and a patient with organ failure does get worse, but there isn’t 
always a facilitating moment. Therefore it’s not always easy to [talk to] such a person, who despite having 
for example lung problems, doesn’t always realize he’s just as terminal as a cancer patient. And I find 
that much harder, … (Male GP, 42 years, FG 5) 
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Only a few GPs with considerable experience in end-of-life care believed that ACP should be initiated 
as early as possible:   
I start [ACP] with my patients as early as possible. Even if they come to me on a consultation for the 
first time and I see the opportunity to bring it up, I will. Because I like to know those things before it 
happens. I like people to give their advice before anything happens to them. It also allows for a more 
open and free discussion. So for me it is: the earlier, the better. And I mean, I do not snub people and 
ask them “what’s your name and what is your vision on the end-of-life?”. But still, if an opportunity 
arises, I will grab it as soon as possible. I like to know how the patients sees things. (Female GP, 35 
years, FG 2) 
 
A patient’s lack of awareness of diagnosis and prognosis in heart failure and dementia was expressed 
as a barrier to the initiation of ACP compared with cancer patients. Although most heart failure patients 
are informed that they are suffering from a heart condition, the prognosis is not always communicated 
because GPs can have difficulty in explaining potential events such as the risk of sudden death without 
creating anxiety. The fear of creating anxiety or depression for dementia patients by explaining the 
expected deterioration of their mental capacity was similarly mentioned as a barrier. GPs considered it 
too difficult to initiate ACP at any point with patients who are unaware of their diagnosis or prognosis.  
I think we’ve got quite a lot of patients with dementia, but you won’t immediately start telling these people: 
soon you won’t know what you’re doing anymore. It’s time that you do something about it, that you start 
planning this, I think it’s a bit of a taboo to start discussing this, to tell someone with Alzheimer’s, in a 
year you won’t know what you’re doing anymore. (Male GP, 44 years, FG 3) 
 
According to the GPs in our focus group, cancer patients were more aware of their diagnosis as opposed 
to patients with heart failure and dementia, which can create an opening for the discussion of prognosis 
and types of treatment: 
Patients are often sent home with a diagnosis. They know what is going on, but they haven’t received very 
specific information from the specialists. They wonder: “What will happen to me? Is there really nothing 
they can do for me?”. (Male GP, 60 years, FG 2) 
 
Lack of patient initiation of ACP in heart failure and dementia was mentioned as a barrier in all focus 
groups. The GPs described cancer patients as the easiest group with whom to initiate ACP, because they 
spontaneously make the association with death and dying when hearing their diagnosis.  
But it’s different, because in this case the question won’t come from the patient that often, I think. For 
cancer it’s known, “cancer – death”, people do make that association. While heart failure is like, yeah, 
he’s got heart problems.(Male GP, 38 years, FG 4) 
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Because patients with dementia and heart failure are often unaware of or in denial about the life-
threatening nature of their disease according to most GPs, they rarely initiate ACP themselves. 
It has never happened [that a patient with dementia starts discussing ACP on his/her own initiative] 
(Male GP, 69 years, FG 3) 
Cancer patients do however. (Male GP, 65 years, FG 3) 
 
Future lack of decision-making capacity of dementia patients was given great weight as a barrier to 
initiating ACP. Many GPs felt uncomfortable about discussing and planning end-of-life care with 
patients who are losing the capacity to express a change in preference or confirm their wishes at the end 
of life. As patient’s wishes and circumstances may change over time, some GPs were also reluctant to 
make formal documentation of decisions expressed by dementia patients.  
Because I think for the category of people with a deteriorating level of consciousness it’s a different 
story than for people with cancer or kidney failure, with whom you can hold conversations until the 
very end sometimes… I think this is a really difficult category of people compared to a person who can 
still talk to you about what he wants or doesn’t want. (Female GP, 44 years, FG 1) 
I think in the really early stages of dementia we actually don’t discuss this with the patient because it’s 
often diagnosed very late. At that moment, discussing it is actually no longer possible. (Male GP,44 years, 
FG 3) 
 
On the other hand, some GPs considered the future loss of a patient’s decision-making capacity the very 
reason for initiating ACP: 
It is much better that you discuss this in advance, rather than to discuss it with the patient’s family because 
the patients has dementia. If you previously haven’t talked about it, than you actually have missed your 
chance. So yes, I believe that ACP discussions should start early with the patient instead of talking to the 
family, the nurse, or the care team around a patient that is not able to communicate anymore. (Male GP, 
65 years, FG 5) 
 
In some focus groups, doubts about the legality of advance directives (ADs) drafted by dementia patients 
and anxieties about possible legal proceedings that may follow their implementation were also 
mentioned as a barrier to initiate ACP discussions: 
If the patient signs, and he has been diagnosed with dementia, where do you stand, is it still legal? He 
signed while, according to the court of justice, he no longer knew what he was doing. (Male GP, 44 years, 
FG 3) 
 
Lack of structural collaboration between primary and secondary care for cancer patients was 
mentioned in all focus groups as a barrier to initiating ACP. In the case of cancer particularly, limited 
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contact with patients and lack of information from specialists during treatment phases were considered 
as factors that hinder the initiation of ACP.  
The patient used to be able to report back to you once in a while about what had or hadn’t been decided. 
But nowadays they [the hospital] actually keep them to themselves for a very long time, even in a palliative 
situation I think. Well, at certain wards this is definitely the case. You don’t have to draw their blood 
anymore, they don’t have to come and talk to you. They do that at the hospital for a really long time, even 
the moment they say, now we can’t do anything anymore, maybe you should go to the palliative unit now, 
while the patient actually won’t hear a lot about dying at home if we don’t come and explain it, I think. 
(Female GP, 49 years, FG 1) 
 
Some GPs evaluated the collaboration between GPs and specialist more positively, but acknowledged 
that was mostly due to a longer relationship or a past experience between the GP and specialist: 
I feel that you almost need to have a personal relationship with a specialist before you can have any 
impact. (Male GP, 30 years, FG 1) 
 
Yes, there is indeed a big difference. I also hear that from colleagues who work in a completely different 
area, where there is a smaller local hospital. They have a much closer relationship with the specialist 
than here. I think here some older colleagues who have some experience have much more direct contact 
with the specialists, so a lot more things are possible. (Male GP, 29 years, FG 1) 
 
The tendency of specialists to persist with curative treatment even when patients are deteriorating 
appeared to be an obstacle to initiating ACP for many GPs.  
You do tell the family, just keep him here because he’s dying, he only has a couple of weeks left, 
whereas the oncologist told them 2 days before ‘you really need to come, because this will still make 
you feel good’. So there you are then. (Male GP, 65 years, FG 5) 
As a GP, you really can’t go against this. (Male GP, 46 years, FG 5) 
 
Discussion 
Summary of main findings 
The GPs in our study reported multiple barriers to initiating ACP relating to their own characteristics, 
the characteristics of the patients and their families and the structure and organization of the health care 
system. They also perceived certain of these barriers to relate more to the specific trajectories of cancer, 
heart failure or dementia. In cancer patients, a GP’s lack of knowledge about treatment options and the 
lack of structural collaboration between the GP and specialist were expressed as barriers. Barriers that 
occurred more often with heart failure and dementia patients were the lack of GP familiarity with the 
terminal phase, the lack of key moments to initiate ACP, the patient’s lack of awareness of their 
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diagnosis and prognosis and the fact that patients did not often initiate such discussions themselves. The 
future lack of decision-making capacity of dementia patients was reported by the GPs as a specific 
barrier for the initiation of ACP. 
 
Strengths and limitations of the study 
To our knowledge, this is the first qualitative study providing in-depth insight into the similarities and 
differences in the barriers to initiation of ACP between cancer, heart failure and dementia patients, as 
perceived by the GP. By using different sampling strategies we gained insight into the complex range 
of views and experiences regarding ACP in daily practice from GPs with diverse backgrounds, 
experience and interest in ACP. This study provides a better understanding of the problems that need to 
be overcome when developing interventions or training programmes to enhance the initiation of ACP 
in general practice [29]. Our description of the barriers remained as close as possible to the phrasing 
used in the focus groups and we divided them into three main categories as relating to the GP, to the 
patient and family and to the health care system; however many barriers are interrelated and should not 
be interpreted as isolated factors. The focus group composition may have presented a limitation. Most 
of the participating GPs were male (n= 27), so female GPs (n= 9) were underrepresented, as were GPs 
younger than 39 years (n= 6 vs. n= 30). Secondly, the perspective of the GPs themselves is valuable in 
obtaining the information essential for making changes in education and innovation in practice. However, 
other perspectives such as those of patients and family members, and of specialists, could provide 
additional insights that could also contribute to a better understanding of the problems of ACP and to 
the formation of useful educational approaches. 
 
Comparison with existing literature 
The findings of this qualitative study confirm many barriers to GP initiation of ACP found in previous 
studies [1;5;30], but are here placed in the context of the three illness trajectories of cancer, heart failure 
or dementia. Four of the seven barriers for which a difference was identified, pertained to heart failure 
and dementia patients. The barriers pertaining to both heart failure and dementia patients seem mainly 
to be consequences of the less predictable disease course of these conditions, leading to GPs 
experiencing difficulty with predicting the terminal phase of disease [31;32]. The clearer demarcation 
between curative and palliative care in cancer patients, often used as a trigger and also considered as the 
most appropriate moment by the GPs in our focus groups to initiate ACP, is less distinct in heart failure 
and dementia. This challenges GPs to identify other key moments to initiate ACP, one of the main 
problems for GPs that needs to be addressed according to previous studies [33;34]. Previous research 
also shows that GPs find diagnosing heart failure and giving a prognosis particularly challenging, 
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making it difficult for them to relay information back to patients [31]. Many patients are never actually 
told that they have heart failure because doctors are reluctant to use the term [35] and similar concerns 
have been raised for dementia [36]. Communicating a diagnosis and prognosis is however an important 
element in informing patients of treatment and end-of-life care choices. Recently, experiential skills-
building communication training in cancer has been shown to improve clinicians’ skills in 
communication about end-of-life care [37;38]. As GPs’ experience with ACP was also considered to be 
a facilitator in this study, offering GPs such training may improve their confidence and skills with 
initiating ACP for all patients in relation to chronic life-limiting conditions. 
The barriers pertaining to cancer patients (lack of knowledge about treatment options and lack of 
structural collaboration between primary and secondary care) seem to be related to the increasing 
specialization and complexity of cancer treatments. While heart failure and dementia are largely 
managed in primary care, most follow-up and surveillance of cancer patients remains in the hands of 
specialists [39]. As a consequence, GPs often lose touch with their patients during active treatment, 
which is not countered by effective collaboration or information transmission between GPs and 
specialists [40]. Although GPs are generally identified, including by specialists, as the most appropriate 
professionals to initiate ACP, GPs themselves have reported a lack of clarity about whose role it is [41]. 
Addressing a GP’s need for detailed and timely information regarding their patient’s care by improving 
the standard communication procedures between GPs and specialists could facilitate the initiation of 
ACP for GPs. It is however also important for GPs to acknowledge that the discussion of treatment 
options is only a part of ACP and the difficult subject of end-of-life care should not be disregarded.  
The future lack of decision-making capacity was the only specific barrier reported to the initiation of 
ACP with dementia patients. Previous research has pointed out that diagnosing dementia is a complex 
task and usually when diagnoses are formally assessed, patients are already suffering from some form 
of cognitive impairment [36;42]. However, in the early stage of dementia there is a time span when 
patients can talk about their values and goals in a way that could inform end-of-life care decisions when 
they have lost the capacity to make decisions [43]. A number of explanations are possible for the 
reservations GPs express about assessing such patients’ capacity to participate in ACP discussion. Firstly, 
as this study also shows, GPs have doubts about the relevance or the value of ACP in the context of 
future loss of capacity to confirm previously planned decisions and they perhaps adopt the attitude that 
advance care planning for dementia patients is invalid [44]. Secondly, physicians don’t always recognize 
that dementia can be a terminal illness, which may explain why patients with dementia are less likely 
than those with cancer to have advance directives [45]. Finally, a lack of knowledge about the extent to 
which advance statements or decisions should be followed and to which extent they are legally binding, 
which was reported as a barrier by the GPs in our study, may further strengthen their negative attitudes 
or beliefs. 
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Conclusion and implications for practice, policy and research 
 
Because GPs in Belgium, as in many other countries, have a central role in the coordination of patients’ 
care, they are considered to be ideally placed to initiate ACP with their patients. To put this into practice, 
a broad range of barriers relating to the GPs, to the patients and family and to the health care system 
needs to be overcome. Educational training and the development of guidelines adapted to the Belgian 
context can play an important role in achieving this goal [46], as most of the perceived barriers identified 
in this study were related to skills, knowledge and attitudes. Future large scales studies may contribute 
to a more complete picture of the prevalence and importance of the barriers encountered by GPs when 
initiating ACP. Future research is also necessary on when GPs can elicit patients’ wishes for future end-
of-life care before time-critical situations occur, especially for patients with heart failure and dementia 
(two conditions with a less predictable end-of-life trajectory than cancer patients [47]). Introducing the 
concept of ACP in advance of illness and as part of standard care may be a realistic strategy and requires 
further research. 
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Abstract 
Objectives 
To explore how GPs conceptualise ACP, based on their experiences with ACP in their practice. 
Methods 
Five focus groups were held with 36 GPs. Discussions were analysed using a constant comparative 
method. 
Results 
Five overarching themes in the conceptualisations of ACP were discerned: (1) the organisation of 
professional care required to meet patients’ needs, (2) the bad news conversation, (3) choices of 
treatment and goals of care for the patient, (4) the completion of documents regarding patient preferences 
and (5) the exploration and understanding of patients’ preferences. Within these themes, ACP was both 
conceptualised in terms of content of ACP and in terms of tasks for the GP (establishing consensus about 
the appropriate care and coordinating patient’s care, providing comfort and reassurance, providing 
information about ADs, and initiating conversations). 
Conclusions 
This study illustrates that GPs have varying conceptualisations of ACP, of which some are more limited 
to specific aspects of ACP. A shared conceptualisation of the key elements of ACP and agreement on 
the purpose and goals of ACP is needed to ensure successful implementation, as well as a systematic 
integration of ACP in routine practice that could lead to a better uptake of all the important elements of 
ACP. 
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Introduction 
Good quality communication between patients and health care professionals is essential in enabling 
patients with a life-limiting illness to understand their diagnosis, prognosis, treatment options and end-
of-life care options in order to help them prepare and plan for their future care if they so desire [1]. 
Advance care planning (ACP) is a process of discussions with a patient about their wishes for future 
healthcare, in preparation for a time when they might lose capacity [2;3]. This process, involving 
healthcare professionals and family members or others, may be formally documented in an advance 
directive (AD) [4]. ACP is gaining attention worldwide for its perceived benefits in improving patient 
autonomy [5], concordance between patients’ preferences and end-of-life care received [6-8] and the 
quality of end-of-life care [9].  
The traditional purpose of ACP has been to have patients prepare for incapacity and make treatment 
decisions in advance so that clinicians can attempt to provide care consistent with their goals at the end 
of life [10]. Emphasis was mainly put on the documentation of an agreement regarding medical care 
between the physician and patient through ADs. Yet, internationally their uptake remains limited [11;12]. 
Evidence also shows that there is no guarantee that these documents as such improve end-of-life care or 
correspond with future care preferences [13;14]. ADs are too narrowly focused on the patient’s right to 
refuse unwanted life sustaining treatment, they are often physically unavailable when needed, too vague 
to be useful in decision-making or at odds with the patient’s current clinical circumstances. In response 
to these concerns, there has been a shift from ACP as a static documentation of specific treatment 
preferences to an ongoing process of discussion and communication about a patient’s wishes [15]. It is 
expected that these changes in how ACP is operationalised can address these previously described 
concerns and increase the uptake and implementation of ACP [6].  
In the Belgian health care system, as in many other countries, general practitioners (GPs) are core 
providers of medical care and the majority of people (95%) have a fixed GP with whom they have often 
built up a long-term relationship [16;17]. The GP is likely to have good clinical and contextual 
knowledge of each patient and is probably best placed to initiate an ACP discussion in a timely manner 
[18-20]. GPs play an important role in providing and coordinating end-of-life care in primary care, often 
in consultation with palliative home care teams [21;22]. Nonetheless, studies show that the practice of 
ACP in GPs remains limited [23-25]. It has been suggested before that differences in the 
conceptualisation of ACP have implications on how ACP is delivered and promoted in practice[15] . 
However, it remains unclear how ACP is conceptualised by GPs and how they perceive their role in it. 
Previous studies have focused mainly on the factors impeding GPs and patients in raising the topic of 
end-of-life care, but the way in which GPs already engage in ACP has not been studied [26-29], and 
would be an important step towards improving the standard of practice by delineating how GPs currently 
understand and conceive ACP in their practice. 
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Conceptualisations are an abstract or general idea derived from specific events or situations. The aim of 
this qualitative study is to explore how GPs conceptualise ACP, by asking the participants about their 
experiences with ACP in practice. The aim of this qualitative study is to explore how GPs conceptualise 
ACP, by asking participants to describe their experiences with ACP in their practice. The goal of 
understanding the range of conceptualisations circulating among GPs is to provide new insights into 
how GPs can be helped to engage in the full and complex process of ACP. 
 
Methods 
Research design 
In order to have an in-depth understanding of GPs’ perceptions and experiences regarding ACP, a 
qualitative study design was considered the most suitable. This study used the methodology of focus 
groups given the flexible approach this allows for opens discussion and interaction between the 
participants [30]. The focus groups were conducted in Flanders, Belgium in 2012. 
 
Recruitment of participants 
Participants in three focus groups were recruited by using existing peer-review groups for GPs, 
contacted via email. Nearly 97% of all full-time practicing GPs in Belgium are affiliated to such peer-
review groups, where practice-related aspects are discussed four times per year [31]. Every GP who 
wants to be accredited in Belgium needs to be affiliated to such a group and attendance at two out of 
four meetings per year is mandatory. A fourth focus group was organised by contacting the coordinators 
of the palliative care networks in Flanders with the request to disseminate our invitation to participate 
in a focus group to the GPs active in palliative home care teams. Because of lower response, this focus 
group was complemented with other GPs recruited via the professional contacts of the network 
coordinators. A fifth focus group was organized with members from a large practice located in an urban 
region. 
 
Data collection 
Each focus group was moderated and observed by two researchers (ADV, KP, RVS or LD) and lasted 
on average one and a half hours. At the start of each group the participants were informed that the 
discussions would be audiotaped, to which they all gave written informed consent. A topic guide, 
consisting of open questions and a set of prompts for each question, was used to generate the discussion. 
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This topic guide was developed and reviewed within a multidisciplinary team of sociologists (ADV, 
DH, LD), psychologists (KP, KB) and one GP (RVS) and covered four themes: (1) experiences of GPs 
with ACP in their current practice, (2) attitudes regarding ACP, (3) perceived barriers to and facilitators 
for initiating ACP and (4) ways to improve initiation of ACP in general practice. At the beginning of 
each focus group, participants were asked whether they knew or were familiar with the term ACP. After 
this question, a theoretical definition of ACP as stated in the literature was introduced in the focus group. 
ACP was defined as the voluntary process by which patients discuss their future treatment and end-of-
life care preferences with their care providers, in case they lose capacity to make decisions or 
communicate their wishes for the future [3].  
 
Data analysis 
The focus group discussions were transcribed verbatim. Analysis of the data was guided by a constant 
comparative method [32;33]. Firstly, ADV & KB independently read and openly coded two full focus 
group transcripts. The codes were discussed and mutually compared for similarities and differences until 
they could be grouped into categories related to the research questions. Subsequently, the five focus 
group transcripts were independently read and compared with the primary coding framework by all the 
members of the research team. Codes were added, modified or merged where necessary. ADV coded 
the remaining transcripts by applying the final coding framework, which was additionally checked by 
KB and KP for agreement on interpretation. After this, coding saturation was judged to be achieved by 
the research team as no new categories emerged. An ongoing refinement of the coding framework 
resulted in overarching themes deduced from the categories. Finally, quotes were selected and approved 
by the research team to illustrate the results. The qualitative analysis software QSR NVIVO 10 was used 
for this research. 
 
Ethical aspects 
Ethics approval for this study was given by the Commission of Medical Ethics of the University Hospital 
of Brussels.  
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Results 
Five focus groups were held with a total of 36 GPs (n=9, n=11, n=4, n=5, n=7). The participants’ 
demographic characteristics are presented in Table 1. 
The GPs’ conceptualisation of ACP was explored by asking the participants to describe their experiences 
with ACP. At the beginning of each focus group, participants were asked whether they knew or were 
familiar with a definition of ACP. Not many GPs knew the specific term, but once a general definition 
was introduced in the focus groups, the GPs could described a range of experiences in this area. After 
analysis, GPs’ conceptualisation of ACP could be categorized in 5 overarching themes. Within these 
themes, the GPs conceptualised ACP both in terms of the content of ACP and in terms of tasks for the 
GP. Some GPs had several conceptualisations of ACP in their narrative. Others only used one 
conceptualisation to describe ACP in their practice. 
 
 (1) Organisation of professional care to meet patients’ and families’ needs 
Firstly, ACP was sometimes conceptualised as the process and discussions surrounding the organisation 
of professional care to meet patients’ and families’ needs, e.g. initiating (palliative) home care or moving 
to a nursing home. Planning care to address patients’ and families’ changing care needs often comprises 
collaboration between different informal and formal caregivers. A first important task in the 
organisational preparation for care is to establish a consensus between the patient’s preferences and the 
perspectives of the GP and of family members regarding adequate care (the initiation of palliative home 
care, moving to a nursing home, community nurse visits), which could sometimes require many 
discussions according to the GPs. The GPs indicated that it is not always an easy task to mediate between 
different perspectives about patients’ future care, especially if different distressed family members are 
involved.  
“It can be very difficult. For example, I am taking care of patient now that is really not doing well. Since 
a few days, he can’t get out of bed anymore. I tried to have a conversation with that man and his wife 
about the end of life, but on my way out his wife said to me: ‘He does not like to talk about that, we are 
not going to do that anymore.’ So it is very difficult for me to organize palliative home care for them. 
They do not want to hear about it.” (Male GP, 44 years, FG 3) 
  
The coordination of care often involves communication and collaboration with other health care 
professionals (e.g. specialists, community nurses or palliative home care teams). Although this  
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Table 1: Characteristics of participating GPs (n=36) 
Characteristics N 
Sex 
Male 
Female 
 
27 
9 
Age (years) 
≤ 29 
30-39 
40-49 
50-59 
60-69 
 
1 
5 
13 
9 
8 
Practice location 
Urban 
(Semi-)Rural 
 
9 
27 
Number of terminal patients in 
the last year 
None 
1-3 
4-6 
7-9 
≥ 10 
 
 
4 
9 
11 
3 
9 
Number of participants  
Focus group 1 
Focus group 2 
Focus group 3 
Focus group 4  
Focus group 5 
 
9 
11 
4 
5 
7 
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communication and collaboration was not always judged as optimal, several GPs saw an important task 
for themselves in these contacts: 
“A very important point for me, is the contact with the social services in the hospital, which does not 
happen enough. You [the GP] have to make time for that and pick up the phone. That is important.” 
(Male GP, 65 years, FG 5) 
 
(2) Bad news conversations 
Secondly, ACP was also conceptualised in terms of “bad news conversations”. The GPs construed ACP 
discussion then as the process of communicating a terminal diagnosis to patients and their families. In 
this context, ACP was also described as the process of patients and their family preparing for death 
(psychologically, financially, etc). Although many participants felt it is also the treating specialist’s 
responsibility to explain the diagnosis and prognosis or discuss future treatment options with their 
patients, most GPs saw an important task in discussing palliative care options, comforting patients and 
reassuring terminal patients that they will be available and provide support until the end of life: 
“I believe that’s when you’ve got to tell them about what is available in palliative care, that they won’t 
be in any pain, that you’ll be there for them, that you’ll be able to... give them all the peace they need 
and a bit of assurance that you’ll walk that bit of road with them.” (Male GP, 42 years, FG 5) 
“Nowadays, they [the hospital] actually keep patients to themselves for a very long time, even at the 
point when nothing can be done for them anymore I think. Well, at certain wards this is definitely the 
case. They do that at the hospital for a really long time, even the moment they say, now we can’t do 
anything anymore, maybe you should go to the palliative unit now, while the patient actually won’t hear 
a lot about dying at home if we don’t come and explain it, I think.” (Female GP, 49 years, FG 1) 
 
(3) Choices of treatment and goals of care 
Thirdly, the discussion and reflection on choices of cancer treatments, the experience of a hospital 
admission and the possibility of future admissions were mostly mentioned by the GPs when discussing 
goals and types of care and treatment with patients. However, this conceptualisation was mostly linked 
to patients suffering from serious chronic or progressive illnesses such as cancer or organ failure, but 
not patients with dementia. No specific tasks for the GP were mentioned within this theme during the 
focus groups. 
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(4) ACP documents 
Fourthly, some participants talked specifically about the completion of documents regarding patient 
preferences in their conceptualisation of ACP. This was often in reference to the written plans about 
future care for their patients in nursing homes (either ADs or GP treatment orders) or the AD on 
euthanasia that was brought up by patients in their practice. 
“Something that we often see are ADs on euthanasia, when patients come by and say ‘look, this is in 
case if something happens to me, if I get a terminal illness’. They then want to sign a document in which 
they choose euthanasia and then don’t want to think about any more. That happens very often.” (Male 
GP, 45 years, FG 4) 
 
The GPs explained that patients often have misunderstandings regarding ADs and it was considered an 
important task of the GP to inform their patients about ACP, the limitations of ADs, and ensure that 
ADs are valid and accurate. 
“Many patients say ‘if I am suffering dementia, I want euthanasia’, only there is no legal standing on 
that yet”. (Female GP, 48 years, FG 2) 
“Yes, I also often have to explain that.” (Female GP, 35 years, FG 2) 
 
(5) Exploring and understanding patients’ preferences  
The participants explained that ACP discussions are also initiated by patients expressing vague end-of-
life care wishes. A number of participants considered actively initiating ACP discussions as an important 
task for GPs, but acknowledged that this often depends on the competencies and attitudes of the GP 
regarding ACP. Others were more reluctant to actively initiate ACP and commented that patients need 
to take initiative for these discussions, but it is the GP’s task at that moment to elaborate on the topic.  
Being aware of trigger moments, listening to patient cues for initiating ACP, and making the right 
judgment of a patient’s willingness to discuss the topic were considered important skills for the initiation 
of ACP. However, a number of younger GPs indicated that experience with or expertise in ACP 
discussions is an important factor in actively initiating these discussions. 
“I think there are many different ways about it, as was said just before. Sometimes it’s because of a 
sudden diagnosis and you can talk to them [the patients] about it actively. Or sometimes you notice that 
patients try talks to you about it if you are a good listener.” (Female GP, 41 years, FG 1) 
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“Also, many elderly people you visit quite often before they get ill and you know these people, so if you 
have a certain talent for it, there are many occasions to speak to them about it.” (Female GP, 60 years, 
FG 5) 
  
However, it was also noted that not all GPs further explored patients’ vague preferences such as “when 
needed, you [the GP] will help me”. Especially in cases of terminally ill or very old patients, a few GPs 
stated to know their patients well enough to know it means not to prolong life unnecessary. However, 
most of the GPs responded to feel uncertain when patients expressed such vague wishes and preferred 
to explore these. 
 
Discussion and conclusion 
Summary of main findings 
Our study identified a diversity of conceptualisations of ACP in general practitioners (GP)s. Five 
overarching themes in the conceptualisations of ACP were discerned: (1) the organisation of 
professional care required to meet patients’ needs, (2) the bad news conversation, (3) choices of 
treatment and goals of care for the patient, (4) the completion of documents regarding patient preferences 
and (5) the exploration and understanding of patients’ preferences. Within these themes, ACP was both 
conceptualised in terms of content of ACP and in terms of tasks for the GP.  
 
Strengths and limitations 
To our knowledge, this is the first qualitative study to explore GPs’ conceptualisation of ACP on the 
basis of their experiences when engaging in ACP with their patients. The qualitative design, using 
different recruitment strategies [26], allowed us to gain insight into the complex range of views and 
experiences regarding ACP in daily practice from GPs with diverse backgrounds, experience and levels 
of interest in ACP. The multidisciplinary composition of the research team guaranteed interpretation of 
the data from a range of perspectives. However, the focus group composition may have presented a 
limitation. Most of the participant GPs were male (n= 27), so female GPs were underrepresented, as 
were GPs younger than 39 years (n= 6 vs. n=30) although the national average age of GPs is 49 years 
in Belgium. Secondly, although our study is aimed at theoretical rather than statistical generalization, 
the findings may not necessarily be generalizable to other countries were euthanasia is not legalized or 
countries that may have a very different context in which ACP is (partly) structurally embedded in 
national health care strategies [34].  
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Comparison with existing literature 
While ACP is suggested in the relevant literature as a comprehensive and multifaceted process of care 
planning that should be initiated at an early stage of a serious illness, the conceptualisations circulating 
among GPs tend to be more limited sometimes. For example, the conceptualisation of ACP as a 
process that is to be initiated very late in the disease trajectory when death is imminent in order for 
patients and family to prepare for death seems to be prevailing among some GPs. Based on the 
narratives about how they perform ACP in their own practice, the results of this study also suggest that 
the conceptualisation of ACP sometimes implies an engaging in specific aspects of ACP rather than 
engaging in multiple discussions that address all key elements as recommended in the literature 
[4;10;35-37]. These are ascertaining patients’ information and decision-making preferences, wishes 
for family involvement, understanding patients’ values, quality of life, fears and goals, explaining the 
nature and trajectory of serious illnesses, but also discussing disease outcomes, eliciting patients’ 
preferences for care and encouraging them to document their preferences and/or choose an appropriate 
surrogate decision maker. Previous studies have argued that time constraints and the fact that GP 
consultations are mostly focused on a patient’s acute care needs restrict the possibilities of initiating 
these sensitive and time-consuming discussions [38;39]. However, implementing ACP as an iterative 
and multifaceted process of discussion throughout the illness course can help GPs in introducing 
difficult subjects gradually without having to find a single ‘perfect’ moment to introduce ACP. It is 
noticeable that GPs consider experience as an important factor in actively initiating ACP. 
Communication skills can be learned and retained and do not reliably improve with experience alone. 
Offering GPs practical guidance on the content of ACP discussions might thus increase their use of it 
[40;41]. 
 
Conclusion and implications for policy and practice  
It has been recognized before that health care professionals have an important role in the promotion of 
ACP. They have a responsibility to initiate ACP in a timely way, by informing and educating patients 
[42]. However, our findings highlight significant differences in how ACP is conceptualised among GPs, 
which can cause confusion and conflict because the practice of individual GPs may vary according to 
how ACP is conceptualized [15]. Therefore, differences in the conceptualisation of ACP have important 
implications on how ACP should be promoted among GPs. A shared conceptualisation of the key 
elements as described above and agreement on the purpose and goals of ACP is needed to ensure 
successful implementation. Recently, the first guideline on ACP for health care professionals in Flanders 
was published, which can help in promoting a common view on ACP [43].  
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Nonetheless, previous studies have shown that the barriers to initiating ACP for GPs are complex and 
multifaceted [39;44]. It has been suggested that the combination of several interventions hold promise 
in implementing and systematizing the initiation of ACP with patients: education of physicians, systems 
to identify and trigger early discussions for eligible patients, patient and family education, structured 
formats to guide the discussions, dedicated sections in the electronic health record for recording 
information and continuous measurement [18;35].  
Postponing ACP discussions until the end of life or waiting for patients to raise the subject may result 
in withholding from patients the right to receive information and plan their future care accordingly. This 
study illustrates that GPs have considerably varying conceptualisations of ACP in terms of the content 
of ACP discussions and in terms of tasks for the GP, of which some are more limited to only specific 
aspects of ACP. This can lead to confusion as the role of GPs may vary according to how ACP is 
conceptualised. A shared conceptualisation on the goals and key elements of ACP is needed to ensure a 
successful implementation of ACP. 
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Abstract 
Background: Most patients with life-limiting illnesses are treated and cared for over a long period of 
time in primary care and guidelines suggest that Advance Care Planning (ACP) discussions should be 
initiated in primary care. However, a practical model to implement ACP in general practice is lacking. 
Therefore, the objective of this study is to develop an intervention to support the initiation of ACP in 
general practice. 
Methods: We conducted a Phase 0-I study according to the Medical Research Council (MRC) 
Framework. Phase 0 consisted of a systematic literature review about the barriers and facilitators for 
general practitioners (GPs) to engage in ACP, focus groups with GPs were held about their experiences, 
attitudes and concerns regarding initiating ACP in general practice and a review of ACP interventions 
to identify potential components for the development of our intervention. In Phase 1, we developed a 
complex intervention to support the initiation of ACP in general practice in patients at risk of 
deteriorating or dying, based on the results of Phase 0. The complex intervention and its components 
were reviewed and refined by two expert panels. 
Results: Phase 0 resulted in the identification of the factors inhibiting or enabling GPs’ initiation of 
ACP and important components underpinning existing ACP interventions. Based on these findings, an 
intervention was developed in Phase 1 consisting of: (1) a training for GPs in initiating and conducting 
ACP discussions, (2) a register of patients eligible for ACP discussions, (3) an educational booklet on 
ACP for patients to prepare the ACP discussions that includes general information on ACP, a section 
on the role of GPs in the process of ACP and a prompt list, (4) a conversation guide to support GPs in 
the ACP discussions and (5) a structured documentation template to record the outcomes of discussions.  
Conclusion: Taking into account the barriers and facilitators for GPs to initiate ACP as well as the key 
factors underpinning successful ACP intervention in other health care settings, a complex intervention 
for general practice was developed, after gaining feedback from two expert panels. The feasibility and 
acceptability of the intervention will subsequently be tested in a Phase II study. 
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Background 
Many patients receive inappropriate or futile care at the end of life and this mostly results from a 
mismatch between the needs of patients and the norms of current practice(1). A possible response to this 
concern is advance care planning, as it is a means to discuss patients’ potential needs and care 
preferences during their illness trajectory. Advance care planning (ACP) is the voluntary process by 
which patients discuss and reflect with their care providers upon topics such as goals and preferences 
for future care, quality of life, decision-making preferences, fears or anxieties, and also palliative care 
options, do-not-resuscitate orders, end-of-life decisions and surrogate decision-making in future disease 
stages(2;3). These discussions may or may not result in the documentation of these decisions in an 
advance directive (AD)(4).  
ACP discussions can play a major role in facilitating adaptation to illness realities by providing patients 
with information about diagnosis and prognosis, by leading to appropriate decision-making, by 
alleviating anxiety and by improving quality of life throughout the trajectory of the illness(5;6). Previous 
studies have shown that ACP interventions stimulate discussions about goals of care between patients 
and their care providers(7;8), improve concordance between a patient’s preferences and the end-of-life 
care they receive(9-11) and improve the quality of care at the end of life(12) and they are also associated 
with positive family outcomes such as improved satisfaction with care and reduced stress and anxiety(9). 
Effective ACP discussions support not only end-of-life care but quality of life throughout the illness 
trajectory, including the period before death is imminent. 
Most patients with serious chronic illnesses are treated and cared for over a long period of time in 
primary care(13) and guidelines suggest that ACP discussions should be initiated in there(4). Initiating 
ACP optimally requires a proactive approach by a health care professional who is likely to have a good 
knowledge of the patient in terms of medical, psychosocial and social background(14). Given their often 
longstanding and trusting relationship with patients, including in Belgium, it is assumed that general 
practitioners (GPs) have good knowledge of the patient and family context. They are also according to 
other health care professionals(15) in an ideal position to initiate and facilitate timely a structured 
discussion about the patient’s wishes for future care(1;16-18). 
However, a practical model to implement ACP in general practice is lacking and a cross-national survey 
showed that only a minority of patients in Belgium had discussed treatment preferences with their 
GP(19). Therefore, our study aims to develop an intervention to support the initiation of ACP in general 
practice following the UK Medical Research Council’s (MRC) guidance for developing complex 
interventions(20).  
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Methods 
Study design 
The development of this intervention was conducted following the Medical Research Council’s (MRC) 
framework on complex intervention design(21;22). The MRC framework addresses strategies for 
developing and evaluating complex interventions and proposes a phased approach going from Phase 0 
to Phase IV, which take place as an iterative process (Figure 1)(20). This study entails a Phase 0-I, 
comprising the development and modelling of a preliminary complex intervention.  
 
 
Figure 1 MRC framework for design and evaluation of complex interventions to improve health 
 
Phase 0: Exploring potential components of the intervention 
Three methods were applied to provide information and evidence for the key components of the 
intervention. The key components of an intervention refer to the features (i.e. building blocks) of a 
program that are judged necessary and most effective to produce the desired outcomes(23). Key 
components are intended to be, or have been, demonstrated through research to be positively associated 
with the outcomes that address the identified needs. 
First, we performed a systematic literature review about the barriers to and facilitators for GPs to engage 
in ACP, to identify the relevant factors inhibiting or enabling their initiation of ACP in practice and to 
guide the choice of intervention components that could overcome the modifiable barriers and enhance 
the facilitators(24).  
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Second, focus groups with GPs were held covering their experiences, attitudes and concerns regarding 
initiating ACP in general practice and investigating their reasons for initiating or not initiating ACP 
discussions(25). Five focus groups were held with a purposefully sampled group of GPs to maximize 
variation in experience, age and practice (n=36). GPs’ experiences and perceptions were used for further 
delineating the key components of the intervention that would target the specific barriers and facilitators 
for GPs in Belgium.  
Third, a focused literature search was conducted to identify systematic reviews with regard to ACP 
interventions. We searched journal articles with the keywords ‘advance care planning’ and publication 
type ‘systematic review’. From the systematic reviews, we retrieved the randomized controlled trials 
with a successful outcome on at least one of their intended outcome measurements. The included studies 
were read in full and analysed for their components, in order to inductively obtain a comprehensive 
overview of key features underpinning successful interventions and to identify potential components for 
the development of our intervention.  
 
Phase I: Modelling the intervention to general practice  
Based on the results of Phase 0, a first draft of a preliminary complex intervention to support the 
initiation of ACP in general practice was developed by the research team, by selecting appropriate 
intervention components. Subsequently, the first draft of the complex intervention was presented to 
expert panels which reviewed the key components and the possible and best course of action to 
implement the intervention in practice. For the composition of the expert panels, we purposefully 
sampled either GPs, persons with considerable experience in conducting ACP conversations, academics 
in the field of ACP or patient-physician communication and/or persons experienced in giving 
communication trainings to physicians. Most participants in the expert panels had experience in a 
number of these fields. The two expert panels (n=4, n=5) were held in January 2015 and consisted of 
five GPs, one hospital geriatric, one palliative care consultant and two academic researchers 
(psychologists) with expertise in the field of ACP and health care communication. During the panels, 
the experts were asked to evaluate the completeness of the intervention’s components, to review the 
components on feasibility and acceptability and to identify the implementation barriers for each 
component. The expert panels were both consulted in a two-hour long meeting. The panel discussions 
were audiotaped (for which the participants gave verbal consent) and transcribed verbatim by ADV. The 
results were categorized for each component and further analysed within the research team to refine the 
intervention.  
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Ethical aspects 
The research protocol for the qualitative focus group study was approved by the Commission of Medical 
Ethics of the University Hospital of Brussels. A signed informed consent was obtained from each 
participant before the focus group interview. Anonymity was assured by removing participant 
information that could lead to identification from the transcripts. 
 
Results 
Phase 0: Exploring potential components of the intervention  
Identification of the factors inhibiting or enabling GP initiation of ACP  
Both the systematic review and the focus groups showed that GP, patient and healthcare system factors 
all influence the initiation of ACP.  
1) GP factors influencing the initiation of ACP 
A lack of confidence, skills and knowledge about ACP and how to initiate it were identified as important 
barriers inhibiting GPs from holding ACP discussions. Many GPs felt poorly prepared to conduct ACP 
discussions and a lack of awareness of the different components of ACP was shown through their 
varying conceptualisations of it. Some GPs had a comprehensive view of what constitutes ACP, while 
others had a limited conception. The difficulty of defining the right time to initiate ACP was also 
reported as an important barrier for the GPs. They indicated that, especially in patients with a less 
predictable disease course such as dementia or chronic heart failure, they lacked awareness of the key 
moments to initiate discussions. ACP discussions were more easily initiated with cancer patients, who 
have a relatively more predictable illness trajectory and clearer key moments. Difficulties with judging 
a patient’s mental capacity to participate in ACP and concerns about the legal implications of following 
their documented wishes were also reported as barriers. Being aware of the potentially positive outcomes 
of ACP and having positive attitudes towards anticipating future scenarios were identified as important 
facilitating factors to initiating ACP. Positive experiences with ACP in the past also encouraged GPs to 
initiate ACP with their patients. 
 
2) Perceived patient factors influencing the initiation of ACP 
Most GPs in the focus groups considered patients suffering from a life-limiting illness such as cancer to 
be most eligible for initiating discussions with. However, a barrier that was often mentioned was the 
concern that initiating ACP discussions too early might deprive patients of hope or create anxiety. Both 
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the patient’s denial and lack of awareness about the prognosis of a serious illness were identified as 
patient-related factors that contribute to the challenges of GPs initiating ACP. Many GPs also expressed 
concerns about patients’ lack of understanding regarding ACP. Knowing that patients are prepared to 
participate in ACP or patients initiating ACP discussions themselves were perceived as important 
facilitators for GPs to engage in these discussions.  
 
3) Healthcare system factors influencing the initiation of ACP 
Knowing and caring for the patient for a long time was identified as an important facilitating factor for 
engaging in ACP discussions while a lack of time discourages GPs from initiating them during routine 
consultations. Poor communication and collaboration between GPs and specialists was also perceived 
as a barrier for ACP. Especially where patients are mainly being treated by a specialist, it may not be 
clear whose role it is to discuss ACP. The lack of a central system for recording the patient’s wishes 
across different health care settings also contributed to the perceived irrelevance of ACP and was 
perceived as a challenge to initiating it. Many GPs expressed uncertainty about the usefulness of ADs 
as these are not always readily available in a patient’s medical records or consistently recorded across 
the health care system.  
 
Key components underpinning ACP interventions 
The examination of ACP interventions identified four common features underpinning successful ACP 
interventions: A) the involvement of a trained or experienced facilitator, B) a selection process to 
identify patients eligible for ACP, C) the use of ACP tools to support the discussions D) structured and 
patient-centred ACP discussions and E) the opportunity to complete ACP documents (Box 1). 
 
Box 1. Summary of key features underpinning ACP interventions 
A) Trained or experienced facilitators 
In all interventions the ACP discussions were facilitated by a trained health care professional (mostly nurses or 
allied health workers)(9-11;26-29) or by health care professionals already experienced in counselling and 
communicating with patients about ACP, such as social workers or palliative care physicians(7;30). The facilitator 
trainings ranged from half a day to two days and used a competency-based educational approach, comprising 
interactive discussions about the key components of ACP, role play exercises, reading materials, and learning to 
assess a person’s capacity to engage in ACP(9-11;26;28;29). A minority of studies did not provide training to the 
health care professionals involved(31) (8;32).  
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B) Identification of patients 
In most interventions, patient selection was focused on those with a serious advanced life-limiting illness, such as 
advanced cancer, COPD, end-stage renal disease or end-stage congestive heart failure(7;8;10;26;27;30;33;34). 
Other indicators used to select patients with whom ACP was initiated were age (e.g. all patients ≥  65 
years)(9;28;30;31;33;34), admission to a health care facility (hospital or nursing home)(9;27-29;31) and the 
expectation of serious complications or death within the next year(10;26;27).  
C) Tools 
A number of interventions used specific tools such as individualized patient-specific questionnaires about the 
patient’s preferences for discussing ACP(8), a question prompt list about end-of-life care provided to patients 
before their consultation to stimulate conversations(7), or educational material about ACP mailed to patients in 
advance(30;34) to prepare them and to facilitate patient-centred discussions. Structured preference-elicitation and 
decision aids for ACP to help patients consider their health care options were also implemented as tools during the 
ACP discussions(9;10). 
D) Structured discussions 
All interventions included structured discussion of the patient’s values, goals and beliefs(9;27), an assessment of 
their understanding of their illness(10;26;27;29), discussion of their future treatment preferences(9-11;26;27;29), 
the assessment of their surrogates’ understanding of their illness and treatment preferences and their role as health 
care agents(9-11;26-28;31) and the opportunity to complete ADs(9;10;26;28-31). The discussions reportedly 
lasted between one and one and a half hours(9;10;28). In all studies, the patient was encouraged to include their 
family.  
E) Completion of ACP documents 
Most ACP interventions provided the opportunity to complete ACP documents (e.g. documentation of treatment 
preferences, appointment of a health care proxy, appointment of a surrogate decision-maker)(9-11;27-34). A 
number of studies reported that the completed documents were filed in the patient’s medical records or 
charts(9;11;29). In two studies conducted in an inpatient setting, extra time was dedicated during the 
interdisciplinary team meeting after the ACP intervention to discussion of the care wishes of the patient (11;27).  
 
Phase I: Modelling phase 
Table 1 indicates how we linked specific barriers and facilitators to the selection of intervention 
components. This was informed by the features underpinning successful ACP interventions (Box 1). 
The final selection of intervention components was further informed by what was considered by the 
research team as relevant for the context in Belgium, was likely to be feasible and could be implemented 
as a cohesive intervention. The components of the intervention are: 1) a training program for GPs, 2) an 
register of patients eligible for ACP, 3) an educational booklet for patients about ACP, 4) a conversation 
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guide to support GPs during discussions and 5) a structured documentation template to record the 
outcomes of the discussions. The components of the intervention were reviewed by two expert panels 
to refine and improved the intervention.  
1) The training session is based on a two hour educational programme about ACP specifically developed 
for GPs that has been shown to improve their confidence and ability to undertake ACP conversations 
with patients(35). It includes active, practice-oriented strategies such as role-play exercises, feedback, 
the use of video role modelling, group discussions and feedback during the session as these are 
educational strategies which have shown to be most effective in improving communication skills(36). 
Pre-reading material and information provision will also be a part of the training programme as lack of 
knowledge about the potentially positive outcomes of ACP and about its legal implications were 
identified as important barriers. A previous study also showed that improved clinician knowledge about 
decision-making capacity legislation positively correlated with ACP participation(37). The experts 
perceived two hours as too short to complete all training elements and recommended spreading the 
training over two sessions which would permit reinforcement and allow for home work exercises in 
between. 
2) Standardised triggers for the timely identification of all patients who are at risk of deteriorating or 
dying in the near future was considered essential to support GPs in defining a key moment and 
prompting them to initiate ACP discussions. While the timing of ACP must be sensitive to patients’ 
readiness to enter into such conversations, a pragmatic three-step guide that has been proposed for 
physicians is to consider ACP if: (a) No is the answer to the surprise question “Would you be surprised 
if this patient died within the next year?”, (b) The patient’s general health is poor (eg limitations in self-
care or multiple hospitalisations), and (c) If disease-specific indicators indicate a poor prognosis (eg 
advanced organ failure, dementia, progressive malignancies)(1). Identified eligible patients will be 
documented in a register. These patients should be invited to consider ACP. 
3) To overcome the patient-related barriers to GPs in initiating ACP, an educational booklet for assisting 
patients and their caregivers and improving their knowledge about ACP was considered helpful to 
increase patient and family engagement(1;38). This booklet was based on an already existing booklet 
‘Planning your future care’ developed by the University of Nottingham and published by the NHS as 
part of the Dying Matters campaign in the UK(39). This booklet was deemed suitable by the expert 
panels as it includes general information on ACP and a section on the role of GPs in the process of ACP. 
However, most experts considered this booklet as too long and suggested to shorten it and slightly adapt 
its content to our target group of patients. A prompt list was also included as research showed that a 
prompt list helped patients to ask questions about prognosis and end-of-life care, and discuss more issues  
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Table 1: Description of the components within a complex intervention to support the initiation of ACP in general practice 
Components of a complex intervention to support the initiation of ACP in general practice (evidence based key feature described in Box 1) 
Component 1: A training program for GPs (A) 
Content of the component to overcome the barriers and enhance the facilitators: 
• Prior to the training, participants will receive reading materials to ensure baseline 
knowledge on ACP and the relevant law and to limit the time of the training 
• The training consists of information provision, case studies addressing the 
identified barriers to initiating ACP, facilitated group discussion and video 
demonstration of how to conduct ACP discussions and how to incorporate the 
initiation of ACP into standard consultations, and role play exercises with 
feedback from an expert instructor to practice the taught skills, which have been 
shown to be the best strategies to improve communication skills 
• GPs will learn about the key elements that should be addressed with patients, 
including exploring prognostic understanding and acceptance of diagnosis and 
providing patients with information about prognosis to the degree desired by the 
patient 
• Instructions are provided for GPs during the training to collect all information 
regarding the patient’s health status and treatment options, and to contact other 
health care professionals when necessary for this.  
• Training will be led by an expert instructor 
• After the training sessions, GPs will be able to practice their skills at home 
through e-simulation exercises with fictive patients 
 
 
 
Barriers and facilitators that are addressed by the component: 
! Lack of skills, knowledge about ACP and confidence to discussions 
! Lack of awareness about the different elements of ACP 
! Lack of knowledge about decision-making capacity legislation 
! Recognizing the relevance of ACP 
! Positive attitudes towards anticipating future scenarios and initiating ACP 
! Patients’ denial and lack of awareness about prognosis 
! Lack of adequate communication between GPs and the multiple clinicians 
involved in the patient’s care 
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Component 2: Establishing a register of patients eligible for ACP discussions (B)  
Content of the component to overcome the barriers and enhance the facilitators: 
• Systematic and selective identification of patients at risk of deteriorating or dying 
will be done using a pragmatic three-step guide of triggers for when to initiate 
ACP 
• During the training, GPs will be taught how to identify eligible patients using 
these triggers and to set up an ACP register, which is a constantly updated list of 
patients for whom ACP should be initiated at upcoming appointments 
Barriers and facilitators that are addressed by the component: 
! Most GPs in the focus groups considered patients suffering from a life-limiting 
illness to be most eligible for initiating ACP with 
! Difficulties with defining a key moment to initiate ACP 
! Cancer patients are more easily involved in ACP as opposed to non-cancer 
patients (eg dementia, advanced organ failure, etc) 
Component 3: Educational booklet about ACP for patients (C) 
Content of the component to overcome the barriers and enhance the facilitators: 
• The goal of an educational booklet is to provide patients with appropriate 
information on ACP in advance and to prepare them for a patient-centred 
discussion adapted to their individual information needs 
• This educational booklet includes a question prompt list for patients and family 
• Patients are encouraged to reflect on and clarify their wishes together with their 
relatives through discussion  
Barriers and facilitators that are addressed by the component: 
! Patients’ lack of understanding regarding ACP 
! Patients are prepared to participate in ACP 
Component 4: Patient-centred ACP discussions with the help of a conversation guide (D) 
Content of the component to overcome the barriers and enhance the facilitators: 
• The conversation guide includes the following topics: understanding of 
prognosis, information preferences, prognostic information, patient’s previous 
experiences with ACP, patient goals and quality of life, fears, acceptable 
function, family involvement and contains examples of questions and 
communication tips 
 
 
Barriers and facilitators that are addressed by the component: 
! Lack of awareness about the different elements of ACP 
! Varying conceptualisations of ACP among GPs 
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covered by the question prompt list with their physician(7). The educational booklet would be given to 
patients during a routine visit and would facilitate subsequent patient-centred ACP discussions. 
4) A conversation guide was developed to support GPs and to assure a better uptake of all the key 
elements of ACP discussions(38). A draft was made based of a conversation guide for communication 
about serious illness care goals that was developed on the basis of a review and synthesis of best practice 
and afterwards validated in the expert panels. The key elements addressed in the conversation guide are: 
1) understanding of prognosis, 2) decision making and information preferences, 3) prognostic disclosure, 
4) patient goals and quality of life, 5) fears, 6) level of functioning acceptable to the patient, 7) trade-
offs that might be necessary to achieve different outcomes and 8) family involvement and choosing an 
appropriate surrogate decision-maker. The experts suggested shortening the conversation guide to a one-
page topic list. Most experts found a structured conversation guide useful to assure the completion of 
key steps in the conversations, but emphasized that it should be made clear in the training sessions that 
the conversation guide should not be used as a checklist or static script. 
5) A documentation template was developed that is standardised, simple and patient-friendly and that 
allows the opportunity to record and document the outcomes of ACP conversations. In the expert panels 
consensus was reached that the document should be complementary to an AD and record key 
information such as the patient’s values and goals, quality of life, fears and anxieties, etc. to help guide 
complex decisions. It was decided that this template could follow the same structure as the conversation 
guide. To improve the exchange of information about patient values and goals, instructions are also 
provided for GPs to communicate this document to other involved health care professionals with the 
patient’s permission, and patients will be encouraged by the GP to make this document available to other 
care providers. 
 
Discussion 
This article describes in detail the development process of an intervention to support the initiation of 
ACP in general practice consisting of five key components: 1) a training program for GPs in initiating 
and conducting ACP, 2) a register of patients who should be invited for ACP, 3) an educational booklet 
for patients to prepare them for ACP discussions, 4) a conversation guide to support GPs in ACP 
discussions and 5) a structured documentation template to record the discussions. 
An important strength of the study is that it was systematically developed using the MRC framework 
for the development and evaluation of complex interventions. To our knowledge, this is the first 
development of a complex intervention aiming to support the initiation of ACP for patients at risk of 
deteriorating or dying in general practice. It has been recognized that the development of interventions 
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calls for a systematic approach with a strong rationale for design and for the explicit reporting of the 
development process(40). The framework aims to helps researchers identify the core components of 
interventions and adopt the appropriate evaluation methods. Since its publication, a number of 
researchers in palliative care have applied the MRC framework to develop their interventions(41-43).  
Some limitations have to be acknowledged. Firstly, our search strategy was limited to systematic reviews 
about the effect of ACP interventions, which were screened for successful intervention studies that were 
then analysed by the research team for their key components. Observational studies as well as studies in 
which ACP was one component of a larger intervention were not included in our scope. Including 
different study designs such qualitative studies could have provided additional insights. Second, the 
composition of the expert panels might have presented a limitation. Although the panels were 
purposively sampled, not all relevant disciplines, such as patient representatives, were represented. 
Nonetheless, academic researchers and experts in the field of health care communication and the 
development of booklets and decision aids were attending. Third, a key component mentioned in a 
recently published clinical review on ACP could not be included in the intervention. It was found that 
not only a structured template for documenting the discussions should be provided, but also that a 
specific page in the electronic medical record (EMR) should be designated that can be easily accessed 
by all health care professionals involved(38). A small study recently examined the quality of ACP 
documentation templates in the EMR. This study found a great potential for making ACP documentation 
standardized and easily accessible in EMRs. The vast majority of notes in patients’ EMR contained 
important information regarding desired surrogate decision-makers and care preferences. In Belgium, 
cross-setting electronic health records do not exist yet and can thus not be used as a tool for 
communication across the health care system. Therefore, GPs are given the instruction to notify all 
involved health care professionals by communicating the documentation template that records the 
outcomes of the ACP discussions (with patients’ approval).  
The key components of our intervention largely correspond with the key factors identified in a recent 
narrative review on the enhancement of patient-professional communication about end-of-life issues. 
This narrative review did include intervention studies as well as observational studies and qualitative 
studies(44). Important features of a successful ACP model are shown to be focused participant-led 
training, the use of effective communication to improve patient understanding and flexible patient-led 
ACP discussions. The authors argue that the development of an ACP intervention for patients with life-
limiting conditions should include careful consideration of these features. Findings also showed that 
ACP should ideally take place over a number of meetings, with a trained professional with sufficient 
time to answer questions. ACP discussions should focus more on the goals of care than specific 
treatments and discussions should be tailored to the individual patient. Lastly, discussions should be 
supported with written documentation. A number of recently published systematic reviews on the effects 
of ACP on end-of-life care confirmed that complex ACP interventions may be more effective in meeting 
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patients’ preferences than written documents alone(45;46). Interventions focusing on ADs as well as 
those that also included communication about end-of-life care increased the chances of an AD being 
completed and the occurrence of end-of-life care discussions between patients and healthcare 
professionals. But interventions that also included communication about ACP improved concordance 
between preferences for care and delivered care(46). 
The developed ACP intervention differs from other interventions, most of which tend to be delivered by 
a trained facilitator who is not always knowledgeable about the clinical profile and social context of 
individual patients. This study took as the point of departure the proposition that ACP discussions should 
be initiated and facilitated by a health care professional with whom the patient feels comfortable about 
discussing their wishes and goals of care. The evidence suggests that other health care professionals can 
successfully conduct ACP, yet patients continue to state that they expect their primary care physician to 
initiate such conversations(47). In the Belgian health care system GPs are core providers of primary care 
and the majority of people have a GP with whom they often have a long-term relationship. GPs are 
usually cognisant of both the physical and non-physical domains of the patient’s health. So by targeting 
GPs, the time consuming nature of ACP conversations can possibly be limited (in contrast to the reported 
discussions of 1.5h in Box 1) because GPs in Belgium mostly know and care for their patients and their 
families over a long period time.  
A study on the implementation and embedding of ACP interventions in routine clinical practice showed 
that the factors that promote implementation in practice are largely concerned with structural 
mechanisms(48). These include prescheduled interventions and administrative procedures applied to 
selected patients, dedicated teams to organize the interventions, specifically trained facilitators to deliver 
the interventions and a dedicated document and organisational policies or guidelines to support the 
process. This intervention takes into account these factors by training GPs to manage the interactional 
processes with their patients, equipping them with simple tools such as a register for patients eligible 
for ACP discussions, a conversation guide, and documentation templates to record the ACP discussions. 
A patient brochure that will assist and increase the knowledge of patients and their caregivers of the 
potentially positive outcomes of ACP will also increase their willingness to engage in it with their GP. 
Educating patients on ACP and letting them prepare for the discussions with the educational booklet can 
also possibly contribute to limiting the time involved in conducting ACP discussions. It is however 
crucial that such tools are not considered as a replacement for meaningful communication between the 
GP, their patients and their families; they should rather precede, facilitate and support ACP 
discussions(49).  
Further research should focus on testing the feasibility and acceptability to patients and GPs of the 
intervention’s components and on explaining how the various components work together in a Phase II 
study(50;51). When trials have shown to be effective, it is usually difficult to understand how the 
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intervention caused it’s effect or what the critical components were in achieving success. In Phase II 
study, a combination of quantitative and qualitative research methods is recommended to identify the 
barriers for implementation and participation, to understand the best way to implement the components 
in standard care, to explain how the intervention works and to revise the results of Phase 0-I 
accordingly(22), which will greatly improve the intervention design and evaluation. Having developed 
and modelled this intervention to support the initiation of ACP in general practice, it will be important 
to evaluate its effectiveness thoroughly. 
 
Conclusion 
Performing a phase 0-I study according to the MRC framework helped us to develop a complex 
intervention to support the initiation of ACP in general practice for patients at risk of deteriorating or 
dying. Taking into account the barriers to and facilitators for GPs to initiate ACP as well as the key 
factors underpinning successful ACP interventions in other health care settings, we developed and 
modelled a complex intervention for general practice in patients with serious or life-limiting illnesses, 
after gaining feedback from two expert panels.  
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Introduction 
The research objectives of this dissertation were two-fold: (1) to describe the information preferences 
and experiences of the general public regarding advance care planning and (2) to develop an intervention 
to support the initiation of advance care planning in general practice.  
In this part, the main results of the studies undertaken to meet the objectives of this dissertation will be 
discussed. First, the main findings of the studies will be summarized, followed by a discussion on the 
methodological strengths and limitations of the studies and a general discussion of the most important 
findings. Finally we propose some implications for policy, practice and future research.  
 
Summary of the main findings 
I. Experiences of the general population regarding advance care planning and their information 
preferences when faced with a life-limiting illness 
In Chapter 1 and 2, we reported the results of the 2008 cross-sectional Health Interview Study on the 
involvement in advance care planning (ACP) and the information preference when faced with a life-
limiting illness of a representative sample of 9651 respondents of the Belgian population.  
Of all respondents, around 4.4% had spoken to their physician about their wishes regarding medical 
treatment at the end of life, while 1.8% reported to have an advance directive (AD) on euthanasia. Of 
the respondents who had discussed their wishes regarding medical treatment at the end of life with a 
physician, 22.2% had an AD on euthanasia. Vice versa, 55.4% of the respondents who had an AD on 
euthanasia, had discussed their wishes regarding medical treatment at the end of life with a physician. 
The probability of having discussed their wishes with a physician significantly increased with age, was 
higher for women compared to men, and for those respondents with a poorer health status compared to 
a good health status. This study also showed that having more contact with a GP was associated 
significantly with discussion of end-of-life care wishes. People older than 55 years were more likely to 
have an AD on euthanasia compared with the youngest age category. Those living in the Walloon region 
of Belgium were less likely to have an AD on euthanasia compared with those living in Flanders. 
Around 82% of respondents wanted to be informed always about diagnosis, chances of cure and 
available treatments, 77% wanted to be informed on life expectancy, 72% on options regarding palliative 
care and 67% on possibilities of prolonging or shortening life. Around 55% wanted their relative to be 
informed always about diagnosis, chances of cure, life expectancy and different treatments available, 
while 50% wanted this in relation to the options regarding palliative care and 46% to the possibilities of 
prolonging or shortening life. A minority of the respondents did not want to receive any information 
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either at all or only if they requested it. Compared with the youngest age category, people aged 25 to 34, 
35 to 44 and 45 to 54 were more likely always to want information, as well as more highly educated 
respondents. People living in Wallonia were overall less likely to want information on these six specific 
topics always as opposed to people living in Flanders. Women were less likely to want their relative to 
know about their life expectancy, different treatment options, options regarding palliative care and 
possibilities of prolonging or shortening life. People aged 25 to 34 and 35 to 44 were less likely to want 
their relative to know about their diagnosis and chances of cure, as were people with an educational 
level of lower secondary. In contrast, being 75 years and older was associated with wanting relatives to 
know about these topics.  
 
II. The development of an intervention to support the initiation of ACP in general practice 
Phase 0: Exploring potential components of the intervention 
To develop this intervention, a Phase 0-I study according to the Medical Research Council (MRC) 
Framework was conducted. Phase 0 consisted of 1) a systematic literature review about the barriers and 
facilitators for GPs to engage in ACP, 2) focus groups with GPs that were held about their experiences, 
attitudes and concerns regarding initiating ACP in general practice, and 3) a review of ACP interventions 
to identify potential components for the development of our intervention. In Phase 1, we developed a 
complex intervention to support the initiation of ACP in general practice for patients at risk of 
deteriorating or dying, based on the results of Phase 0. The complex intervention and its components 
were reviewed and refined by two expert panels. 
 
Systematic review 
For the systematic literature review studies were searched in four electronic databases (PubMed, 
CINAHL, EMBASE, PsycINFO). All reported factors hindering or facilitating GPs to engage in ACP 
were related to three groups: GP characteristics, perceived patient characteristics and health care system 
characteristics. Stronger evidence (factors reported in two or more high quality studies) was found for 
the following barriers: a lack of skills to act in response to vague patient requests to discuss ACP, 
difficulties with defining a right moment to initiate ACP discussions, the attitude that patients should 
initiate ACP discussions and the fear of depriving patients of hope when initiating ACP. A lack of GP 
knowledge, the emotional impact of ACP discussions, patients’ denial of death and a lack of resources 
were barriers for which medium evidence was found (factors reported in one high quality study or two 
medium quality studies). The perceived facilitators for which stronger evidence was found were 
previous gathered skills by conducting ACP discussions, the willingness or awareness to foresee and 
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discuss future health problems, and the skills to react to and address patient initiation of ACP. Cancer 
patients are also more involved in ACP discussions., as well as patients capable of decision-making. A 
longstanding patient-GP relationship and being able to conduct discussion in the home setting were also 
perceived as important facilitators for GPs to engage in ACP. Sufficient time and financial 
reimbursement to conduct ACP discussions were facilitators for which medium evidence was found. 
 
Qualitative focus groups 
Five focus groups were held with 36 GPs in Flanders, Belgium. In this qualitative study, the GPs 
reported multiple barriers to initiating ACP relating to their own characteristics, the characteristics of 
the patients and their families and the structure and organization of the health care system. Certain of 
these barriers were perceived to relate more to the specific trajectories of patients with cancer, heart 
failure or dementia. In cancer patients, a lack of knowledge about treatment options for all different 
cancer types and their possible effects and the lack of structural collaboration between the GP and 
specialist were expressed as barriers by a number of GPs. More specifically, the limited contact with 
patients and a lack of information from specialists during curative treatment phase were considered as 
factors that hinder the initiation of ACP for GPs. Barriers that occurred more often with heart failure 
and dementia patients were the lack of GP familiarity with the terminal phase and a lack of key moments 
to initiate ACP as opposed to the trajectory of cancer patients for which a number of key moments were 
identified. Not only was the terminal phase described less clear than with cancer but for some GPs the 
life-limiting nature of heart failure and especially dementia was also not always apparent or recognised. 
Consequently, the need to discuss end-of-life care does not always arise. Patients’ lack of awareness of 
diagnosis and prognosis as compared to cancer patients and the fact that patients did not often initiate 
such discussions themselves were also reported as barriers to discuss ACP. Prognosis is not always 
communicated because GPs can have difficulty in explaining potential events such as the risk of sudden 
death without creating anxiety. Consequently, these patients rarely initiate ACP themselves. The 
possible lack of decision-making capacity of dementia patients was reported by the GPs as a specific 
barrier for the initiation of ACP. Although, some GPs considered the future loss of a patient’s decision-
making capacity the very reason for initiating ACP, many felt also uncomfortable about discussing and 
planning end-of-life care with patients who are losing the capacity to express a change in preference or 
confirm their wishes at a certain point. Concerns were also expressed regarding the legal implications 
of implementing the documented wishes of patients with dementia who may lack decision-making 
capacity. 
In this qualitative study, participants were also asked at the beginning of each focus group whether they 
knew or were familiar with a definition of ACP. Not many GPs knew the specific term, but once a 
general definition was introduced in the focus groups, the GPs could describe a range of experiences in 
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this area. After analysis, GPs’ conceptualisation of ACP could be categorized in terms of the content of 
ACP and in terms of tasks for the GP. With regard to content of discussions, ACP was firstly 
conceptualised as the organisation of professional care required to meet patients’ needs. Secondly ACP 
discussions were also described as bad news conversations. In this context, ACP was also conceptualised 
as a process of preparing for death. Thirdly, ACP was conceptualised as the discussion and reflection 
on choices of treatment and types of care for the patient, and fourthly by some participants as the 
completion of documents regarding patients’ preferences. These conceptualisations could occur 
simultaneously in the narrative of a GP, however some GPs used only one of the conceptualisations to 
present ACP in their practice. With regard to the tasks for the GP, ACP was considered in terms of 
exploring and understanding patients’ preferences, also when patients mention the completion of an AD 
on euthanasia during a consultation. The GPs explained that patients often have misunderstandings 
regarding this AD. Coordinating care to address patients’ and families’ needs was also described as a 
task for the GP with regard to ACP, which often comprises collaboration between different informal and 
formal caregivers. It was however not always perceived as an easy task to mediate between different 
perspectives involved in patients’ care. While some participants were reluctant, a number of participants 
considered actively initiating ACP discussions as an important task for GPs, but acknowledged that this 
often depends on the competencies and attitudes of the GP regarding ACP. Finally, most GPs found that 
discussing palliative care options, comforting patients and reassuring terminal patients that they will be 
available and provide support until the end of life are important tasks for the GP related to ACP 
discussions. 
 
Key components underpinning ACP interventions 
A Medline search was conducted to identify systematic reviews with regard to ACP interventions. From 
these systematic reviews, we retrieved the intervention studies with a successful outcome regarding the 
occurrence of discussions, completion of advance directives, and improved end-of-life care and these 
were read in full and analysed for their components, in order to obtain a comprehensive overview of key 
features underpinning successful interventions and to identify potential components for the development 
of our intervention. This scope of ACP interventions identified four key features underpinning 
successful ACP interventions: 1) the involvement of a trained or experienced facilitator, 2) a selection 
process to identify patients eligible for ACP, 3) structured and patient-centred ACP discussions and 4) 
the opportunity to complete ACP documents (for a more detailed description of these key features, see 
Box 1 in Chapter 6). 
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Phase I: Modelling a complex intervention to support the initiation of ACP in general practice 
Phase 0 resulted in the identification of the factors inhibiting or enabling GPs’ initiation of ACP and 
important components underpinning existing ACP interventions. Based on these findings, an 
intervention was developed in Phase 1 consisting of five components: (1) A training program for GPs 
in initiating and conducting ACP discussions. The training is based on an educational programme about 
ACP specifically developed for GPs that has shown to improve their confidence and ability to undertake 
ACP conversations with patients. (2) A register of patients eligible for ACP discussions. A standardised 
tool for the timely identification of people who are at risk of deteriorating or dying was considered 
essential to support GPs in defining a key moment and prompting them to initiate ACP discussions. (3) 
An educational booklet on ACP for patients to prepare the ACP discussions that includes general 
information on ACP, a section on the role of GPs in the process of ACP and a prompt list about ACP. 
(4) A conversation guide to support GPs in the ACP discussions. The key elements the are addressed in 
the conversation guide are: understanding of prognosis, decision making and information preferences, 
prognostic disclosure, patient goals and quality of life, patient’s fears, acceptable function for the patient, 
trade-offs that might be necessary to achieve different outcomes, family involvement and appropriate 
surrogate decision-maker. (5) A structured documentation template to record the outcomes of 
discussions. A documentation template was developed that is standardised, simple and patient-friendly 
that allow the opportunity to record and document the outcomes of the ACP conversations. A detailed 
description of these five components can be found in Chapter 6 and appendix I of this dissertation. The 
key components of this intervention are available in a preliminary version and will be tested and finalised 
in a subsequent feasibility and pilot study (Phase II). 
 
Methodological strengths and limitations 
This doctoral thesis has made use of several research methods to address the specific research aims, each 
having their own strengths and limitations. 
 
Cross-sectional Health Interview Survey 
To describe the experiences of the general population with regard to ACP and their information 
preferences when faced with life-limiting illness and (objective 1), data was used from a population-
based study founded on a representative sample of the Belgian population. Other important strengths 
include the large sample size (N= 9651), the robustness of the methodology and the quality of research 
procedures. We used data from the Health Interview Survey (HIS), which has a long history of data 
collection in the Belgian population and is not based only on a specific interest in end-of-life care, but 
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obtains information about life style, health status, prevention and the use of health care facilities1. 
Several procedures were used to ensure data quality: the content of the HIS questionnaire was discussed 
in workgroup sessions with academic experts, health government agencies and fieldwork experts. The 
questionnaires were pre-tested: firstly, questions from other European surveys that were added to the 
HIS 2008 questionnaire benefited from a large scale pre-test and secondly, the HIS questionnaire was 
pre-tested by the WIV-ISP in a small, diverse sample of people to evaluate the length, comprehension, 
readability etc. of questions1. However, this population-based study also has some limitations. Because 
of the lower response-rate among the contacted households (55%), non-response bias cannot be 
excluded. The missing values for the outcome variables on ACP are around 23% and around 25% for 
the outcome variables on information preferences. Non-response analysis of those missing values 
showed that those missing values were more likely to be male, older, have a lower educational level and 
live in Wallonia or Brussels. As a result, it is possible that some of our findings are biased because of 
non-response. Because this population-based study examined the respondent’s own report of their 
involvement in ACP, the results may be subject to recall bias. Finally, as the majority of the respondents 
considered their health to be good, it might have been difficult for them to imagine a scenario where 
they have a life-limiting illness and to foresee what their information preferences would be in that case. 
 
Systematic literature review 
To identify the perceived factors that hinder or facilitate GPs in engaging in ACP with their patients, a 
systematic literature review was carried out. Four electronic databases were searched for studies 
published between 1990 and 2011: PubMed, CINAHL, EMBASE and PsycINFO. A search strategy was 
developed for Medline and adapted to each database separately. A combination of controlled vocabulary 
and free text words was used to search in titles and abstracts. An important strength of the study is that 
all required methodological steps to complete a systematic review were implemented and performed 
separately by two reviewers (ADV & DH). The titles and abstracts of all identified reports were screened 
independently these two reviewers using a standardized study selection form, as well as the eligibility 
of selected studies. Disagreement was resolved by discussion and a third reviewer (KP) was available 
for arbitration. The characteristics of the studies included were extracted to a standardized data-
extraction form under the headings of general information, country, research question, design, 
participants, barriers and facilitators and quality assessment scores. 
The quality of studies was appraised and evaluated using the Critical Appraisal Skills Programme 
(CASP)2. However, since no CASP tool is available for cross-sectional studies, an additional critical 
appraisal tool developed by Crombie (21-items list) had to be used3. In addition, the body of evidence 
from the multiple studies was graded using the three important elements for grading systems suggested 
by the Agency for Healthcare Research and Quality: quality, quantity and consistency4. This is a less 
General discussion 
165 
 
common approach, but it allows to provide a conclusion that incorporates both the results and quality of 
the studies and has been used successfully in other systematic reviews5. Given the variation in how ACP 
was defined in the included studies and the variation in GP practice, our findings may not be 
generalizable to all countries and health care systems. Also, we retrieved only qualitative research and 
observational studies though in our opinion such research designs provided the best way of addressing 
the research question. Moreover, we believe that the combination of qualitative and quantitative research 
methods within this study contributed to stronger validation of the results (data triangulation). 
 
Focus groups 
A qualitative research design was used in Chapter 4 and 5, which was considered to be most suitable to 
explore the perspectives of GPs regarding ACP. We chose focus group discussions as the best approach 
to explore the opinions and experiences of GP, given the flexible approach that allows for opens 
discussion and interaction between the participants6;7. Focus groups have proven to be a useful 
methodology to gain insights into a wide range of views8;9. 
Participants in three focus groups were recruited by using existing peer-review groups for GPs, 
contacted via email. Nearly 97% of all full-time practicing GPs in Belgium are affiliated to such peer-
review groups, where practice-related aspects are discussed four times per year10. Every GP who wants 
to be accredited in Belgium needs to be affiliated to such a group and attendance at two out of four 
meetings per year is mandatory. Using such pre-existing groups has proven to be beneficial, as group 
discussions are naturally occurring during these meetings11. However, it is also possible that some GPs 
might have feel restricted to report on their practice or experiences with ACP. A fourth focus group was 
organized by contacting the coordinators of the palliative care networks in Flanders with the request to 
disseminate our invitation to participate in a focus group to the GPs active in palliative home care teams. 
Because research shows that ACP usually takes place with patients who are terminally ill and close to 
death, we specifically also wanted to enroll GPs who supposedly have more experience with palliative 
patients. The indirect recruiting strategy, via the coordinators of the palliative networks, was probably 
the reason for the lower participation rate of these GPs (n=2). Because of lower response, this focus 
group was complemented with other GPs recruited via the professional contacts of the network 
coordinators (snowball sampling)12. Nonetheless, during the focus groups, it became clear that the nurses, 
who are also part of a palliative home care teams, are the ones who are mainly in contact with the patients 
at home. During the focus groups, the GPs active in a palliative home care team also mostly shared 
experiences from their own practice. Therefore, we believe this has not biased the results. A fifth focus 
group was organized with some members from a large practice located in an urban region as opposed to 
the rural and semirural regions where the other focus groups took place. As a result of the recruitment 
procedure for the fourth and fifth focus groups, these participants might have had an increased interest 
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in the topic, which we believe was not necessarily the case for the focus groups that were organized 
using peer-review groups. Nonetheless, by using different sampling strategies we gained insight into the 
complex range of views and experiences regarding ACP in daily practice from GPs with diverse 
backgrounds, experience and interest in ACP7. The focus group composition may have presented a 
limitation. Most of the participating GPs were male (n= 27), so female GPs (n= 9) were underrepresented, 
as were GPs younger than 39 years (n= 6 vs. n= 30).  
The focus group discussions were transcribed verbatim. For analyzing the data, constant comparative 
analysis was used13;14. In this approach, analysis is usually done in several stages of coding and 
interpreting the data. Firstly, two researchers (ADV & KB) independently read and openly coded two 
full focus group transcripts. The codes were discussed and mutually compared for similarities and 
differences until they could be grouped into categories related to the research questions. Subsequently, 
the focus group transcripts were independently read and compared with the primary coding framework 
by all the members of the research team. Codes were added, modified or merged where necessary. The 
remaining transcripts were coded by applying the final coding framework, which was additionally 
checked by the research team for agreement on interpretation. After this, coding saturation was judged 
to be achieved by the research team as no new categories emerged. An ongoing refinement of the coding 
framework resulted in overarching themes deduced from the categories. This approach allowed us to 
refine the results while focusing on the research questions. Moreover, the results were discussed in each 
stage of the data analysis within the research team to further improve consistency of the results. The 
multidisciplinary composition of the research team (consisting of medical sociologists, psychologists, a 
GP and an anthropologist, all with experience in qualitative research), guaranteed interpretation of the 
data from a range of perspectives. 
 
Medical Research Council Framework (Phase 0-I) 
We adopted the Medical Research Council (MRC) Framework to develop an intervention to support the 
initiation of ACP in general practice15;16. The MRC framework was published in 2000 and subsequently 
revised in 2008 to reflect the experience that had accumulated since the initial publication. Although the 
version published in 2000 proposed a stepwise, linear approach to designing and evaluating complex 
interventions (following a structure analogous to the development of pharmaceutical therapies)15, the 
2008 framework proposed a nonlinear approach that emphasizes both piloting and implementation 
studies; integrates process and outcome evaluation; acknowledges the importance of alternative, non-
experimental research methods and highlights the importance of understanding the intervention’s 
context16.  
Phase 0-I of the MRC framework encompasses the “development” phase which includes 2 sub-phases: 
(1) theory and evidence identification and (2) intervention modelling17. In this phase, it is suggested that 
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evidence is accumulated through systematic literature reviews, epidemiological research, qualitative 
research and expert opinion. For our Phase 0-I study, we used robust research methods: 1) a systematic 
review about the barriers and facilitators indicated by GPs to engage in ACP, 2) focus groups with GPs 
covering their experiences, attitudes and concerns regarding the initiation of ACP in general practice, 3) 
a literature search in order to obtain a comprehensive overview of key features that underpin successful 
ACP interventions and 4) a review of the preliminary complex intervention by an expert panel consisting 
of five GPs, one hospital geriatric, one palliative care consultant and two academic researchers in the 
field of ACP and health care communication. By using these research methods, we gained insight into 
the barriers and facilitators for GPs to initiate ACP with their patients, the conceptualisations of GPs 
regarding ACP in terms of the content of ACP discussions and the tasks for GPs in the process of ACP, 
and the potential components of an intervention to support the initiation of ACP in general practice. By 
using different research methods, data-triangulation was achieved, which we believe is an important 
strength of our Phase 0-I study. Moreover, the expert panel helped to identify the possible and best 
course of action to implement the intervention in practice. 
It has been recognized that the development of interventions calls for a systematic approach with a 
strong rationale for design and for the explicit reporting of the development process18, which we 
provided in Chapter 6. However, some limitations have to be acknowledged. Other perspectives such as 
those of patients and family members could have provided additional insights that could have 
contributed to a better understanding of the underlying problems of initiating ACP in general practice. 
Furthermore, when exploring the key components underlying existing ACP interventions, our search 
strategy was limited to systematic reviews about the effect of ACP interventions. These reviews were 
screened for successful intervention studies that were then analysed by the research team for their key 
components. Observational studies as well as studies in which ACP was one component of a larger 
intervention were not included in our scope. Including different study designs could have provided 
additional insights into the barriers and facilitators for implementation of the intervention. Despite these 
perceived limitations, we believe to have succeeded to thoroughly and correctly perform a Phase 0-I 
study according to the MRC framework. 
 
Discussion of the findings 
The participation of the general population in ACP 
Our results show that only a small proportion of people have in fact discussed their wishes for medical 
treatment at the end of life with a physician (Chapter 1). A cross-sectional survey in the Netherlands 
indicated that 13% of the general population had discussed issues related to medical decision-making at 
the end of life with a physician, as opposed to 4% of the general public in Belgium19. These figures 
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suggest that the involvement of the Belgian general population in ACP could be further stimulated. ACP 
is increasingly being viewed as a public health issue given its potential to prevent unnecessary suffering 
and to support individuals’ decisions and preferences related to future care and the end of life20. When 
ACP is implemented as an ongoing process of communication, it promotes the communication of 
patients’ preferences to family and friends, and it can improve concordance between a patient’s 
preferences and the end-of-life care received, as well as improve patient and carer satisfaction and 
quality of life21-24. It is thus important to raise public’s awareness concerning the importance of 
communicating their values and preferences for future care to their family members, surrogate decision-
makers and health care providers, such as the Speak Up initiative in Canada or Dying Matters in the 
United Kingdom25;26. However, our study also showed that among those who have an AD on euthanasia, 
only half had discussed their wishes regarding medical treatment at the end of life with a physician. A 
reason for this is that, in general, ADs do not have to be discussed with, drafted in the presence of or 
signed by a physician. However, a recent study of ACP in primary care showed that ADs were perceived 
by GPs as an instrument towards further communication between physicians, patients and their 
relatives27. It was also stated in our focus group study that ACP discussions are initiated by patients 
mentioning or asking about the completion of an AD on euthanasia during a consultation, but also that 
patients often have misunderstandings regarding this AD (Chapter 5). Most GPs considered it an 
important task to correctly inform their patients about the benefits and limitations of ADs, and to ensure 
that their patients’ ADs are valid and accurate. It is however also possible that people do visit their 
physician with the intention of discussing the completion of an AD on euthanasia and actually more 
broadly their wishes for care at the end of life, but that the physician omits to take up the opportunity to 
elaborate on this28;29.  
It is known that the formulation of documents should ideally be framed within a process of 
communication and consultation and that ADs should be seen as a potential outcome of the process of 
ACP30. The willingness of physicians to adhere to directives has also been shown to be dependent on 
whether or not the directive was coupled with physician-patient discussions31. Fried & Drickamer (2010) 
have recommended before that people should be made aware of the importance of ACP as a 
communication process through the development of a public health message by providing accurate 
information about the benefits of timely engaging in ACP and the potential negative consequences of 
failing to engage32.  
 
Information preferences of the general population 
The results presented in Chapter 2 revealed that a majority of people in Belgium would always want to 
be informed about their diagnosis, their chances of being cured, the available treatments, and their life 
expectancy in the scenario of having a serious life-limiting illness33. These results were also found in a 
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European population survey that revealed a wide-spread public preference to always be informed in the 
scenario of having a serious illness with less than a year to live34. Additionally, our study showed that 
in Belgium around 70% of the respondents also indicated to always want information on palliative care 
and the possibilities of prolonging or shortening life. The results of this cross-sectional survey can be 
placed within the context of an increased societal importance of patient autonomy and participation in 
decision-making on the one hand (as discussed in the introduction of this dissertation) and the open 
public debate on end-of-life issues engendered by the process of legalization of euthanasia in Belgium 
on the other hand35-37. The Belgian general public is regularly confronted with reports on euthanasia as 
an end-of-life decision in the media38, which might have influenced the public preferences to be 
informed about these topics. Previous studies have already shown that a markedly high public 
acceptance of euthanasia was found in a small cluster of Western European countries, including the 
three countries that have legalized euthanasia (Belgium, the Netherlands and Luxembourg), which is 
strongly related to a belief in the right to self-determination39;40.  
It is important to note that these questions were asked in the general population in the hypothetical 
scenario of having a life-limiting illness, which might have been difficult for respondents to imagine. 
However, the preferences for information on all of these specific topics were previously also studied in 
newly diagnosed advanced lung cancer patients36. In comparison to our study in the general population, 
the preference of these patients to always want to be fully informed were higher on the specific topics 
of diagnosis, treatment and cure rate and life expectancy, while fewer wanted to have always information 
about palliative care and end-of-life decisions. This shows that the willingness to receive information 
on specific topics such as diagnosis and treatment options is generally high, but also that patients’ 
preferences for information may shift when their health changes. Remarkably, it was found that only 
half of the respondents wanted their relatives to always be informed about these topics. Previous research 
has shown that patients vary in how involved they want family members to be and how much they want 
their own values as opposed to those of family members, to determine care at the end of life41. 
Nonetheless, most would opt for shared decision-making with loved ones and physicians. Sudore et al. 
(2010) indicated that the main objective of ACP is to prepare patients and their surrogates to participate 
with physicians in making the best in-the-moment decision42. In doing so, a first important step for 
patients is choosing a surrogate decision-maker. Physicians should explore these issues and patients 
should be stimulated to think about who they would consider appropriate to make medical decisions for 
them if they would lack the capacity to do so. 
These data provide evidence that, as part of a patient-centred approach, physicians might do well to 
inquire patients up front about their preferences for information. Exploring patients’ preferences for 
information is one of the first elements that should be addressed when engaging in ACP with patients43-
45. Physicians should be alert to patients’ specific information preferences depending on the topic and 
verify whether they want their relatives to be informed or not. They should anticipate most patients 
Part IV 
170 
 
wanting full knowledge on disease and treatment-related matters (although a minority of respondents 
indicated to not want to know at all or unless they were asked first). This will require the appropriate 
skills from physicians to elicit information preferences and knowledge to provide the desired 
information46. 
 
Barriers to and facilitators for the initiation of ACP 
Findings from the 2008 Belgian Health Interview Survey in Chapter 1 & 2 demonstrate that almost 95% 
of the population, including care home residents, have a fixed GP whom they consult regularly (78% of 
the population have at least one encounter per year). Moreover, the number of GP contacts increases 
with age: persons aged 75 or over make an appeal four times more often to their GP compared with 
persons younger than 45, and they are seen by their GP on an almost monthly basis47. Evidence-based 
guidelines suggest that ACP is preferably initiated by a health care professional when patients are in a 
stable state of health and in anticipation of future ill-health, before crisis situations occur48;49. Primary 
care settings remain a critical setting to engage these patients in ACP50;51. Given their longstanding and 
trusted relationship with patients, GPs are likely to have good clinical and contextual knowledge of their 
patients and explore patients’ and families’ willingness to engage in ACP52. Our study showed that 
patients who have been in frequent contact with their GP had discussed their wishes for medical 
treatments at the end of life more than patients who had no contact with their GP (Chapter 1), which 
might suggest that GPs can play a special role in empowering patients to participate in ACP.  
Nonetheless, GPs face significant barriers to engage in ACP with their patients. Many barriers found 
throughout this dissertation were either related to GPs’ lack of skills, knowledge or attitudes towards 
ACP (Chapter 3 & 4). Some GPs are reluctant to discuss end-of-life issues and tend to wait until the 
patient raises the topic. Remarkably, studies show that patients would appreciate the chance to discuss 
ACP but they wait for their doctor to broach the subject, which suggests that there is a gap in expectation 
between patients and GPs53-55. During the focus groups, the GPs explained that ACP discussions are 
sometimes initiated by patients by either expressing vague end-of-life care wishes or asking about the 
AD on euthanasia during a consultation. These moments may provide opportunities for GPs to initiate 
ACP, but a lack of skills to address patients’ initiation or patients’ vague requests about end-of-life care 
were reported as barriers for GPs (Chapter 3). As the GPs recognized themselves during the focus groups, 
actively initiating ACP often depended on their experience with initiating ACP, their perceived 
competencies (good communication skills) and positive attitudes of the GP regarding ACP (Chapter 5), 
which is confirmed by other research56. 
Although the literature provides common terms and definitions used in ACP48;57, many GPs found it 
difficult to define ACP in a consistent way. As a consequence, their conceptualisations of ACP ranged 
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from a comprehensive and multifaceted process of planning to completing specific documents or the 
process of preparing for death (Chapter 5). The conceptualisations sometimes also implied an engaging 
in specific aspects of ACP rather than engaging in multiple discussions that address all key elements as 
recommended in the literature58;59. During the focus groups, it was also stated that ACP discussions were 
mostly conducted in an informal way and sometimes perceived as something that is already discussed 
with patients between the lines. Previous research already showed that health care professionals 
perceived no difference between day-to-day care planning and ACP60;61. However, the National Health 
Service in the UK makes a clear distinction in their National End of Life Care Programme between 
‘general care planning’ on the one hand and ‘advance care planning’ on the other57;62. General care 
planning encompasses the care of people both with and without capacity to make their own decisions, 
whereas ACP always requires the involvement of patients who have the mental capacity to establish and 
express their preferences. ACP is always about patients with capacity expressing preferences with the 
aim to aid decision-making and direct future care in the event when patients’ decision-making capacity 
is later lost62. General care planning indeed involves a process of assessment and patient-centred 
dialogue to establish a person’s needs, preferences and goals of care and making decisions about how 
to meet these in the context of available resources, but it focuses on the current situation.  
Recently, the first guideline on ACP was published for GPs in Flanders63. This guideline is currently 
being endorsed among GPs via two hour workshops in local peer review GP groups. Local peer-review 
GP groups are geographically determined groups of GPs that meet four times a year to discuss their 
practice. The workshops consist of a presentation on the content of ACP and an evaluation of patient 
case reports in terms of the need for ACP. The development of guidelines and training programmes can 
be helpful to change the skills, attitudes, and beliefs of GPs, and to provide good role models for the 
difficult task of initiating communication about end of life. It is also important that a training programme 
for GPs is time efficient because it will lead to greater access and completion by these physicians64. 
However, a training programme on ACP also needs to include active, practice-oriented strategies such 
as role-play exercises, feedback, the use of video role modelling, group discussions and feedback during 
the training session as these are educational strategies which have shown to be most effective in 
improving physicians’ competencies65-68.  
Moreover, the findings of this dissertation show that the barriers to ACP are more complex than a lack 
of skills and knowledge but instead extend to entire health systems, which is confirmed by other studies69. 
A number of barriers and facilitators identified for GPs to initiate ACP were related to health care system 
characteristics (Chapter 3 -5). Ineffective communication between health care providers across settings, 
as well as difficulties with sharing the outcomes of ACP discussions across the health care system were 
perceived by GPs as important reasons for not initiating ACP. The GPs in our study indicated that they 
often lose touch with their patients when they are mainly being cared for by the specialist. According to 
them, this is not countered by effective collaboration or information transmission across health care 
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settings (Chapter 4). Furthermore, personalized and comprehensive ACP discussions can be time 
consuming and the GPs in our focus groups also argued that during regular consultations time constraints 
restricted them from initiating ACP discussions70. A financial reimbursement was in the systematic 
literature review also identified as a structural factor that could facilitate GPs’ engagement in ACP. 
Financial incentives have already been suggested by other research as needed to stimulate clinicians to 
engage in ACP69. However, a financial reimbursement as such does not guarantee that ACP will be 
carried out properly and safeguards will need to be built in. Concerns have already been raised by health 
care professionals that otherwise ACP may be reduced to merely a check-box exercise69.  
It has been indicated before that to systematically implement ACP in practice, an intervention may not 
rest solely on improving communication skills71. Few health care systems have developed structures and 
processes that systematically address ACP59. As other authors have suggested, to embed ACP into 
routine practice, it is necessary that all health care organisations (including general practices) need to 
become “conversation ready”; this means systematically eliciting, documenting and enacting patients’ 
preferences72-74.  
 
The development of an ACP intervention for general practice 
A systematic, multicomponent intervention holds the greatest potential for improving ACP and is 
aligned with existing evidence44;69. The barriers and facilitators indicated by GPs to initiate ACP found 
in this dissertation are complex and multifaceted. Therefore, a complex intervention was deemed 
necessary to support the initiation of ACP in general practice. Complex interventions are defined as 
interventions comprising a number of components that may act both independently and inter-
dependently15;75. A recently published systematic review regarding the effects of ACP on end-of-life 
care showed that complex or multicomponent ACP interventions may be more effective in meeting 
patients’ preferences than written documents alone76. These interventions were found to result in an 
increased frequency of out-of-hospital and out-of-ICU care and in increased compliance with patient’s 
end-of-life wishes and satisfaction with care. Moreover, patients and families who participated in ACP 
did not report more stress, anxiety or depression compared to patients or families who did not participate.  
With the development of a complex intervention to support the initiation of ACP in general practice, we 
aim to improve communication between patients and their GP, increase quality of life and well-being of 
patients and their relatives, enhance provision of care consistent with patient goals and preferences, and 
increase satisfaction with care21-23;77. Research has shown that system-wide processes are needed that 
will consistently 1) invite all eligible patients to consider ACP for future care relevant to their stages of 
illness, 2) provide competent assistance by trained and accountable personnel and 3) ensure written and 
documented plans78. Recent research on successful ACP programmes identified a number of elements 
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that are shared by these programmes: a facilitated, clinician-initiated discussion process to develop 
individualized care plans, standardized documentation and forms, proactive yet appropriately staged 
timing of discussions, systems and processes that ensure planning occurs, ongoing evaluation of the 
programme and quality improvement79. Other elements that were shown to be promising facilitators of 
ACP include the use of easy-to-understand ACP educational materials, systematic clinician training in 
communication skills and extensive clinician-led discussions over time about patient values71;79. 
Following phase 0-I of the UK Medical Research Council’s (MRC) guidance for developing complex 
interventions80;81, we developed a complex intervention to support the initiation of ACP in general 
practice in Flanders, Belgium (Chapter 6 & Appendix 1). Our intervention is somewhat different from 
existing ACP programmes such as the Respecting Choices Program82, as it will be delivered by patients’ 
GP instead of a trained non-medical facilitator. We aimed for the initiation of ACP to occur with a health 
care professional who is likely to have good clinical and contextual knowledge of the individual patient, 
is aware of both the physical and non-physical domains of health and is in a trusting relationship with 
patients, or able to develop such a relationship78;83. By targeting GPs, we considered that the time 
consuming nature of ACP could possibly be limited to some extent because GPs in Belgium, as in many 
other countries, mostly know and care for their patients and their families over a long period time. A 
study on the implementation and embedding of existing ACP initiatives in routine clinical practice 
showed that the factors that promote the implementation are largely related to following procedures84: 
prescheduled interventions applied to selected patients, a dedicated team to organize the interventions, 
specifically trained facilitators to deliver the interventions and a dedicated document and organisational 
policies or guidelines to support the process. Our intervention takes these factors into account by training 
GPs in managing the interactional processes with their patients, equipping them with simple tools such 
as a register for patients eligible for ACP discussions, a conversation guide, and a standardized template 
to document the ACP discussions. An additional challenge to address in this intervention was the lack 
of communication between the different health care providers involved in patients’ care. In Belgium, 
cross-setting electronic health records to disseminate and access patients’ medical files by different 
health care providers does not exist yet and can thus not be used as a tool for communication across 
health care settings85. Therefore, specific guidelines were linked to the standardized documentation 
template for the GPs. Patients need to be encouraged by their GP to talk about this documentation 
template to their other care providers. But GPs are also given the instruction to notify other involved 
health care professionals about the outcomes of the ACP discussions (of course with patients’ approval), 
for example by sending a copy of the standardized documentation template together with patients’ 
referral letter to the involved specialist.  
Another important barrier identified by the GPs was the uncertainty about when to initiate ACP. As the 
findings presented in Chapter 5 show, ACP was conceptualised by some GPs as discussions in terms of 
communicating a terminal diagnosis or as discussions about the initiation of palliative home care, which 
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suggests that in actual practice ACP is sometimes initiated rather late in the course of disease. A 
literature review on ACP in primary care confirmed that most physicians only initiate ACP 
conversations when patients are terminally ill or suffering from potentially fatal illnesses27. Previous 
research already showed that ACP is strongly related to the provision of palliative care35;56;86, but also 
that palliative care is still often associated with terminal care which is mostly initiated relatively close 
to death9;87;88. When developing our intervention, it was considered to be an important aspect of 
implementation to take into account when or with whom GPs feel most comfortable with initiating ACP. 
Most GPs in the focus groups considered patients suffering from a life-limiting illness to be most eligible 
for initiating ACP with. However, the initiation of ACP in patients with non-cancer conditions such as 
heart failure or dementia also proved to be more challenging (Chapter 4). These diseases were often 
perceived as non-terminal and therefore not as relevant to the principles of ACP (Chapter 4). According 
to the GPs, cancer patients were more easily involved in ACP. It was therefore considered important to 
standardize the timing of ACP discussions by identifying in general patients at risk of deteriorating or 
dying (and documenting these patients in a register). A number of triggers have been proposed in the 
literature as a guide for health care professions to initiate ACP72;89. GPs can make use of general triggers 
such as a poor general health of the patient (limitations in self-care or multiple hospitalization) or age 
(e.g. all patients older than 80 years), prognosis-related triggers such as the surprise question “Would 
you be surprised if this patient died in the next year?” or condition-based criteria by using the Supportive 
and Palliative Care Indicators Tool (SPICT) which is a simple, one page format that contains general 
indicators of deteriorating health commonly present in advanced conditions44;83;90-92.  
Lastly, an educational booklet that will assist and increase the knowledge of patients and their caregivers 
of the potentially positive outcomes of ACP will also increase their willingness to engage in it with their 
GP. Moreover, educating patients on ACP and preparing them for the discussions could also contribute 
to limiting the time involved in conducting ACP discussions, which was perceived as a barrier by the 
GPs. Because ACP can be a time-intensive process, helping patients and families begin this process on 
their own is useful59;93. The challenge that awaits us now, is to test this complex intervention in a Phase 
2 study, in order to determine the feasibility and acceptability of the intervention in a sample of patients 
and GPs16;94 (see recommendations for future research).  
   
Implications for policy, practice and future research 
This dissertation reveals a number of issues concerning the initiation of ACP in general practice. This 
section contains several recommendations for policy makers and GPs (although we believe many of 
these recommendations may apply to or profit other caregivers) regarding the initiation of ACP in 
clinical practice. Lastly, several important points for future research are identified. 
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Policy recommendations 
Despite the potential advantages of ACP, it is initiated rarely or rather late in the disease trajectory of 
patients. This suggests that stimulation of both patients and physicians to engage in ACP discussions 
would be useful as part of efforts to enhance ACP in practice. 
Public information campaigns can increase the public’s awareness on the importance of having 
timely ACP discussions. Public health campaigns may have a strong impact on the population and they 
could also lower the barriers for physicians to address ACP with their patients. As the GPs in our study 
indicated, many of their patients lack knowledge about ACP and ADs. Public health messages can 
increase people’s knowledge by providing accurate information about the benefits of engaging in ACP 
and the potential negative consequences of failing to do so. Our study showed that younger people, men, 
those living in the Walloon region of Belgium, those with poorer health and those with few GP contacts 
are target groups for education because of their lower uptake of ACP. Younger people in good health 
tend not to feel the need for ACP because they are less confronted with the consequences of a life-
limiting illness than older adults and do not want to think about the end of life. Nonetheless, they can 
also be stimulated to engage in ACP or to appoint a surrogate decision-maker because sudden serious 
illness or injury can quickly render adults of all ages incapable of decision-making95. A strategy that has 
been proposed by other authors would be to encourage them first to identify a surrogate decision-maker, 
which may eventually lead them to initiate discussions about their preferences and goals of care, which 
may be possibly followed by an AD96. Older people are another key target group for ACP, as they are 
at higher risk of needing end-of-life care. Of those older than 75 years, our study showed that only a 
minority has ever had a discussion with their physician about their wishes regarding medical treatment 
at the end of life. Public information campaigns may help to overcome important barriers for patients to 
engage in ACP, including the perception that ACP is irrelevant or that they have to wait for their 
physician to initiate these discussions. A study on the impact of the Terri Schiavo media coverage in the 
US found that her story motivated the majority of participating adults to define their own goals for 
medical care and to talk to their family and friends about ACP97. Terri Schiavo was a 41-year-old women 
who was in a persistent vegetative state after suffering a cardiac arrest in 1991. After a prolonged legal 
battle, her feeding tube was finally removed in 2005. 
GPs can also have an important role in the promotion and initiation of ACP98;99. However, a lack of time, 
experience and training to discuss ACP often discourages them from initiating such conversations with 
their patients. As this dissertation showed, one of the problems is that the skills, knowledge and attitudes 
of GPs can strongly influence whether or not ACP is (timely) initiated. Policy should therefore aim to 
motivate and support GPs to introduce ACP to their patients. Barriers caused by lack of training 
and experience in ACP could be addressed by education or training programmes. It is important that 
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GPs are trained in conducting ACP discussions so they feel less hindered when confronted with 
situations that require these discussions. GPs should better understand what ACP is, what its 
significance and goals are, and improve their communication skills so they can talk effectively to their 
patients about their values and goals for future care. This can be done by ensuring that formal education 
on ACP is included in the medical curricula for GPs and by stimulating further postgraduate training on 
ACP.  
ACP is a complex and time consuming task, which can lead physicians avoiding the initiation of ACP 
or shifting the responsibility for it towards other professionals. An appropriate financial recognition 
for the time invested has been suggested as a way to further encourage physicians to have such 
conversations with their patients69. It has also been suggested by the International Society of Advance 
Care Planning and End of Life Care to establish formal credentials for those health care professionals 
providing ACP. These credentials could assist in legitimizing the role of the ACP facilitator within 
healthcare, provide a consistent approach to training, and facilitate reimbursement for activities related 
to ACP100. 
Lastly, a central electronic register that holds information about patients’ advance care planning 
could improve communication and facilitate health care professionals’ access to this information. This 
central register must be accessible for all relevant health care professionals. Today, a central register 
that stores patients’ ACP-related information has not been implemented in Belgium, hence alternative 
ways must be found to share a written record of the ACP process quickly and efficiently between the 
different health care settings. Since 2012, patient-held wallet cards have been introduced in Belgium to 
flag the existence of ADs (i.e. LEIF card)101. This card does not replace the paper version of an AD but 
indicates whether a patient has an AD.  
 
Recommendations for practice 
We recommend for GPs to participate in adequate training programmes in order to enhance their 
competencies in conducting ACP discussions and improve their knowledge on the process, benefits and 
outcomes of ACP. Many GPs find these conversations difficult and as this dissertation showed, whether 
or not GPs are willing to initiate ACP greatly depends on their attitudes, knowledge and skills. Based 
on evidence from the literature, a training programme on ACP was developed as part of our complex 
intervention to support the initiation of ACP in general practice. This training programme will include 
active, practice-oriented strategies such as role-play exercises, feedback, the use of video role modelling, 
group discussions and feedback during the session. 
Standardizing the timing and conduct of ACP discussions by identifying patients eligible for ACP 
discussions can also be helpful for timely initiating ACP. This study indicated that many GPs experience 
General discussion 
177 
 
difficulties with defining a key moment to initiate ACP, especially in patients with organ failure and 
dementia as opposed to cancer patients. There is no agreed standard on when to initiate ACP, but a 
pragmatic three-step guide that can be used by GPs is to consider ACP if: 1) ‘no’ is the answer to the 
question “Would you be surprised if this patient died within the next year?”, 2) the patient’s general 
health is poor (e.g. multiple hospitalisations, limitations in self-care) and 3) disease-specific indicators 
point to a poor prognosis (e.g. progressive malignancies, dementia, advanced organ failure, disabling 
neurological conditions). Specific triggers to discuss ACP might include: patients initiating the 
conversation, the diagnosis of a progressive life-limiting illness, change in a patient’s personal 
circumstances such as moving into a care home or loss of a family member83. 
Another possible measure to facilitate ACP for GPs is to make use of tools such as brochures or 
information leaflets for patients. In that way patients can already consider ACP before talking to their 
doctor. A preliminary version of a patient brochure on ACP was developed as part of our complex 
intervention to support the initiation of ACP. To address ACP in a more systematic way, it is important 
that patients are informed about ACP and the benefits of engaging in it, and that these information 
resources are widely available. GPs can hand out brochures or information leaflets to their patients who 
are interested or in need of ACP discussions. The use of a conversation guide could also support GPs 
during ACP discussions by providing an overview of the key elements that should be addressed with 
patients. Our findings highlight the importance of checking patients’ preferences in advance as to the 
extent and the specific topics about which they want to be informed. An examination of the role of 
relatives is also warranted (as only half of the people want a relative to always be informed). By 
exploring these issues with the patient, GPs can help them to develop a plan to engage relatives in these 
discussions and choose an appropriate surrogate decision-maker. As part of our intervention to support 
the initiation of ACP in general practice, a draft of a conversation guide was developed and approved 
by an expert panel, consisting of the following key elements: understanding of prognosis, decision 
making and information preferences, prognostic disclosure, patient goals and quality of life, fears, level 
of functioning acceptable to the patient, trade-offs that might be necessary to achieve different outcomes, 
family involvement and a surrogate decision-maker. 
Lastly, it is recommended that patients’ wishes, preferences, goals of care and decisions are documented 
in their medical record. This information must be timely, accurate, relevant and understandable, but also 
easily retrievable and transferable wherever the patient is being treated. As part of our intervention, we 
developed a structured template that can be used to document the outcomes of ACP discussions. It is 
important that the outcomes of ACP discussions are communicated to all health care providers involved 
in the patient’s care.  
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Recommendations for future research 
In this dissertation, a cross-sectional survey was performed to quantify the information preferences of 
the general population when faced with a life-limiting illness and their involvement in ACP. However, 
several study findings are in need of further clarification. We for instance observed that although the 
majority of people in Belgium wants to be informed about different topics related to their illness when 
faced with a life-limiting illness, people’s preference for always wanting their relatives to be informed 
about these topics is less prevalent. Reasons for this are however not clear. Similarly, it was observed 
that there are differences in information preferences or the involvement in ACP of the general 
population between the different regions in Belgium. Qualitative research with patients could lead to 
additional insights and to new suggestions for how to address ACP with patients and their relatives, 
especially in patients with non-malignant life limiting diagnoses as they continue to achieve lower 
rates of ACP compared to patients with cancer diagnoses. In addition, as health care professionals will 
increasingly be faced with a growing number of immigrants with whom ACP discussions can be 
conducted, research on the experiences and attitudes, barriers and facilitators for ACP of people with 
different racial and cultural backgrounds is warranted, which is today still underexposed in research 
regarding ACP63;102.  
Performing a Phase 0-I study according to the MRC framework helped us to develop a complex 
intervention to support the initiation of ACP in general practice. However, it is known that evaluations 
of complex interventions are often accompanied by problems because researchers have not fully defined 
and developed the intervention through an iterative phased approach. Future research should therefore 
aim to reveal the effectiveness of the intervention’s components we developed. It should also focus on 
the best way to implement the components in standard care procedures by testing the feasibility of the 
intervention’s components and on explaining how the various components can work together to achieve 
the desired outcomes94. The Phase II study serves to establish the probable active components of the 
intervention so that they can be delivered effectively during a subsequent large-scale randomized 
controlled trial that evaluates the effectiveness of the intervention (Phase III study).  
In Phase II, the information gathered in Phase 0-I is used to develop the optimum intervention and study 
design. Firstly, this involves testing the feasibility of delivering the intervention and its acceptability to 
providers and patients. This means that the intervention may have to be adapted to achieve optimal 
feasibility16. For example, the patient brochure developed for our intervention can be tested through 
qualitative interviews with a number of patients in which they are asked for their feedback. A focus 
group interview with GPs may provide insights into the feasibility and acceptability of the conversation 
guide and the template for documenting the outcomes of the ACP discussions. This study should also 
focus on how triggers to identify eligible patients for ACP can be embedded in routine care. The training 
for GPs may be tested with a small group of participants that can complete an evaluation before and 
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after the training programme. The content and educational materials can also be evaluated by the GPs 
following the education. If it is found that certain components of the intervention are unacceptable to 
potential recipients, these components may have to be re-examined.  
Secondly, in Phase II, appropriate outcome measures for the main trial have to be carefully selected and 
piloted during the exploratory study. Recently, a number of systematic reviews on the effects of ACP 
were conducted77;103. However, the authors concluded that a meta-analysis to define which ACP 
approach is the most effective, was not possible because of the variability in the definitions and 
measurements of the outcomes77. Therefore other researchers have recommended to use validated 
instruments in future intervention studies to make the comparison of outcomes across different studies 
possible. Nonetheless, it has also been recognized that ACP interventions may turn out to be 
unsuccessful because they are based on the narrow outcome of AD document completion and the 
assumption that the value of ACP depends on whether the plans are followed, and that the intervention 
was unsuccessful if they are not98. However, the completion and adherence to ADs may not necessarily 
be the main reasons why patients, their families and health care professionals engage in ACP (as is 
discussed in the introduction of this dissertation)104;105. With this complex intervention, we aim to 
ultimately improve the initiation of ACP in general practice. In doing so the following goals can be 
achieved, i.e. enhance provision of care consistent with patient goals and preferences, increase patients’ 
and relatives’ satisfaction with care and contribute to the quality of life and well-being of patients and 
their relatives. 
Thirdly, as part of Phase II, the complex intervention is evaluated in an exploratory pilot trial that ideally 
should be randomised so effect size and variability of the effect can be estimated and potential problems 
in the implementation of the trial detected (such as the feasibility of the recruitment process and 
measurement, randomization, adherence and drop out, etc).  
To perform Phase II, a combination of quantitative and qualitative research methods are recommended 
to evaluate the intervention106;107. This is necessary to understand the barriers for participation and 
implementation, to clarify why the intervention works or not and accordingly revise and improve the 
intervention design and evaluation. Phase II provides an understanding of which components of the 
intervention are probably essential and should be retained and which ones can be modified without 
jeopardizing outcomes. This approach ensures that when the intervention is ready to be rolled out and 
evaluated in a large-scale Phase III study, it is feasible within the target context and that the processes 
of its implementation are understood. 
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Conclusion 
This doctoral thesis reveals that few people of the general population in Belgium have discussed their 
wishes regarding medical treatment at the end of life with their physician or have completed an AD on 
euthanasia. Younger people, men, inhabitants of the Walloon region of Belgium, people with a poorer 
health status and people with fewer GP were less likely to engage in ACP. However, the majority of the 
Belgian population indicated the preference to always be informed concerning disease-related topics 
and end-of-life care topics when faced with a life-limiting illness. Younger adults, people with a higher 
education and people with a regular GP were more likely to always want to be informed on these topics. 
Younger adults and women were less likely to want their relatives to be always informed. Information-
giving is an essential aspect of clinical care, so understanding the public preferences for information in 
advanced disease and participation in ACP is not only necessary to promote communication about future 
treatment and end-of-life care, but also to support and train clinicians in responding appropriately.  
In the Belgian health care system, GPs were considered ideally placed to initiate an ACP discussion in 
a timely manner. However, in this thesis we found multiple reasons of why GPs do not initiate ACP 
with their patients that could be allocated to either their own characteristics, the characteristics of the 
patients and their families, or the structure and organization of the health care system. We also gained 
insight into the specific barriers for GPs to initiate ACP placed in the context of the three illness 
trajectories of cancer, heart failure and dementia. Key barriers and facilitators were not only related to 
GPs’ skills knowledge and attitudes about ACP, but also to structural elements such as the lack of 
collaboration and communication between the involved care providers in different health care settings. 
Additionally, we found varying conceptualisations of ACP among GPs in terms of the content of ACP 
discussions and the task for GPs in the process of ACP, of which some are more limited to only specific 
aspects of ACP. This can lead to confusion as the role of GPs may vary according to how ACP is 
conceptualised. A shared conceptualization is needed to ensure a successful implementation of ACP. 
The barriers and facilitators found in this dissertation are complex and multifaceted. Therefore, the 
development of a complex intervention is needed to support the initiation of ACP in general practice. 
The construction of this complex intervention was based on the results of 1) a systematic review about 
the barriers and facilitators indicated by GPs to engage in ACP, 2) focus groups with GPs covering their 
experiences, attitudes and concerns regarding the initiation of ACP in general practice, 3) a literature 
search in order to obtain a comprehensive overview of key features that underpin successful ACP 
interventions and 4) a review of the preliminary complex intervention by an expert panel. The 
intervention consists of five key components: 1) training for GPs in initiating and conducting ACP 
discussions, 2) a register of patients eligible for ACP discussions, 3) an educational booklet for patients 
to prepare them for ACP discussions, 4) a conversation guide to support GPs in ACP discussions and 5) 
a structured template to document the outcomes of the discussions. A future challenge will be to test and 
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finalize the intervention in a subsequent feasibility and pilot study (Phase II). With this complex 
intervention, we aim to ultimately improve the initiation of ACP in general practice. In doing so the 
following goals can be achieved, i.e. enhance provision of care consistent with patient goals and 
preferences, increase patients’ and relatives’ satisfaction with care and in the long run contribute to the 
quality of life and well-being of patients and their relatives. 
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Inleiding 
Een belangrijk aspect van kwaliteitsvolle en patiëntgerichte levenseindezorg is de mate waarin de zorg 
overeenstemt met de wensen van de patiënt. Dit veronderstelt dat de wensen en voorkeuren van 
patiënten m.b.t. hun levenseindezorg gekend zijn alvorens ze wilsonbekwaam worden om zelf hun 
voorkeuren te uiten en beslissingen te nemen. Voorafgaande zorgplanning (VZP) kan daartoe een 
belangrijke bijdrage leveren. VZP is een proces dat mensen de mogelijkheid biedt om, in overleg met 
hun naasten en verzorgers, op voorhand doelstellingen en keuzes te formuleren in verband met de 
manier waarop zij willen dat er voor hen wordt gezorgd wanneer zij niet langer in staat zullen zijn om 
voor zichzelf in te staan. Dit communicatieproces kan uitmonden in een aantal beslissingen die 
schriftelijk kunnen worden vastgelegd. In een positieve wilsverklaring kunnen patiënten toestemmen 
in een medische tussenkomst of een uitdrukkelijk verzoek doen tot medische tussenkomst (bv. een 
voorafgaand verzoek tot euthanasie). Positieve wilsverklaringen zijn juridisch niet afdwingbaar. Een 
voorafgaande wilsverklaring inzake euthanasie is een voorbeeld van een positieve wilsverklaring. In 
een negatieve wilsverklaring kunnen patiënten preciseren welke behandelingen en onderzoeken ze al 
dan niet nog wensen wanneer ze zelf niet meer in staat zijn te oordelen. Een negatieve wilsverklaring 
is juridisch wel afdwingbaar. Tenslotte kan ook een wettelijke vertegenwoordiger worden aangeduid, 
die erover waakt dat de wensen van de patiënt nageleefd worden wanneer een patiënt zijn wil niet 
meer kan uiten. 
De voordelen van VZP zijn uitgebreid beschreven en worden door zorgverleners van verschillende 
disciplines erkend. VZP leidt tot een betere overeenstemming tussen de wensen van de patiënt en de 
zorg aan het levenseinde, het stimuleert communicatie tussen patiënten, hun naasten en zorgverleners 
en leidt tot een grotere tevredenheid over de zorg bij patiënt en nabestaanden. Daarenboven toont 
onderzoek aan dat VZP geen aanleiding geeft tot verhoogde angst of depressie bij patiënten. Een 
sleutelfiguur in het VZP-proces is de huisarts: hij kent zijn patiënten meestal goed en heeft met hen 
vaak een vertrouwensband. Toch blijkt uit (inter)nationale studies dat dergelijke gesprekken niet zo 
frequent worden aangegaan, wat erop wijst dat huisartsen bepaalde remmingen ervaren om over VZP 
te spreken. Omwille van de positieve uitkomsten van VZP voor de patiënt en zijn naasten, wordt VZP 
ook steeds meer als een belangrijk domein van volksgezondheid beschouwd. Niet alleen het aantal 
mensen dat zorg rond het levenseinde nodig heeft, is drastisch gestegen maar ook de wijze waarop 
zorg rond het levenseinde wordt aangeboden, is veranderd. In onze samenleving werd overgegaan van 
traditionele naar meer liberale waarden, waarbij meer belang wordt gehecht aan de autonomie van de 
persoon en rekening wordt gehouden met een groeiende steun voor een ‘recht op sterven’ wetgeving. 
De tendens naar een meer patiënt-georiënteerde benadering van het levenseinde legt de nadruk op de 
rol van de voorkeuren en wensen van mensen in het nemen van medische beslissingen. Een 
kwaliteitsvolle zorg bij het levenseinde dient daarom duidelijk geënt te zijn op de houdingen en 
voorkeuren hieromtrent van de bevolking. Voor België ontbrak echter elke informatie hieromtrent.  
191  
Doelstellingen en onderzoeksvragen 
Dit proefschrift heeft twee algemene doelstellingen: (1) beschrijven in welke mate het Belgische 
publiek betrokken is bij VZP en wat de informatievoorkeuren zijn van de Belgische bevolking in het 
geval van een levensbedreigende ziekte en (2) ontwikkelen van een complexe interventie om de 
initiatie van VZP te verbeteren in de huisartsenpraktijk bij patiënten met een ernstige chronische of 
levensbedreigende aandoening. 
 
Binnen de eerste doelstelling hebben we getracht volgende onderzoeksvragen te beantwoorden: 
1. In welke mate hebben personen uit de algemene bevolking ooit al met een arts gesproken 
over hun wensen met betrekking tot medische behandelingen aan het levenseinde, in welke 
mate beschikken mensen uit de algemene bevolking over een voorafgaande wilsverklaring 
inzake euthanasie en welke factoren of kenmerken zijn hieraan verbonden? 
2. In welke mate willen personen uit de algemene bevolking dat ze zelf geïnformeerd worden 
en dat hun naasten geïnformeerd worden over diagnose, kans op genezing, levensverwachting, 
behandelingsmogelijkheden, opties op het vlak van palliatieve zorg en mogelijkheden om het 
leven te verlengen of verkorten, en welke factoren of kenmerken zijn hieraan verbonden? 
 
Binnen de tweede doelstelling hebben we getracht volgende onderzoeksvragen te beantwoorden: 
3. Wat zijn de belemmerende en bevorderende factoren voor huisartsen om VZP ter sprake te 
brengen bij hun patiënten? 
4. Is er een verschil voor huisartsen in belemmerende factoren om VZP te initiëren bij 
patiënten met kanker, hartfalen of dementie? 
5. Op welke manier wordt VZP geconceptualiseerd door huisartsen, op basis van hun 
ervaringen in de praktijk? 
6. Wat zijn de componenten van een complexe interventie om de initiatie van VZP in de 
huisartsenpraktijk te bevorderen bij patiënten met een ernstige chronische of 
levensbedreigende aandoening? 
 
 
Methoden 
1) Gezondheidsenquête 2008 (hoofdstuk 1 & 2) 
Om de eerste twee onderzoeksvragen te beantwoorden, gebruikten we data van de nationale 
gezondheidsenquête verzameld in 2008 bij een representatieve steekproef van de Belgische bevolking. 
De nationale gezondheidsenquête wordt georganiseerd door het Wetenschappelijk Instituut voor 
Volksgezondheid (WIV-ISP) en werd in 2008-2009 voor de vierde maal uitgevoerd. Aan de hand van 
een meertrapse, gestratificeerd geclusterde steekproeftrekking worden ongeveer 6000 private 
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huishoudens willekeurig geselecteerd uit het nationale bevolkingsregister. Van deze geselecteerde 
huishoudens wordt telkens een maximum van vier personen bevraagd (het gezinshoofd en de partner, 
en twee extra willekeurige leden behorend tot het huishouden). De datacollectie werd uitgevoerd via 
een vragenlijst dat ingevuld werd door alle geselecteerde personen van 15 jaar of ouder (N= 9651). De 
participatiegraad onder de geselecteerde huishoudens was 55% (ongeveer 6000 huishoudens werden 
gecontacteerd). De gegevensverzameling via de gezondheidsenquête heeft betrekking op de 
gezondheidstoestand, medische consumptie, leefstijl, socio-economische status en andere 
gezondheidsdeterminanten en heeft als doel informatie in te winnen over de algemene 
gezondheidstoestand van de bevolking en hun gezondheidsbehoeften. In de gezondheidsenquête van 
2008 werd voor de eerste en enige maal een specifieke module rond houdingen ten aanzien van het 
levenseinde opgenomen. 
 
2) Medical Research Council Framework voor de ontwikkeling en evaluatie van complexe 
interventies (hoofdstuk 4 - 6) 
Bij de ontwikkeling van deze interventie werd als methode gebruik gemaakt van de internationaal 
erkende richtlijn van het Medical Research Council (MRC) voor de ontwikkeling en evaluatie van 
complexe interventies (MRC Guidance for Developing and Evaluating Complex Interventions). Deze 
richtlijn stelt onderzoekers in staat de juiste methoden te herkennen en toe te passen en is reeds zeer 
invloedrijk geweest in de ontwikkeling van interventies binnen de gezondheidszorg. De MRC richtlijn 
gaat uit van een procesmatige aanpak, gaande van Fase 0 t.e.m. Fase IV. Fase 0-I omvat de 
ontwikkeling van de interventie. Fase 0-I werd uitgevoerd op basis van verschillende methoden die 
hierna kort beschreven worden. 
 
Fase 0: Exploreren van de potentiële componenten van een interventie 
Systematische literatuurstudie (hoofdstuk 3) 
Voor het beantwoorden van de derde onderzoeksvraag werd een systematische literatuurstudie 
uitgevoerd naar belemmerende en bevorderende factoren voor huisartsen om VZP ter sprake te 
brengen bij hun patiënten. Er werd op zoek gegaan naar wetenschappelijke studies gepubliceerd tussen 
1990 en 2011 over drempels en faciliterende factoren in vier databases: PubMed, Cinahl, Embase en 
PsycInfo. Daarenboven werden de literatuurlijsten van de geïdentificeerde studies gescreend op 
mogelijk relevante studies en werden de eerste auteur van de geïncludeerde studies en experten op het 
vlak van VZP gecontacteerd voor mogelijke bijkomende studies. Tenslotte werden ook de recentste 
uitgaven van de 10 meest relevante wetenschappelijke tijdschriften doorzocht.  
Studies werden gescreend en geïncludeerd volgens vooropgestelde inclusie- en exclusiecriteria. De 
geïncludeerde studies werden beoordeeld op hun kwaliteit aan de hand van specifieke instrumenten 
die ontwikkeld werden voor de kwaliteitsbeoordeling van bepaalde types van studies (in dit geval 
kwalitatieve studies en cross-sectionele studies). De totale kwaliteitsscores voor de studies werden 
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uitgedrukt op een schaal van 0 tot 10. Op basis van de kwaliteitsscores konden de studies opgedeeld 
worden in studies met een lage kwaliteit (score  ≤5), een middelmatig kwaliteit (score 6 of 7) of 
studies met een hoge kwaliteit (scores 8-10). Wanneer drempels of faciliterende factoren 
gerapporteerd werden in 2 of meer studies met een hoge kwaliteit, dan werden deze factoren 
beschouwd als factoren waarvoor sterkere evidentie werd teruggevonden in de literatuur.  
 
Kwalitatieve focusgroepstudie (hoofdstuk 4 & 5) 
In 2012 werden in Vlaanderen vijf focusgroepen met huisartsen georganiseerd om dieper in te kunnen 
gaan op de belemmerende factoren voor huisartsen om VZP te initiëren en het verschil tussen de 
initiatie van VZP bij patiënten met kanker, hartfalen en dementie, alsook om een beter inzicht te 
krijgen in de ervaringen van huisartsen met VZP in de praktijk. In totaal namen 36 huisartsen deel aan 
deze focusgroepstudie (n= 9, n= 11, n= 4, n= 5, n= 7). De deelnemers aan deze focusgroepen werden 
op verschillende manieren gerekruteerd om voldoende variatie te bekomen in de ervaring, leeftijd, en 
de locatie van de huisartsen. Tijdens de focusgroepgesprekken werd gebruik gemaakt van een 
gesprekshandleiding (topiclijst) waarbij de volgende onderwerpen bevraagd werden: 1) ervaringen met 
VZP in de praktijk, 2) attitudes omtrent VZP, 3) ervaren drempels en faciliterende factoren om VZP 
aan te snijden, 4) mogelijke hulpmiddelen of interventies om VZP te verbeteren in de 
huisartsenpraktijk. De data van de focusgroepen werd geanalyseerd volgens de constante 
vergelijkingsmethode. 
 
Fase 1: Modelleren van de interventie naar de huisartsenpraktijk met behulp van een expertenpanel 
(hoofdstuk 6) 
Een eerste ontwerp van een interventie om de initiatie van VZP te verbeteren in de huisartsenpraktijk 
werd ontwikkeld door het onderzoeksteam door de resultaten uit Fase 0 te combineren en te 
integreren. Dit ontwerp werd vervolgens voorgelegd aan twee expertenpanels (n= 4, n= 5) in januari 
2015. Voor de samenstelling van de expertenpanels werd doelbewust op zoek gegaan naar huisartsen, 
personen met ervaring in het voeren van VZP-gesprekken, academici met expertise op het gebied van 
VZP of patiënt-arts communicatie en/of personen die ervaringen hadden met het geven van 
communicatietrainingen aan artsen. De meeste deelnemers hadden ervaring op meerdere vlakken. 
Tijdens de expertenpanels werd gevraagd de volledigheid van de interventie en de haalbaarheid en 
aanvaardbaarheid van de componenten te beoordelen en de drempels voor de implementatie van de 
componenten te identificeren.  
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Belangrijkste bevindingen 
De prevalentie in de algemene bevolking van een voorafgaande wilsverklaring inzake euthanasie 
en de bespreking van wensen met betrekking tot het levenseinde (hoofdstuk 1) 
In deze studie werd bij een representatieve steekproef van de Belgische bevolking nagegaan in welke 
mate mensen communiceren over de wijze waarop ze wensen te sterven. In het licht van de sinds 2002 
goedgekeurde wet op euthanasie wordt nagegaan in welke mate mensen al beschikken over een 
voorafgaande schriftelijke wilsverklaring inzake euthanasie. In deze studie werden enkel de gegevens 
van respondenten ouder dan 18 jaar geanalyseerd (N = 9324).  
De resultaten van deze studie tonen aan dat 4.4% van de bevolking ooit met een arts heeft gesproken 
over de medische behandeling die toegepast zou moeten worden tijdens de laatste fase van hun leven 
en nauwelijks 1.8% van de bevolking geeft aan over een schriftelijke wilsverklaring inzake euthanasie 
te beschikken. Vooral ouderen (12% van de personen van 75 jaar en ouder) hebben het ooit met hun 
arts gehad over de medische behandelingen aan het levenseinde; bij jongeren is dit percentage 
verwaarloosbaar. Hetzelfde geldt voor het beschikken over een schriftelijke voorafgaande 
wilsverklaring inzake euthanasie; pas vanaf de leeftijd van 55 jaar is deze praktijk iets meer courant. 
Vrouwen, oudere respondenten, mensen met een slechtere gezondheidsstatus en respondenten met 
veel huisartscontacten hebben een statistisch significant hogere kans om ooit met hun arts gesproken 
te hebben over medische behandelingen aan het levenseinde. Wat een voorafgaande wilsverklaring 
inzake euthanasia betreft, is de kans groter dat respondenten ouder dan 55 jaar en inwoners van het 
Vlaams of Brussels gewest hierover te beschikken. 
 
Informatievoorkeuren van de algemene bevolking in geval van een levensbedreigende ziekte 
(hoofdstuk 2) 
Aan de hand van de gegevens van de nationale gezondheidsenquête uit 2008 werd nagegaan wat de 
informatievoorkeuren van de algemene bevolking in België zijn indien men geconfronteerd zou 
worden met een levensbedreigende aandoening, of levensbedreigend ziek zou worden. In deze studie 
namen in totaal 9651 respondenten deel. 
De resultaten tonen aan dat een meerderheid van de Belgische bevolking altijd geïnformeerd wil 
worden door de arts indien een levensbedreigend ziek zou vastgesteld worden. Ongeveer 82% wil 
altijd geïnformeerd worden over de diagnose, de kans op genezing en mogelijke behandelingen, 
terwijl 77% van de respondenten altijd geïnformeerd wil worden over de levensverwachting. Uit de 
resultaten blijkt tevens dat 72% altijd geïnformeerd wil worden over de opties op het vlak van 
palliatieve zorg en 67% over de mogelijkheden van verlenging of verkorting van het leven. Een andere 
belangrijke bevinding is dat maar ongeveer de helft van de respondenten wenst dat hun naasten altijd 
geïnformeerd zouden worden over diagnose, kans op genezing, mogelijke behandelingen, 
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levensverwachting, opties op het vlak van palliatieve zorg en mogelijkheden om het leven te verlengen 
of te verkorten.  
Vooral jongvolwassenen (jonger dan 54), mensen met een hoger opleidingsniveau en mensen met een 
vaste huisarts hebben een significant hogere kans om zelf altijd informatie te wensen van hun arts 
wanneer ze levensbedreigend ziek zouden worden. Jongvolwassenen en vrouwen hebben minder kans 
om hun naasten altijd te informeren in het geval van een levensbedreigende ziekte. 
 
Drempels en faciliterende factoren voor huisartsen bij het ter sprake brengen van voorafgaande 
zorgplanning: een systematisch literatuuronderzoek (hoofdstuk 3) 
In de hierbij besproken studie werd de internationale literatuur nageplozen op de factoren die 
huisartsen als een drempel of als faciliterend ervaren wanneer ze het gesprek over VZP willen 
aangaan. Op basis van 16 artikels identificeerden de auteurs drempels en faciliterende factoren op het 
vlak van (1) kenmerken van de huisartsen, (2) kenmerken van de patiënt of (3) kenmerken van het 
gezondheidssysteem. Sterke evidentie werd gevonden voor volgende drempels bij huisartsen om VZP 
te bespreken: een gebrek aan vaardigheden om met vage wensen en voorkeuren om te gaan, het 
moeilijk kunnen bepalen van het juiste moment om VZP aan te snijden, het idee dat patiënten zelf 
over VZP moeten beginnen en de angst om patiënten hoop te ontnemen. Faciliterende aspecten met 
sterke evidentie waren opgebouwde communicatievaardigheden m.b.t. VZP-gesprekken, de 
bekwaamheid om toekomstige gezondheidsproblemen in te schatten, vaardigheden om in te gaan op 
het initiatief van de patiënt inzake VZP, wilsbekwame patiënten, een lange relatie met de patiënt en 
een thuissetting. Voor faciliterende factoren en drempels met een matige tot zwakke evidentie 
verwijzen we naar het volledige artikel in dit proefschrift. 
 
Drempels voor voorafgaande zorgplanning bij patiënten met kanker, hartfalen en dementie: 
ervaringen en visies van huisartsen (hoofdstuk 4) 
Om zicht te krijgen op de drempels bij huisartsen en hoe deze mogelijkerwijs verschillen naargelang 
het ziektetraject (m.n. kanker, dementie of hartfalen) werden in Vlaanderen 5 focusgroepen (n= 9, n= 
11, n= 4, n= 5, n= 7) met huisartsen samengesteld. Huisartsen rapporteerden verscheidene drempels 
om VZP op te starten en brachten die in verband met zichzelf (bv. gebrek aan opleiding in VZP), 
kenmerken van de patiënt en zijn familie (bv. veranderende voorkeuren van de patiënt m.b.t. 
levenseindezorg) en de structuur en organisatie van de gezondheidszorg (bv. gebrek aan tijd om VZP 
te bespreken in de huisartsenpraktijk) (voor de gedetailleerde opsomming verwijzen we naar de 
originele paper). Sommige van de drempels waren specifiek voor een van de drie ziektetrajecten. Bij 
kankerpatiënten gaven huisartsen aan dat onvoldoende kennis van behandelingsopties en het gebrek 
aan structurele samenwerking tussen huisarts en specialist belangrijke drempels vormden. Drempels 
die vaker voorkwamen bij patiënten met hartfalen en dementie bleken een te geringe vertrouwdheid 
met de terminale fase, het ontbreken van sleutelmomenten om VZP op te starten, te weinig kennis bij 
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de patiënt over zijn diagnose en prognose en het feit dat deze patiënten niet vaak zelf dergelijke 
gesprekken begonnen. Een specifieke drempel om bij dementiepatiënten over VZP te praten, was het 
feit dat deze patiënten hierover in de toekomst zelf geen beslissing meer zouden kunnen nemen.  
 
Hoe wordt voorafgaande zorgplanning geconceptualiseerd door huisartsen in de praktijk? Een 
kwalitatieve studie (hoofdstuk 5) 
Aan de hand van vijf focusgroepen met huisartsen gingen we na op welke manier huisartsen 
voorafgaande zorgplanning (VZP) conceptualiseren, op basis van hun ervaringen in de praktijk. Deze 
conceptualisaties konden ingedeeld worden in vijf thema’s: (1) de organisatie van professionele zorg 
die nodig is om tegemoet te komen aan de noden van de patiënt, (2) het slecht-nieuwsgesprek, (3) 
keuzes van behandeling en zorgdoelen voor de patiënt, (4) invullen van VZP documenten met 
betrekking tot voorkeuren en wensen van de patiënt, (5) het exploreren en begrijpen van de wensen 
van de patiënt.  
Binnen deze thema’s werd VZP zowel geconceptualiseerd in termen van inhoud van VZP als in 
termen van taken voor de huisarts. Binnen de organisatie van de zorg om tegemoet te komen aan 
veranderende zorgnoden van patiënt en familie zagen huisartsen twee belangrijke taken voor zichzelf. 
Enerzijds de communicatie en het overleg met informele zorgverleners zoals de familie en 
mantelzorgers van de patiënt en anderzijds de samenwerking en communicatie met andere 
professionele zorgverleners zoals specialisten, thuisverpleegkundigen of verpleegkundigen van de 
palliatieve thuiszorgequipes. Bij het voeren van slecht-nieuwsgesprekken werd het inlichten van de 
patiënt over opties op het vlak van palliatieve zorg ook als een belangrijke taak voor de huisarts 
vermeld. Huisartsen worden in de praktijk ook vaak geconfronteerd met patiënten die een 
wilsverklaring (meestal een voorafgaande wilsverklaring inzake euthanasie) hebben ingevuld (of 
patiënten die van plan zijn om deze in te vullen). Volgens de huisartsen bestaan er echter veel 
misverstanden bij patiënten over wilsverklaringen en de meeste huisartsen beschouwden het dan ook 
als een belangrijke taak om patiënten hierover goed te informeren. Tenslotte waren een aantal artsen 
ook van mening dat het een belangrijke taak was voor de huisarts om VZP zelf te initiëren. Andere 
huisartsen waren eerder van mening dat de patiënt het initiatief hiervoor moet nemen, maar dat 
huisartsen wel de taak hebben om steeds goed te luisteren naar signalen van de patiënt en hierop in te 
gaan. Een belangrijke bevinding in deze studie is dat de verschillende conceptualiseringen van VZP 
bij sommige huisartsen allemaal aan bod kwamen bij het beschrijven van VZP in hun praktijk. Maar 
sommige huisartsen gebruikten slechts een van de conceptualiseringen om hun praktijk te beschrijven. 
 
De ontwikkeling van een complexe interventie om de initiatie van voorafgaande zorgplanning in 
de huisartsenpraktijk te verbeteren: een Fase 0-I studie (hoofdstuk 6) 
VZP is een complex proces dat gaat over meer dan een interventie of een moment. Een complexe 
interventie is dan ook aangewezen om VZP structureel te verbeteren in de huisartsenpraktijk. In deze 
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Fase 0-I studie werd een complexe interventie ontwikkeld om de initiatie van VZP in de 
huisartsenpraktijk te verbeteren voor patiënten met een ernstige of levensbedreigende aandoening. In 
Fase 0 werden relevante theorieën en mogelijke componenten van de interventie geëxploreerd. Fase 0 
werd uitgevoerd op basis van 3 verschillende methoden: 1) ten eerste werd een overzicht van 
systematische literatuurstudies over interventies om VZP te bevorderen opgesteld met als doel de 
belangrijkste componenten van succesvolle interventies te identificeren. De gemeenschappelijke 
componenten van succesvolle VZP interventies betreffen getrainde facilitators voor het voeren van de 
VZP-gesprekken, een specifieke doelgroep die aanmerking komt voor VZP, het gebruik van tools 
zoals bv. brochures, gestructureerde gesprekken, de mogelijkheid tot het invullen van documenten. 2) 
ten tweede werd een systematische literatuurstudie over de drempels en bevorderende factoren voor 
huisartsen om VZP op te starten uitgevoerd met als doel de relevante factoren te begrijpen die het ter 
sprake brengen van VZP voor huisartsen bevorderen of faciliteren en waar rekening mee moet worden 
gehouden in de interventie (de resultaten van deze studie staan beschreven in hoofdstuk 3 van dit 
proefschrift), 3) ten derde werden 5 focusgroepen met huisartsen uit verschillende regio’s in 
Vlaanderen georganiseerd om te peilen naar hun ervaringen, opvattingen en bezorgdheden met 
betrekking tot VZP in de dagelijkse praktijk, met het oog op het verder afbakenen van de belangrijkste 
componenten die moeten opgenomen worden in de interventie. Vervolgens werd in Fase I de 
interventie gemodelleerd voor de huisartsenpraktijk door het selecteren van de belangrijkste 
componenten van de interventie op basis van Fase 0. Een eerste ontwerp van de interventie werd 
vervolgens voorgelegd aan een expertenpanel om de verschillende componenten, de haalbaarheid en 
de aanvaardbaarheid van de interventie te beoordelen. 
De uiteindelijk ontwikkelde interventie om de initiatie van VZP te verbeteren in de huisartsenpraktijk 
bestaat uit vijf componenten: 1) een interactieve training voor huisartsen, 2) een register van patiënten 
die in aanmerking komen voor VZP, 3) een patiëntenbrochure over VZP bestaande uit educatieve 
informatie en een gerichte vragenlijst, 4) een gesprekshandleiding voor de huisarts, 5) formulieren 
voor het documenteren van het overleg tussen de patiënt en de huisarts. 
 
 
Bespreking van de resultaten 
De deelname van de algemene bevolking in VZP 
De resultaten in  hoofdstuk 1 tonen aan dat slechts een klein percentage van de algemene bevolking 
ooit heeft gesproken met een arts over hun wensen voor medische behandelingen aan het levenseinde 
(hoofdstuk 1). Een gelijkaardige studie in Nederland toonde aan dat ongeveer 13% van de algemene 
bevolking met een arts heeft gesproken over de medische besluitvorming aan het levenseinde, dit in 
tegenstelling tot 4.4% in België. Deze cijfers suggereren dat de betrokkenheid van de Belgische 
bevolking in VZP nog verder gestimuleerd kan worden. VZP wordt steeds meer gezien als een publiek 
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domein van volksgezondheid omwille van de potentiële gezondheidsvoordelen zoals het voorkomen 
van onnodige hospitalisaties aan het levenseinde, een betere overeenstemming tussen de wensen van 
de patiënt en de effectief verkregen zorg aan het levenseinde en grotere tevredenheid bij patiënt en 
naasten. Het is dus belangrijk om het bewustzijn bij de algemene bevolking te verhogen omtrent het 
tijdig communiceren van hun wensen en voorkeuren m.b.t. toekomstige zorg voor het geval patiënten 
in een situatie komen waarin ze hun wil niet meer kunnen uiten. Hierbij kan gedacht wordt aan 
publieke voorlichtingscampagnes zoals het Speak Up-initiatief in Canada of de Dying Matters-
campagne in het Verenigd Koninkrijk. Onze studie toonde aan dat van diegenen die beschikken over 
een voorafgaande wilsverklaring inzake euthanasie, slechts de helft ooit met een arts had gesproken 
over de medische behandelingen die ze wensen aan het levenseinde. Een belangrijke reden hiervoor is 
dat het voor patiënten niet verplicht is om een wilsverklaring op te stellen, te bespreken of te laten 
ondertekenen door een arts. Een recente gepubliceerde studie over ACP in de eerstelijnszorg toonde 
nochtans aan dat artsen een wilsverklaring beschouwen als een bruikbaar instrument om verdere 
communicatie te stimuleren tussen arts, patiënt en hun naasten. Idealiter zou het opstellen van een 
wilsverklaring gekaderd worden binnen een continu proces van communicatie en overleg, waarbij het 
opstellen van een wilsverklaring de mogelijke uitkomst is. Studies hebben reeds aangetoond dat de 
bereidheid van artsen om een wilsverklaring te volgen ook groter is naarmate de wilsverklaring 
gekoppeld was aan gesprekken tussen de arts en patiënt. 
 
Informatievoorkeuren van de Belgische bevolking 
De resultaten van Hoofdstuk 2 tonen aan dat een overweldigende meerderheid van de bevolking wenst 
dat de arts hun medische informatie verstrekt in geval ze met een levensbedreigende ziekte 
geconfronteerd zouden worden. Deze resultaten kunnen enerzijds geïnterpreteerd worden binnen de 
context van het toegenomen maatschappelijk belang van autonomie van de patiënt en 
patiëntendeelname in de medische besluitvorming, maar anderzijds ook binnen de context van het 
publieke open debat in België over levenseindebeslissingen veroorzaakt door de legalisering van 
euthanasie sinds 2002. De Belgische bevolking wordt regelmatig geconfronteerd met berichten in de 
media over euthanasie (en andere levenseindebeslissingen), wat de publieke voorkeuren om 
geïnformeerd te worden over deze onderwerpen misschien ook wel beïnvloed heeft. Voorgaande 
studies toonden reeds een opvallend hoge publieke aanvaarding van euthanasie aan in een aantal West-
Europese landen. Deze hoge aanvaardingsgraad was steeds sterk gerelateerd aan de overtuiging van 
het recht op zelfbeschikking; dit geldt ook in de drie landen waar euthanasie reeds gelegaliseerd is 
(België, Nederland en Luxemburg). Deze studie toont aan dat, als onderdeel van een patiëntgerichte 
aanpak, artsen er goed aan doen om de specifieke informatievoorkeuren (ook steeds per onderwerp) 
van patiënten op voorhand te bevragen. Het exploreren van de informatievoorkeuren van de patiënt is 
een van de eerste elementen die aangekaart zouden moeten worden binnen het proces van VZP. 
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Drempels en faciliterende factoren voor huisartsen om VZP ter sprake te brengen 
In hoofdstuk 3 werd in de resultaten terug gevonden dat zowel de attitude van huisartsen die van 
mening zijn dat patiënten zelf VZP ter sprake moeten brengen ervaren wordt als drempel, als voor het 
feit dat huisartsen het initiatief van de patiënt zelf inzake VZP ervaren als een faciliterend aspect. Dit 
is een opmerkelijk resultaat aangezien veel studies aantonen dat patiënten ervan uitgaan dat het de 
verantwoordelijkheid is van artsen om VZP ter sprake te brengen. Dit suggereert dat er een 
onevenwicht is tussen de verwachtingen van patiënten en van artsen over wie VZP best initieert. Dit 
verschil in verwachtingen werd in eerdere studies beschreven en kan mogelijk verklaren waarom 
gesprekken over VZP vaak pas laattijdig worden opgestart wanneer levenseindebeslissingen effectief 
moeten genomen worden. 
Nog een opmerkelijk resultaat is dat volgens huisartsen patiënten met kanker sneller betrokken worden 
in VZP. Het ziektetraject van patiënten kent een meer voorspelbaar verloop, waardoor het voor artsen 
makkelijker is om een goed moment te bepalen om VZP ter sprake te brengen (Hoofdstuk 4). De 
focusgroepstudie toonde ook aan dat een van de redenen waarom VZP niet werd geïnitieerd bij 
bijvoorbeeld patiënten die lijden aan hartfalen of dementie precies het onbegrip is bij zowel patiënten 
als artsen dat deze aandoening een levensbedreigende aandoening zijn. Het is ook zo dat niet-
kankerpatiënten omwille van een slecht begrip van de diagnose en de prognose zelf minder vaak VZP 
ter sprake brengen, wat een drempel is voor huisartsen. Artsen en patiënten zijn het erover eens dat 
VZP best ter sprake wordt gebracht rond het tijdstip van de diagnose van een levensbedreigende 
ziekte, maar de angst om patiënten hoop te ontnemen houdt artsen vaak tegen (zeker bij 
dementiepatiënten); een drempel waarvoor ook in de systematische literatuurstudie sterkere evidentie 
werd teruggevonden.  
Toch tonen de bevindingen van dit proefschrift aan dat het niet initiëren van VZP meer complex is dan 
een gebrek aan vaardigheden of kennis over VZP bij de huisarts (hoofdstuk 5). Structurele of 
organisatorische factoren, zoals het gebrek aan een systeem in België om informatie overheen de 
verschillende zorgsettings te delen en de soms beperkte samenwerking tussen de eerste- en 
tweedelijnszorg, spelen ook een belangrijke rol. Zo werd een financiële compensatie voor de huisarts 
voor het voeren van VZP-gesprekken ook aangehaald als een structurele verandering die de initiatie 
van VZP zou kunnen stimuleren. Opdat VZP optimaal, goed en effectief geïmplementeerd kan 
worden, is het dus noodzakelijk voldoende aandacht te besteden aan het verbeteren van factoren zowel 
op het niveau van de huisarts, de patiënt als het gezondheidszorgsysteem (en niet enkel te investeren in 
bv. een opleiding voor artsen).  
 
De ontwikkeling van een VZP interventie voor de huisartsenpraktijk 
Met het ontwikkelen van een complexe interventie om de initiatie van VZP in de huisartsenpraktijk te 
verbeteren, hopen we op termijn bij te dragen tot de verbetering van de communicatie tussen 
huisartsen en patiënten, de kwaliteit van leven en het welzijn van patiënten en hun familie en een 
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verbeterde overeenkomst tussen de wensen van de patiënt en de verkregen zorg aan het levenseinde, 
alsook de tevredenheid van de patiënt en zijn naasten te verhogen. Onderzoek heeft aangetoond dat 
interventies (of aanpassingen) op verschillende niveaus van het gezondheidszorgsysteem nodig zijn 
om VZP succesvol in de praktijk te implementeren. Dit houdt concreet in 1) dat patiënten die in 
aanmerking komen voor VZP of hier nood aan hebben, tijdig uitgenodigd worden voor deze 
gesprekken, 2) dat deze patiënten tijdens deze gesprekken bijgestaan kunnen worden door competente 
en opgeleide zorgverleners met voldoende kennis en de juiste communicatievaardigheden en 3) dat de 
uitkomsten van deze gesprekken gedocumenteerd en gedeeld kunnen worden (bv. door middel van een 
elektronisch patiëntendossier). Recent onderzoek toonde ook aan dat de gemeenschappelijke 
elementen van succesvolle VZP-programma’s de volgende zijn: VZP-gesprekken geïnitieerd door de 
arts, gestandaardiseerde documenten om het resultaat van VZP-gesprekken te documenteren, een 
correcte timing van deze gesprekken (afhankelijk van de individuele bereidheid van patiënten) en het 
implementeren van systemen die ervoor zorgen dat de planning uitgevoerd kan worden, dat het VZP 
programma geëvalueerd kan worden en dat daardoor aan kwaliteitsverbetering wordt gedaan. Andere 
veelbelovende elementen van succesvolle VZP-programma’s zijn het gebruik van eenvoudig te 
begrijpen educatief materiaal voor patiënten, interactieve communicatietrainingen voor artsen en het 
organiseren van meerdere gesprekken doorheen het ziektetraject van de patiënt. Deze elementen 
werden geïntegreerd in de ontwikkeling van onze VZP-interventie voor de huisartsenpraktijk. 
Toekomstig onderzoek moet er zich nu op richten om de haalbaarheid en aanvaardbaarheid van de 
componenten van deze complexe interventie te testen in een Fase II pilootstudie. 
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Detailed description of the intervention’s components 
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the potentially positive outcomes of ACP and about its legal implications were identified as important barriers. A previous study also showed that improved 
clinician knowledge about decision-making capacity legislation positively correlated with ACP participation. The experts perceived two hours as too short to 
complete all training elements and recommended spreading the training over two sessions which would permit reinforcement and allow for home work 
exercises in between. 
 
Component 2: Establishing a register of patients eligible for ACP discussions (B) 
Content of the component to overcome the barriers and enhance the facilitators: 
• Systematic and selective identification of patients at risk of deteriorating or dying 
will be done using a pragmatic three-step guide of triggers for when to initiate 
ACP 
• During the training, GPs will be taught how to identify eligible patients using 
these triggers and to set up an ACP register, which is a constantly updated list of 
patients for whom ACP should be initiated at upcoming appointments 
Barriers and facilitators that are addressed by the component: 
! Most GPs in the focus groups considered patients suffering from a life-limiting 
illness to be most eligible for initiating ACP with 
! Difficulties with defining a key moment to initiate ACP 
! Cancer patients are more easily involved in ACP as opposed to non-cancer 
patients (eg dementia, advanced organ failure, etc) 
 
It was considered important to standardize the timing of ACP discussions to support GPs in defining a key moment and prompting them to initiate ACP 
discussions. While the timing of ACP must be sensitive to patients’ readiness to enter into such conversations, a pragmatic three-step guide that has been 
proposed in the literature for physicians is to consider ACP if: (a) No is the answer to the surprise question “Would you be surprised if this patient died within 
the next year?”, (b) the patient’s general health is poor (eg limitations in self-care or multiple hospitalizations), and (c) if disease-specific indicators indicate a 
poor prognosis (eg advanced organ failure, dementia, progressive malignancies). Identified eligible patients will be documented in a register. These patients 
should be invited to consider ACP. 
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ntr
ed
 A
CP
 
dis
cu
ssi
on
s. 
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Co
mp
on
en
t 4
: P
ati
en
t-c
en
tre
d A
CP
 di
scu
ssi
on
s w
ith
 th
e h
elp
 of
 a 
co
nv
er
sa
tio
n g
uid
e (
D)
 
Co
nt
en
t o
f t
he
 co
mp
on
en
t t
o o
ve
rc
om
e t
he
 ba
rr
ier
s a
nd
 en
ha
nc
e t
he
 fa
cil
ita
tor
s: 
• 
Th
e 
co
nv
ers
ati
on
 g
uid
e 
inc
lud
es 
the
 f
oll
ow
ing
 t
op
ics
: 
un
de
rst
an
din
g 
of
 
pro
gn
os
is,
 in
for
ma
tio
n 
pre
fer
en
ce
s, 
pro
gn
os
tic
 in
for
ma
tio
n, 
pa
tie
nt’
s 
pre
vio
us
 
ex
pe
rie
nc
es 
wi
th 
AC
P, 
pa
tie
nt 
go
als
 a
nd
 q
ua
lity
 o
f 
lif
e, 
fea
rs,
 a
cc
ep
tab
le 
fun
cti
on
, 
fam
ily
 
inv
olv
em
en
t 
an
d 
co
nta
ins
 
ex
am
ple
s 
of 
qu
est
ion
s 
an
d 
co
mm
un
ica
tio
n t
ips
 
  
Ba
rr
ier
s a
nd
 fa
cil
ita
tor
s t
ha
t a
re
 ad
dr
ess
ed
 by
 th
e c
om
po
ne
nt
: 
!
 
La
ck
 of
 aw
are
ne
ss 
ab
ou
t th
e d
iff
ere
nt 
ele
me
nts
 of
 A
CP
 
!
 
Va
ryi
ng
 co
nc
ep
tua
lis
ati
on
s o
f A
CP
 am
on
g G
Ps
 
 A 
co
nv
ers
ati
on
 gu
ide
 w
as 
de
ve
lop
ed
 to
 su
pp
ort
 G
Ps
 an
d t
o a
ssu
re 
a b
ett
er 
up
tak
e o
f a
ll t
he
 ke
y e
lem
en
ts 
of 
AC
P d
isc
us
sio
ns
. A
 dr
aft
 w
as 
ma
de
 ba
sed
 of
 a 
co
nv
ers
ati
on
 gu
ide
 fo
r c
om
mu
nic
ati
on
 ab
ou
t s
eri
ou
s i
lln
ess
 ca
re 
go
als
 th
at 
wa
s d
ev
elo
pe
d o
n t
he
 ba
sis
 of
 a 
rev
iew
 an
d s
yn
the
sis
 of
 be
st 
pra
cti
ce
 an
d 
aft
erw
ard
s v
ali
da
ted
 in
 th
e e
xp
ert
 pa
ne
ls.
 T
he
 ke
y e
lem
en
ts 
ad
dre
sse
d i
n t
he
 co
nv
ers
ati
on
 gu
ide
 ar
e: 
1) 
un
de
rst
an
din
g o
f p
rog
no
sis
, 2
) d
ec
isi
on
 m
ak
ing
 an
d 
inf
orm
ati
on
 pr
efe
ren
ce
s, 
3) 
pro
gn
os
tic
 di
scl
os
ure
, 4
) p
ati
en
t g
oa
ls 
an
d q
ua
lity
 of
 lif
e, 
5) 
fea
rs,
 6)
 le
ve
l o
f f
un
cti
on
ing
 ac
ce
pta
ble
 to
 th
e p
ati
en
t, 7
) t
rad
e-o
ffs
 
tha
t m
igh
t b
e n
ec
ess
ary
 to
 ac
hie
ve
 di
ffe
ren
t o
utc
om
es 
an
d 8
) f
am
ily
 in
vo
lve
me
nt/
ch
oo
sin
g a
n a
pp
rop
ria
te 
su
rro
ga
te 
de
cis
ion
-m
ak
er.
 T
he
 ex
pe
rts
 su
gg
est
ed
 
sh
ort
en
ing
 th
e c
on
ve
rsa
tio
n g
uid
e t
o a
 on
e-p
ag
e t
op
ic 
lis
t. M
os
t e
xp
ert
s f
ou
nd
 a 
str
uc
tur
ed
 co
nv
ers
ati
on
 gu
ide
 us
efu
l to
 as
su
re 
the
 co
mp
let
ion
 of
 ke
y s
tep
s i
n 
the
 co
nv
ers
ati
on
s, 
bu
t e
mp
ha
siz
ed
 th
at 
it s
ho
uld
 be
 m
ad
e c
lea
r i
n t
he
 tra
ini
ng
 se
ssi
on
s t
ha
t th
e c
on
ve
rsa
tio
n g
uid
e s
ho
uld
 no
t b
e u
sed
 as
 a 
ch
ec
kli
st 
or 
sta
tic
 
scr
ipt
. 
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Co
mp
on
en
t 5
: A
 st
ru
ctu
re
d t
em
pla
te 
for
 do
cu
me
nt
ing
 th
e o
ut
co
me
s o
f t
he
 A
CP
 di
scu
ssi
on
s (
E)
 
Co
nt
en
t o
f t
he
 co
mp
on
en
t t
o o
ve
rc
om
e t
he
 ba
rr
ier
s a
nd
 en
ha
nc
e t
he
 fa
cil
ita
tor
s: 
• 
A 
str
uc
tur
ed
 t
em
pla
te 
wi
ll 
pro
vid
e 
the
 o
pp
ort
un
ity
 f
or 
rec
ord
ing
 p
ati
en
t 
pre
fer
en
ce
s, 
va
lue
s a
nd
 go
als
 of
 ca
re 
• 
Ins
tru
cti
on
s 
are
 p
rov
ide
d 
for
 G
Ps
 d
uri
ng
 t
he
 t
rai
nin
g 
to 
co
mm
un
ica
te 
thi
s 
do
cu
me
nt 
to 
oth
er 
inv
olv
ed
 h
ea
lth
 ca
re 
pro
fes
sio
na
ls 
(w
ith
 p
ati
en
t p
erm
iss
ion
). 
Th
ese
 in
str
uc
tio
ns
 ar
e a
lso
 be
 in
clu
de
d o
n t
he
 te
mp
lat
es.
  
• 
Pa
tie
nts
 ar
e e
nc
ou
rag
ed
 by
 th
e G
P t
o m
ak
e t
his
 do
cu
me
nt 
av
ail
ab
le 
for
 ot
he
r c
are
 
pro
vid
ers
 
Ba
rr
ier
s a
nd
 fa
cil
ita
tor
s t
ha
t a
re
 ad
dr
ess
ed
 by
 th
e c
om
po
ne
nt
: 
!
 
Di
ffi
cu
ltie
s i
n 
sh
ari
ng
 in
for
ma
tio
n 
ac
ros
s t
he
 h
ea
lth
 ca
re 
sy
ste
m 
wh
en
 p
ati
en
ts 
are
 ca
red
 fo
r b
y (
mu
ltip
le)
 sp
ec
ial
ist
s 
!
 
Un
ce
rta
int
y r
eg
ard
ing
 th
e t
ran
sfe
rab
ilit
y o
f A
CP
 in
for
ma
tio
n a
s t
he
re 
is 
no
 
co
ns
ist
en
t s
tan
da
rd 
for
 lo
ca
tio
n 
 Do
cu
me
nta
tio
n t
em
pla
tes
 w
ere
 de
ve
lop
ed
 th
at 
are
 st
an
da
rdi
sed
, s
im
ple
 an
d p
ati
en
t-f
rie
nd
ly 
an
d a
llo
w 
the
 op
po
rtu
nit
y t
o r
ec
ord
 an
d d
oc
um
en
t th
e o
utc
om
es 
of 
AC
P c
on
ve
rsa
tio
ns
. In
 th
e e
xp
ert
 pa
ne
ls 
co
ns
en
su
s w
as 
rea
ch
ed
 th
at 
the
 do
cu
me
nt 
sh
ou
ld 
be
 co
mp
lem
en
tar
y t
o a
n A
D 
an
d r
ec
ord
 ke
y i
nfo
rm
ati
on
 su
ch
 as
 th
e 
pa
tie
nt’
s v
alu
es 
an
d g
oa
ls,
 qu
ali
ty 
of 
lif
e, 
fea
rs 
an
d a
nx
iet
ies
, e
tc.
 to
 he
lp 
gu
ide
 co
mp
lex
 de
cis
ion
s. 
It w
as 
de
cid
ed
 th
at 
the
se 
do
cu
me
nta
tio
n t
em
pla
tes
 co
uld
 
fol
low
 th
e s
am
e s
tru
ctu
re 
as 
the
 co
nv
ers
ati
on
 gu
ide
. T
o i
mp
rov
e t
he
 ex
ch
an
ge
 of
 in
for
ma
tio
n a
bo
ut 
pa
tie
nt 
va
lue
s a
nd
 go
als
, in
str
uc
tio
ns
 ar
e a
lso
 pr
ov
ide
d f
or 
GP
s t
o c
om
mu
nic
ate
 th
ese
 do
cu
me
nts
 to
 ot
he
r i
nv
olv
ed
 he
alt
h c
are
 pr
ofe
ssi
on
als
 w
ith
 th
e p
ati
en
t’s
 pe
rm
iss
ion
, a
nd
 pa
tie
nts
 w
ill 
be
 en
co
ura
ge
d b
y t
he
 G
P t
o 
ma
ke
 th
ese
 do
cu
me
nts
 av
ail
ab
le 
to 
oth
er 
ca
re 
pro
vid
ers
. 
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